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Abstract 
Proteins are biochemical molecules that are essential for life processes. Their 
function is linked to their structure and so it follows an understanding of their 
structure will assist in an understanding of their function. The predominant method 
of solving protein structures is X-ray crystallography and for this a protein crystal is 
required. The process of obtaining a crystal is amongst the phases of the structure 
determination process with the highest rates of attrition. Analyses are performed 
throughout this thesis, which are intended to help improve output for this bottleneck. 
It has been possible to develop a method to determine pH using a spectrophotometer 
and acid-base indicator in an accurate, rapid and efficient manner. A method for 
predicting the pH of buffered solutions has also been developed and these predicted 
pH values are linked to the isoelectric point of a protein sequence. The isoelectric 
point is in turn used in classification, along with many other features, to determine a 
protein's propensity to crystallise. Finally, the most prevalent and successful 
chemical species in crystallisation are explored, compared and linked. These 
chemicals are used to design a new crystallisation screen. 
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1.  Introduction  
Proteins are biochemical molecules that underpin the processes essential for life 
(Jurisica et al., 2001). They are found in all life forms from viruses to animals, from 
bacteria to plants. They have numerous roles such as hormones, enzymes, 
transporters, receptors and regulators. The function of proteins is related to their 
structure (Wright & Dyson, 1999). For example, the globular protein haemoglobin 
surrounds oxygen atoms while transporting them through blood (Eaton et al., 1999) 
and the fibrous protein collagen provides the backbone for the connective tissues in 
the heart, tendons and cornea (Bolboaca & Jantschi, 2007). For the majority of 
proteins their structure is determined by their sequence (Anfinsen et al., 1961). Their 
sequence is in turn determined by RNA, which is transcribed from genes in DNA. 
 
It is also possible that, although the gene and protein sequence is transcribed 
correctly, the protein folds in a manner such that a different structure can be obtained 
from the same sequence. Such proteins are called prions. They can fold into a 
numerous conformations, some of which can be harmful inducing conformational 
change amongst other proteins and causing the diseases Creutzfeldt-Jakob’s Disease 
(CJD), scrapie and Bovine Spongiform Encephalopathy (BSE) (Pietzsch, 2002, NHS, 
2013). Proteins can also undergo post-translational modification (PTM), meaning 
their structure is modified in one of many ways, after the protein has been formed. 
An example of a PTM is the addition of ubiquitin to proteins. This addition is 
recognised by proteasomes, which in turn begin to degrade and recycle the protein. 
PTMs of the protein tau have been linked to Alzheimer’s disease (Gong et al., 2005). 
 
Structural Genomics seeks to determine the three-dimensional structure of proteins in 
order to understand their function and assist in developing drugs (Navia & Murcko, 
1992). It has been possible to determine the structures of many proteins related to 
drug development (Tickle et al., 1984) including that of haemoglobin (Perutz et al., 
1960). The Nobel Prize was awarded to the scientists who solved the structures of 
haemoglobin and in total, 24 Nobel Prizes have been awarded for efforts focused on 
determining the structure of proteins (Jaskolski et al., 2014).  
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The Protein Data Bank (PDB) is an open access online repository where information 
pertaining to the three-dimensional structure of macromolecules is stored (Berman et 
al., 2000). Along with the coordinates describing the atomic structure, each entry in 
the PDB includes variables such as the organism from which the protein was 
obtained, the protein sequence and the experimental method used to determine the 
structure. In April 2015 there were 100,032 protein structures in the PDB (PDB, 
2015) and the predominant method used to detemine their structure was X-ray 
crystallography (X-ray), the recorded method for 89,977 (89.7%) entries, as shown in 
Figure 1. Nuclear Magnetic Resonance (NMR) was to determine 9,559 (9.5%) 
structures and other methods were used for just 785 (0.8%) structures.  
 
 
Figure 1: Number of entries in the PDB by experimental method. 
In April 2015 the predominant method of protein structure determination was by X-ray, 
accounting for 89.7% of proteins in the PDB, with NMR accounting for 9.5% and other 
methods for 0.8%. 
 
Other methods for structure determination include electron microscopy (EM), the 
most prevalent of the other methods (Elands & Hax, 2004, Morikawa et al., 2015), 
electron crystallography (Yonekura et al., 2015) and electron paramagnetic 
resonance (Fleissner et al., 2009); fibre diffraction (Tewary et al., 2011) and neutron 
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diffraction (Coates et al., 2014); solution scattering (Wu et al., 2009); powder 
diffraction (Von Dreele et al., 2000) and hybrid methods (Howard et al., 2011). The 
number of structures solved using these methods has accounted for 0.5 to 2% of the 
structures deposited each year from 2004. 
 
The number of NMR solved structures has fallen in recent years. Of all the structures 
solved and deposited in the PDB in 2004, NMR was used for 14%. In 2014 it 
accounted for just 4%. Conversely, the number of X-ray solved structures is still 
growing. In 2004, it was used to determine 86% of structures and in 2014 this had 
increased to 94%. X-ray, however, is a much older method than the others, with the 
first X-ray diffraction of a crystal being achieved in 1913 (Bragg & Bragg, 1913), 
allowing for a century of refinement. The first NMR and EM entries were in 1986 
and 1997 respectively, compared to the first X-ray entry in 1971. This means NMR 
and EM are not currently advanced enough to be able to determine the structure of all 
proteins. NMR has limitations on the size of protein that can be used (Smialowski et 
al., 2006) and EM currently lacks powerful resolution (Milne et al., 2013). The 
limitation on size and resolution, coupled with the demand for protein complexes 
(Aloy & Russell, 2006) currently ensures the continued use of X-ray crystallography. 
As many of the recently deposited structures have a sequence similar to those 
previously determined by X-ray crystallography, there has been no reason to change 
the method. However, a major advantage of non-X-ray techniques is that they do not 
require a protein crystal and can be used in structure determination for proteins that 
cannot be crystallised (Elands & Hax, 2004). NMR can also provide dynamic 
information and is less destructive to a sample (McDermott, 2004). These techniques 
can be complementary to X-ray crystallography, with NMR used to determine the 
structures of small protein-binding structures and X-ray crystallography used to 
determine the larger protein structures (Jahnke & Widmer, 2004). 
 
In order to collect X-ray diffraction data it is essential to obtain suitable crystals via 
crystallisation. Before crystallisation, a protein has to be obtained. When a protein 
target is identified for which the structure is to be determined, the gene that encodes 
for the protein is cloned and then inserted into a vector within a host cell. The protein 
is then over-expressed to provide many copies, which are then extracted from the cell 
by several steps of purification that might include sonication, centrifugation (Lesley, 
  
22 
 
2001) and fast protein liquid chromatography (FPLC). The significance of the purity 
of a sample was raised by Kam et al. (1978) who suggested that impurity eventually 
makes further growth energetically unfavourable and therefore could influence the 
terminal size of a crystal. It has also been reported that crystal quality is positively 
correlated to protein purity (Ducruix & Giegé, 1992). In addition to the problem of 
whether impurities are detrimental to crystallisation, protein purity is important for 
the reproducibility of experiments (Lorber et al., 1993). If further buffers or additives 
are required to stabilise the protein these are added to create a protein solution ready 
for crystallisation. 
 
 
Figure 2: Methods of crystallisation recorded in the PDB. 
The predominant method of crystallisation in the PDB is vapour diffusion accounting for 
96.6% of entries, from a sample of 68,202 obtained in March 2015. 
 
Protein crystallisation was first referred to by Hünefeld in 1840, who crystallised 
earthworm haemoglobin. Hünefeld suggested that it was possible to obtain protein 
crystals through a method of controlled evaporation. In 1851, Fünke devised a 
reproducible method that involved the use of alcohol (the first use of organic solvent 
in crystallisation). Throughout the latter part of the 19
th
 century and the early 20
th
 
century crystallisation experiments were undertaken that incorporated many of the 
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chemical species used in crystallisation today. It was in the early 1930s when X-ray 
crystallographers began to look at protein crystals as a method of obtaining structural 
information about proteins (McPherson, 1991).  
 
There are several methods of crystallisation recorded in the PDB. Grouping these 
methods together into the broad categories described by Chayen and Saridakis (2008) 
it can be seen that the predominant method of crystallisation is vapour diffusion 
(Figure 2), accounting for 96.6% (65,870/68,202) (Bolanos-Garcia & Chayen, 2009).  
 
 
Figure 3: A schematic of vapour diffusion. 
Two methods of vapour diffusion, sitting and hanging drop. The different components of the 
setup are indicated by the following numbers: 
1. The mother liquor, a mixture of crystallisation chemicals. 
2. A mixture of the mother liquor and the protein for crystallisation. 
3. The system is sealed to allow vapour diffusion. 
 
 
Hanging Drop 
 
Sitting Drop 
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There are two predominant methods of vapour diffusion, either sitting drop or 
hanging drop, both shown in  
Figure 3. In a vapour diffusion experiment, chemicals used to promote crystallisation 
are mixed and this chemical cocktail, referred to as the crystallisation solution, is 
placed in a crystallisation well (a plastic container). Throughout this thesis the terms 
well, crystallisation solution and condition are used interchangeably. It should be 
noted that there are no standard names for various components of crystallisation 
experiments and as such they vary throughout the literature. A sample of this 
crystallisation solution is taken and combined, typically in a 1:1 ratio with the protein 
solution (Chirgadze, 2001). This mixture of protein and chemical cocktail is then 
offset from the reservoir containing the majority of the crystallisation solution either 
by hanging from a cover slip above (hanging drop) or by sitting in a smaller well 
(sitting drop). The system is then sealed using a water impervious barrier such as 
transparent pressure-sensitive tape. The solutions then equilibrate and the 
concentration of the components in the droplets changes over time. For an indication 
of scale, custom crystallisation experiments described throughout this thesis are 
 
Hanging Drop 
 
Sitting Drop 
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sitting drop where crystallisation solution is 80µl and from this 100nl is taken and 
mixed with 100nl of protein solution.  
 
Some of the lesser used methods to induce crystallisation include: microbatch, in 
which both protein and crystallisation solution are dispensed together under a layer 
of low density paraffin, silicone or a mixture of both; dialysis, in which a 
semipermeable membrane separates the protein and crystallisation solutions; free 
interface diffusion, in which protein and crystallisation solutions sit side by side; and 
microfluidics, which use much fewer nanolitres of protein and chemical solutions 
than standard experiments (Chayen & Saridakis, 2008). 
 
The physics of crystallisation dictate that for a crystal to form the protein solution 
must reach supersaturation via the diffusion process. In vapour diffusion this occurs 
by the evaporation of water from the sitting/hanging drop to the crystallisation 
solution in the reservoir, increasing the concentration within the drop. Too much 
supersaturation will result in precipitation, too little and nucleation will not occur. 
Once nucleation has occurred the protein solution needs to move into a metastable 
state where the growth of crystals can occur. This transition from nucleation to 
crystal growth is where the combined crystallisation parameters such as method, pH, 
precipitants and temperature have their effect (Asherie, 2004, DeLucas et al., 2003, 
Weber, 1997). 
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Figure 4: Attrition rates of the structure determination pipeline. 
The percentages on the right of the phase marker show the proportion of proteins that have 
passed each phased of the process. Those on the left of the arrow show the percentage drop 
in proteins from the previous phase. The data was obtained from TargetDB at 
http://sbkb.org/metrics/ in March 2015. 
 
Despite some understanding of the processes that control protein crystal growth, 
obtaining crystals from which a structure can be determined has the highest rate of 
attrition for any phase of the structure determination pipeline (Chayen, 2003). Just 
24% of those proteins that could crystallise become structures deposited in the PDB, 
as shown in Figure 4. The stage before this, from purification to crystallisation, is 
also challenging with roughly 1 in 2 (55%) proteins forming crystals. This step, 
 
100% 
74% 
36% 
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crystallisation, has been the stage with the highest rate of attrition over the past 
decade (Chayen, 2004, TargetDB, 2010) and is, therefore, described as a bottleneck 
in the protein structure determination process (Chayen and Saridakis (2008), D'Arcy 
(1994), Stevens (2000)).  
 
 
 
Figure 5: Parameters affecting crystallisation. 
Two different crystallisation experiments described in terms of three major parameters: (1) 
physical parameters - experiments performed at different altitude, both gravity, temperature 
and pressure effected; (2) chemical parameters - one solution (the upper) is red indicative of 
an acidic pH, the other solution (the lower) is blue indicative of a basic pH; (3) biochemical 
parameters - two different proteins, one longer than the other and at lower concentration. 
 
The parameters affecting a protein crystallisation experiment (shown in Figure 5) can 
be categorised into one of the following groups: (1) physical parameters, such as the 
temperature and method of experiment; (2) chemical parameters, such as the pH and 
the precipitant used; and (3) biochemical parameters, such as the isoelectric point and 
chemical modifications to the protein sample (McPherson, 1999). 
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Over time, each of the groups has been explored for ways of reducing the number of 
protein crystallisation experiments that do not result in a crystal. Physical parameters 
have been studied in collaboration with the North American Space Agency (NASA) 
and experiments have been performed in microgravity (Gilliland et al., 1996, CASIS, 
2013). Some researchers have explored the use of desiccation (Yin et al., 2010, Xie 
et al., 2012) and others have used computer simulations (Yoshizaki et al., 2004). 
Samudzi et al. (1992) found that most crystallisation experiments were either 
attempted at 3ºc or 21ºc with very little exploration of the temperatures in-between. 
They suggested that temperature needed to be studied further, as 86% of proteins 
display temperature dependence (Christopher et al., 1998). Nucleation is also 
dependent on temperature. A study of four temperatures with the protein SmFru-1,6-
P2ase showed that nucleation only occurs in a narrow range of concentrations at 15 
ºC, but this range increases at 30 ºC (Zhu et al., 2006). Physical parameters are 
arguably the most difficult and expensive to change and may require long term 
planning into infrastructure. The majority of experiments are presumably undertaken 
with constant gravity, pressure and similar amount of vibration. In data pertaining to 
crystallisation trials, unless physical parameters are the focus of the study, they are 
not recorded, therefore, physical parameters are not explored further here. 
 
Usually, there are multiples of 96 combinations of chemicals trialled at any given 
time, each combination in its own well. The collective term for these 96 wells is a 
screen. Although any number of conditions tested at the same time can be called a 
screen, 96 conditions is the number in commercially available screens. An early 
logical approach to screening employed the use of incomplete factorial design 
(Fisher, 1942). A set of conditions was selected that sampled the chemical parameter 
space in a ‘statistically effective manner’ (Carter & Carter, 1979). Following on from 
this other attempts have been made to effectively sample chemical parameter space 
by: searching a small region of chemical parameter space in detail (McPherson, 
1989b); sampling regions known to be favourable for crystal growth (Jancarik & 
Kim, 1991); systematically searching distinct regions of parameter space (Stura et 
al., 1992); focusing the selection of chemicals for particular proteins (Brzozowski & 
Walton, 2001); using minimal spanning set theory to obtain the theoretically most 
efficient screen (Kimber et al., 2003, Page et al., 2003); and including the use of 
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ligands and additives into a screen (Gorrec, 2009). All screens vary the chemical 
species, concentration and pH with the most successful crystallisation species 
including polyethylene glycol (PEG) of various molecular weights, salts and buffers 
(Fazio et al., 2014). Typically each screen is trialled with one protein, which is 
encompassed by the biochemical parameters. Chemical and biochemical parameters 
are explored in this thesis. 
 
There are those who argue that the protein is the most important variable 
(Longenecker et al., 2001) and that it is often overlooked (Dale et al., 2003). 
Researchers have sought to determine the structure of a protein solely from its 
sequence using only computational methods (Chou & Fasman, 1977, Baker & Sali, 
2001, Garnier et al., 1996); used protein properties, such as its hydropathy value 
(Kyte & Doolittle, 1982), to determine its propensity to crystallise (Smialowski et 
al., 2006, Overton & Barton, 2006, Jahandideh & Mahdavi, 2012) and those who 
have used such properties to determine under which conditions a protein will 
crystallise (Samudzi et al., 1992, Hennessy et al., 2000, Kantardjieff & Rupp, 2004). 
This thesis also considers the relationship between a protein’s physical properties and 
the likelihood of its crystallisation. 
1.1. Thesis Summary 
The difficulties surrounding crystallisation are due to the complex nature of the 
interactions between proteins and parameters such as pH, precipitants and 
temperature. Varying the conditions with numerous chemicals in combination makes 
the crystallisation parameter space exceptionally large and impossible to sample 
fully. Similarly, the number of properties which can be calculated for a protein 
sequence is also large, as there are many thousands of combinations of di- and tri-
peptide pairs (Charoenkwan et al., 2013). Fortunately, high-throughput structure 
determination generates lots of data that can be mined. Throughout this thesis we 
make use of data from several repositories to analyse protein crystallisation 
parameters. In those instances where data was not available, we created our own 
through experimentation. The datasets are described in detail in Chapter 2 and the 
methods used are outlined in Chapter 3. Using this data it has been possible to 
implement a new method of determining pH rapidly and accurately as described in 
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Chapter 4. In Chapter 5 a method to predict pH for buffered solutions is used to 
investigate a fiercely contested link between a protein's isoelectric point and the pH 
at which it crystallises. The use of predictors for determining a protein’s propensity 
to crystallise is challenged in Chapter 6. The most widely used chemicals and their 
combinations, which crystallise many proteins, are explored in Chapter 7 and used to 
design a new screen as described in Chapter 8. Finally, similarities in crystallisation 
parameter space are explored in Chapter 9 with the aim of reducing the search space. 
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2. Definitions and Data 
The following chapter defines acronyms and chemicals terms used throughout this 
thesis along with a detailed description of the four datasets used for analyses. The 
datasets were obtained from AstraZeneca, the Structural Genomics Consortium, the 
Protein Data Bank and a dataset produced following customised experiments. 
2.1. Abbreviations and Definitions 
AHA Alpha hydroxy acid. 
Anion  A negatively charged ion. 
AZ AstraZeneca (Alderley Park, Cheshire). 
Bis Tris Bis-(2-hydroxyethyl)imino-tris(hydroxymethyl)methane. 
BMCD Biological Macromolecule Crystallisation Database. 
CAPS N-Cyclohexyl-3-aminopro- panesulfonic acid. 
Cation A positively charged ion. 
Centrifugation The process of separating particles by weight or settling 
solids from a solution by using a centrifuge. 
Chromatography See HPLC. 
Construct ID (SGC) Identifies the specific sequence of amino acids that form a 
(section of a) protein. The construct ID is the same whether 
or not the sequence contains a purification tag, usually 
comprising of six histidines genetically engineered to the 
end of a sequence to assist in purification. 
Counterion  The ion that maintains electric neutrality. 
Divalent A molecule with a valence of two. 
DTT Dithiothreitol. 
Dynamic Light 
Scattering 
A technique that measures fluctuations in light intensity 
from a sample of proteins, which are assumed to be 
spherical. 
GRAVY Grand Average of Hydropathy. 
HCL Hydrogen chloride. 
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HEPES 2-(4-(2-Hydroxyethyl)-1- piperazinyl)ethanesulfonic Acid. 
HPLC High-Performance Liquid Chromatography is a technique 
in which samples are forced at high pressure through a 
matrix that binds to specific particles in the solution. 
LDA Linear Discriminant Analysis. 
MDS Multidimensional Scaling. 
MES 2-(N-morpholino)ethanesulfonic acid. 
MPD 2-methyl-2,4-pentanediol. 
PCA Principal Components Analysis. 
PCTP A broad range buffer system comprising propionic acid, 
cacodylate, bis-trispropane system. 
PDB Protein Data Bank. 
PEG Polyethylene glycol. 
pI Isoelectric point. 
Plate barcode (SGC) The identifier for a specific crystallisation plate in which a 
purified protein is screened. The plate barcode can be used 
to trace: the screen type (random/filter/grid/custom); the 
screen name (the particular sparse/filter screen used); the 
concentration of the protein; the temperature of the plate; 
any added compounds; whether the protein sample was 
fresh or frozen; the name of the crystallographer and the 
date of the experiment. 
Project (AZ) The target protein for which the structure is to be 
determined. All of the protein sequences within a project 
have a fixed percentage sequence similarity. A sequence 
may undergo more than one purification protocol. 
However, in most instances it is assumed that each new 
project relates to a new protein sequence. 
Purification ID 
(SGC) 
Each construct may be purified by more than one method 
and the purification ID identifies the particular method. A 
construct ID may be associated with multiple purification 
IDs. 
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SGC Structural Genomics Consortium (Oxford). 
TCEP Tris(2-carboxyethyl)phosphine. 
Tris 2-Amino-2-(hydroxymethyl)propane- 1,3-diol. 
 
2.2. The AstraZeneca Dataset 
In March 2012, AstraZeneca (AZ) provided a dataset associated with the 
crystallisation of macromolecules at their site at Alderley Park, Cheshire. The dataset 
contained information regarding 655,806 experiments (with each experiment relating 
to a well in a screen) from 26 screens and 163 projects. For each experiment, the 
dataset has several recorded fields, described in Table 1. 
 
Field Description 
Project ID An identifier of the protein 
Trial and Session IDs Identifier of relative time of 
experiment in relation to other 
experiments 
Matrix Name Identification of screen type 
Well ID Location of well within screen 
Annotation (Crystal Size and Type) Manually annotated outcome of 
experiment 
Chemical Name and Concentration Description of chemicals in the well 
Buffer pH The pH of the buffer component of 
the crystallisation solution (where 
applicable) 
 
Table 1: Summary of fields contained within the AZ dataset. 
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The data did not have any information on: 
 temperature of the experiment; 
 inclusion of ligands; 
 purification details; 
 protein sequence; 
 the final outcome of experiment- diffraction quality/structure solved. 
 
The screens for which the largest number of projects were trialled are five evolutions 
of a filter screen (a hybrid of grid and footprint screens, which are described in 
Chapter 8) named Filter 2, Filter 3, Filter 4, Filter 5 and Filter 6 and four generations 
of sparse matrix screens (random screening) named Sparse 0, Sparse 1, Sparse 2 and 
Sparse 3. Other screens were either custom screens or follow-up screens containing 
many experiments with no successful outcome (crystals) and only specific to a single 
project. The nine main screens together provide 87% (568,957 entries) of the total 
data covering 152 projects. Throughout this thesis, reference to the AZ dataset means 
the data from these nine screens. 
 
AstraZeneca Annotation York Scale 
Null, Clear 0 
Skin 1 
Precipitate 2 
Phase 3 
Urchin 4 
Plate, Needle, Leaf 5 
Pyramid, Hexagon, Block 6 
 
Table 2: New annotation of crystallisation results. 
The AstraZeneca annotation is given by a crystallographer. On receiving the data the 
annotations were grouped and assigned a number (York Scale). 
 
The outcome of each crystallisation experiment was scored as shown in Table 2. This 
allowed the number of classes to be reduced so that each class had more examples. In 
this classification system an experiment with a score ≥ 4 is considered to be a 
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successful experiment (crystalline/crystal) and conversely those  4 are considered to 
be a fail. 
2.3. The Structural Genomics Consortium Dataset 
Data was also obtained from the Structural Genomics Consortium (SGC), Oxford in 
November 2012. In its entirety it relates to 62,605 construct IDs, for which there are 
17,591 purification IDs and 54,383 plate barcodes. In total, 608 structures have been 
solved and PDB IDs obtained. The relationships between the terms construct ID, 
purification ID and plate barcode are shown in Figure 6. Descriptive metadata 
includes information pertaining to protein families of proteins, protein sequences, 
purification methods, crystallisation conditions and whether a solved structure has 
been deposited in the PDB.  
 
 
 
Figure 6: Structure of SGC data. 
Each construct ID can be mapped to several purification IDs which in turn can be mapped to 
multiple plate barcodes. This is because a construct can undergo several different 
purification processes and the purified protein then trialled tested in various screens, 
differing in factors such as temperature or whether the protein sample is fresh or has been 
frozen. 
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Figure 7: Entity relationship diagram for SGC data. 
Table headers indicate the stage of the structure determination process; bullet points show 
examples of field names for which there is a record. 
 
Figure 7 shows examples of the data fields in the SGC dataset for each phase of the 
structural determination process. Data analysis was restricted to one screen, SGC 
JCSG +4, which is a sparse (random) matrix screen used to identify regions of 
parameter space under which a protein is likely to crystallise. Successful regions can 
then be searched more rigorously using follow up screens. Analysis was performed 
on this screen because it was the most prevalent screen in the SGC database with 
9,608 plate barcodes associated with 4,154 purification IDs and 2,553 construct IDs 
and. In total, 69 structures have been deposited in the PDB using crystals produced in 
this screen with at least a further 32 from follow-up screens. Each successful 
experiment was annotated as crystal (possibly salt), a protein crystal (as determined 
by X-ray), any crystal diffracting to more than 3.6 Å or as the highest quality- 
structure determined. 
2.4. Crystallisation Conditions from the PDB 
The final dataset used was a snapshot of the PDB. Each PDB ID in the standardised 
PDB snapshot (obtained from Fazio et al. (2014)) has an associated protein sequence 
and components of the crystallisation solution. After removing a number of 
potentially malformed entries, the number of PDB IDs was reduced to 60,999 (97% 
of the original data) to form a dataset referred to as PDB-RAW. Some proteins have 
been deposited in the PDB many times with different ligands, modifications or 
crystallisation space groups. For example, hen egg white lysozyme (Gallus gallus 
lysozyme) alone currently has an associated 460 X-ray structures. We also 
considered the data at different levels of redundancy. The similarity of protein 
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sequences was assessed using BLAST (Madden, 2012) and only one representative 
sequence from any sequence grouped as similar (using a p-value of 10
7
) was 
included in the PDB-UNIQUE dataset (Figure 8). This dataset comprises 37,249 
non-redundant PDB entries. A second dataset, referred to as PDB-BLAST, consists 
of entries from PDB-RAW grouped according the BLAST analysis. This dataset has 
8,958 groups with between one and 2115 (for kinase) similar sequences in each 
group, giving 59,734 entries in total. After removing duplicate entries with the same 
experimental conditions for the same protein (but keeping all entries for the same 
protein where experimental conditions differ), the PDB-BLAST dataset was reduced 
to 44,063 PDB entries. 
 
 
  
Figure 8: Data structure of the PDB snapshot. 
The structure of data used for different types of analysis showing the number of PDB entries 
in the various data subsets. 
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2.5. Custom Crystallisation Experiments 
Protein Source* 
Concentration 
(mg/ml
-1
)
 
Buffer 
Solution 
Protease K212A h 13 1 
Protease K234A h 13.4 1 
Protease K249A h 12.1 1 
ProteaseE171A h 13.2 1 
Concanavalin A s 15 2 
Bovine Catalase s 15 2 
Porcine Trypsin s 31 2 
Thaumatin s 50 2 
α- Chymo A s 15 2 
Galine Lysozyme s 20 2 
Glycolytic A h 30.1 3 
Glycolytic D h 21.9 3 
Glycolytic wt h 9.8 3 
Kinase 1 h 12.2 4 
(a) Proteins used for crystallisation. 
 
1 
20 mM MES, 5mM calcium chloride, 5 mM DTT, 100mM sodium chloride, 300 
mM AHA, pH 6.5 
2 10mM PCTP, 100 mM sodium chloride, 0.5mM TCEP, pH 7.6 
3 20 mM TRIS HCL , 150 sodium chloride, 2mM TCEP, pH 7.5 
4 10 mM TRIS, 50 mM sodium chloride, 1mM DTT, 50 µM zinc acetate, pH 7.5 
(b) Buffer solutions used with the proteins named in (a). 
h In-house 
s Sigma 
 
Table 3: Custom protein solution details. 
Protein solution details for the commercially available and in-house protein targets that were 
screened are shown in (a) with buffer solution details in (b). 
 
Commercial proteins were obtained from Sigma-Aldrich and were buffered at pH 7.6. In-
house proteins were also buffered at near neutral pH (either pH 6.5 or pH 7.5). For each 
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experiment, 80μl of crystallisation solution was dispensed using a Thermo Scientific Matrix 
Hydra II robot. Frozen protein samples were defrosted to room temperature before using a 
Mosquito pipetting robot (TTP Labtech) to dispense 1μl protein with 1μl of the mother 
liquor in MRC Wilden crystallisation trays. Trays were sealed manually using transparent, 
pressure-sensitive adhesive tape (Hampton) and stored in a Formulatrix Rock Imager hotel at 
20° C. All images were assessed for crystallisation after 21 days.  
2.6. Discussion 
One problem with crystallisation data is that it is the result of a high-throughput 
process and the determination of a protein structure is its goal. This means that scores 
assigned to images of crystallisation wells, manually, are likely to be targeted at the 
most promising wells. If the first well scored contains a perfect crystal with good 
diffraction it is of little interest to the crystallographer what happens in the rest of the 
wells. This then creates the illusion that protein x is one that is a poor crystalliser (in 
terms of the number of wells) or that the protein was only tested in a certain set of 
wells (range of conditions). This latter event is observable in the AZ dataset. Thus, 
for certain analyses only projects (proteins) that have a score recorded for every well 
of a screen are included. If a crystallographer scores every image, with each image 
being of a well of a crystallisation screen, they introduce their own opinion and bias 
on whether the precipitate is light or heavy or whether the well contains a crystal or 
just something that shines (such as skin (denatured protein) or cellophane). In an 
attempt to reduce this bias, we reduced the number of annotations in the AZ data to 
create the York Scale. Upon creation this was an incremental scale, with 6 suggesting 
a better crystal than 5 and so on. However, in the analysis that followed, most of the 
results are reported as if the York Scale was binary, either crystal or non-crystal. For 
SGC data and PDB data the results of diffraction provided objective evidence that 
crystals were formed in certain conditions. In our own custom dataset we used the 
binary system of crystal or non-crystal. These were scored images and the images 
were taken after 21-days from creation of the experiment. In this time it is possible 
that crystals were formed and dissolved, however, this aspect of crystallisation was 
not explored. 
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3. Methods 
Machine learning and data mining methods are used to simplify data, recognise 
patterns and provide statistical evidence in support of hypotheses. A general 
overview of the methods used within this work is given here along with an indication 
of which methods were used in the specific analyses described. 
3.1. Cluster Analysis 
Clustering is a method of grouping similar objects together based on characteristic 
properties. In Chapter 9 the objects are crystallisation conditions and their similarity 
is determined by which proteins they crystallise.  
 
 Protein 
Condition u v w x y z 
R ♦ ♦   ♦  
S  ♦ ♦ ♦   
transformation into vector form 
Vector       
R 1 1 0 0 1 0 
S 0 1 1 1 0 0 
 
♦ Crystal 
 
Figure 9: Transforming from experiments to vector form. 
The top table shows the results for six proteins (u, v, w, x, y and z) in two different 
crystallisation conditions (R and S), where the diamonds indicate successful crystallisation. 
The results are transformed to give two binary vectors, in which a 1 indicates successful 
crystallisation and 0 indicates a failed experiment. 
 
Figure 9 shows how the results of a crystallisation experiment are transcribed into 
vector form for clustering. A binary vector of length n is obtained for each 
crystallisation condition tested, where n is the number of proteins trialled. The ith 
element of the jth vector is populated with a one if the ith protein crystallised in the 
jth condition and a zero otherwise. In the example shown in Figure 9, condition R 
crystallised proteins u, v and y and is used to define the object R in the form of a 
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vector [1, 1, 0, 0, 1, 0]. Once such vectors have been generated it is then possible to 
measure their similarity. 
 
There are many different distance metrics available for quantitative data and at least 
12 specific to binary data (Cox & Cox, 2010). It is, therefore, an informed trial and 
error process to decide which measure best reflects the data. In this thesis, the 
Hamming distance, the Jaccard distance and the Euclidean distance are used. The 
first two are measures developed for binary data. 
3.1.1. Binary Distance Measures  
For objects that are defined by binary vectors, the distance between two objects is 
calculated by combining the differences between corresponding elements in the two 
vectors. Figure 10 shows how the number of matched and mismatched elements can 
be counted. Distance metrics for binary data differ in the weight given to the matches 
and mismatches, for example the number of 1 - 1 matches may be considered more 
important than the number of 0 - 0 matches. 
 
  Object S  
  1 0  
O
b
je
ct
 R
 1 a b a + b 
0 c d c + d 
  a + c a + d N = a + b + c + d 
  
Figure 10: The relationship between two objects in binary form. 
The elements of the objects, R and S, can either take the form 1 or 0, as previously shown in 
Figure 9. The value a is a count of where there is a 1 in the same position in R and S. 
Similarly, b is are a count of where there is 1 in R and 0 is S, c is a count of 0 in R and 1 in 
S, and d is a count of where there is a 0 in the same position in both objects (Cox & Cox, 
2010). N is the sum of all the terms, which is the same as the number of elements in the 
objects. This requires both objects to be defined by a vector of the same number of elements. 
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With a, b, c and d defined as in Figure 11, the Hamming distance, H, between R and 
S is defined as: 
 
 
The Hamming distance counts the number of mismatches, i.e. the elements that are 1 
in object R and 0 in the same position in object S, or 0 for R and 1 for S. If all 
elements for both objects are identical then the Hamming distance will be 0, whereas 
if all elements of S are different in R then the distance will be 1. Figure 11 shows the 
terms that each element pair contributes to for an example in which a = 1, b = 2, c = 
2 and d = 1 so that N = a + b + c + d = 6 and the Hamming distance is 0.66. 
 
Object       
R 1 1 0 0 1 0 
S 0 1 1 1 0 0 
Hamming 
Term 
b a c c b d 
 
 (   )   
   
       
      ̇ 
 
Figure 11: Example Hamming distance calculation. 
The Hamming distance between objects R and S is 0.66. This is based on a count of 2 for 
term b plus a count of 2 for term c, divided by the total number of elements in the objects, 6. 
 
As protein crystallisation experiments are much more likely to fail than to result in 
crystals, the data is negatively biased and therefore comparison of conditions using 
the Hamming distance shows two conditions to be highly similar if both fail to 
crystallise the same proteins, which will often happen. Although this provides 
information, it obscures the desired identification of conditions that crystallise the 
same proteins. Use of the Jaccard distance compensates for the effect of negative 
bias.   
 
 
 
  (   )   
   
       
 
   
 
 1 
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The Jaccard distance, J, between objects R and S is defined as: 
 
 
Equation 2 shows that the Jaccard distance, in which two failed experiments (zero 
outcomes) d are not considered and avoids problems caused by negative bias (Cox & 
Cox, 2010, Teknomo, 2006). An example of the Jaccard distance is shown in Figure 
12 using the crystallisation results from Figure 9. 
 
Object       
R 1 1 0 0 1 0 
S 0 1 1 1 0 0 
Jaccard 
Term 
b a c c b d 
 
 (   )   
   
     
      
 
Figure 12: Example Jaccard distance calculation. 
The Jaccard distance between objects R and S is 0.8. This is based on a count of 2 for 
term b plus a count of 2 for term c, divided by the total number of pairs which 
contain a 1.  
3.1.2. The Euclidean Distance 
The Euclidean distance is perhaps the most widely used distance metric and 
measures the distance between two objects as a straight line 'as the crow flies'. The 
Euclidean distance, E, between objects R and S is defined as: 
 
 
where Ri, Si are the ith elements of the n-dimensional feature vectors R and S, which 
may be real numbers but can also binary variables. In Chapter 5 quantifiable features 
   (   )  
   
     
 2 
  (   )  |   |  √∑|     | 
 
   
 3 
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are calculated from protein sequences and the use of clustering to predict crystal 
quality is investigated. An example of the Euclidean distance is shown in Figure 13 
using the crystallisation results from Figure 9. 
 
Object       
R 1 1 0 0 1 0 
S 0 1 1 1 0 0 
|     |
  1 0 1 1 1 0 
 
 (   )   √     
 
Figure 13: Example Euclidean distance calculation. 
The Euclidean distance between objects R and S is 2. This is based on the square root 
of the sum of distances between each element of the objects 
3.1.3. K-means Clustering 
The aforementioned metrics allow the distance between objects to be quantified. K-
means clustering provides a method to group n objects into k clusters based on their 
similarity, where k is a number to be specified by the user. The process for this 
grouping is as follows (MacQueen, 1967): 
 
1. Randomly place k points throughout parameter space, to represent cluster centres. 
2. Assign each object to its nearest cluster centre. 
3. Redefine the cluster centre as the average of all the objects in that cluster. 
4. Repeat steps 2 and 3 until convergence. 
 
In Chapter 5 k-means clustering, implemented in the R programming environment (R 
Core Team, 2012), is used to determine whether four groups of proteins cluster, 
based on 13 properties calculated from their sequence. Here, the Euclidean distance 
metric is used with k = 4.  
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3.1.4. Hierarchical Clustering 
Hierarchical clustering is another method of grouping n objects based on their 
distance from each other. Hierarchical clustering can be agglomerative or divisive. In 
agglomerative clustering every object is initially considered as an individual cluster 
and clusters are gradually combined according to their similarity until all objects 
belong to a single cluster. Divisive clustering on the other hand begins with all 
objects in a single cluster and continues to divide clusters until all objects are 
considered as separate clusters. The process of agglomerative clustering is as follows 
(Johnson, 1967): 
 
1. Assign each object to an individual cluster, giving n clusters. 
2. Calculate the distance matrix between all pairs of clusters. 
3. Group the two clusters with the smallest distance, giving one less cluster. 
4. Calculate the distance between the new cluster (step 3) and all other clusters. 
5. Repeat steps 2 to 4 until all objects belong to the same cluster. 
 
 
Figure 14: An example dendrogram. 
The dendrogram shows the hierarchical clustering of six objects. Here, objects 4 and 6 were 
the first two to be clustered; object 5 then joined this cluster, followed by object 3. Objects 1 
and 2 formed a new cluster that finally joined the cluster with the other four objects. 
Object 1 Object 2 
Object 3 
Object 5 
Object 4 Object 6 
H
ei
g
h
t 
Well 1 Well 2 
Well 3 
Well 5 
Well 4 Well 6 
H
ei
g
h
t 
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Hierarchical clustering can be viewed graphically by means of a dendrogram, in 
which the heights at which clusters are joined are proportional to the distances 
between the clusters, as shown in Figure 14. Hierarchical clustering and dendrograms 
are used Chapter 9, to compare the representation of differences between 
crystallisation conditions given by C6 distance metric against experimental data. 
 
Both k-means and hierarchical clustering can be varied by choosing different 
distance metrics and which point in a cluster is considered to be representative of that 
cluster to define the distance between clusters (the linkage criteria). The average 
linkage method used in this thesis calculates the distance between two clusters as the 
average distance between each object in one cluster to every object in the other 
cluster. 
3.2. Eigenpairs 
A number of multivariate methods, including Principal Components Analysis and 
Linear Discriminant Analysis, described in the next sections, rely on the use of 
eigenvectors and eigenvalues. Eigenvectors are the vectors that undergo no 
transformation, other than scaling, when multiplied by a matrix. They are defined in 
the following way: let M be an n x n square matrix, and let e be a column vector of 
length n. Then the constant   is an eigenvalue of M, with corresponding eigenvector, 
e, if Me =  e. The eigenvector and corresponding eigenvalue together are referred to 
as an eigenpair. Eigenpairs are obtained from square matrices and are typically found 
using iterative computational methods. A matrix of orthonormal vectors (unit vectors 
that are perpendicular to one another) is representative of a rotation in Euclidean 
space and therefore can be used as a data transformation matrix  
3.2.1. Principal Components Analysis 
Principal Components Analysis (PCA) is a technique that uses eigenpairs for data 
reduction and visualisation of a feature matrix, X. A new coordinate system, P, is 
obtained by a rotation that maximises that variance in the first few dimensions and is 
achieved by finding the eigenvectors, A, of the data covariance matrix. The 
eigenvector with the largest eigenvalue is referred to as the first principal component 
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and gives the direction in the data with the largest variation. The second principal 
component is orthogonal to the first and is the eigenvector with the second highest 
eigenvalue, giving the direction in which there is most variation not already 
accounted for by the first eigenvector and so on (Rajaraman & Ullman, 2012). For 
dimensionality reduction only those eigenvectors with eigenvalues of ‘significant’ 
size are used. The number of eigenvectors may be chosen according the proportion 
of the total variance accounted for, but the choice is subjective and a number of 
different rules of thumb exist (Valle et al., 1999). While removing eigenvalues and 
their respective eigenvectors results in a loss of some information,  , this is 
minimised by ensuring that most of the variance in the data is in the first few 
components.  
 
A data matrix X with n observations with m features, transformed by k principal 
components can be written as 
 
 
where, P is a n × k matrix of the transformed data, or scores, A is a k × m matrix of 
the eigenvectors, or loadings and   is the n × m matrix of residuals when k < n. In 
Chapter 5, the PCA scores are used for visualisation to determine any grouping of 
proteins according to 13 calculated protein features, m = 13 and k = 2. Protein 
properties are also used in Chapter 6 in the classification of proteins that can and 
cannot be crystallised. PCA was employed in order to reduce the set of properties, m 
= 87, before use in for machine learning algorithms. A review of dimensionality 
reduction techniques in 2009, found that PCA could not be outperformed by non-
linear techniques (Van der Maaten et al., 2009). PCA was implemented in the R 
programming environment using the prcomp function (Zurich, 2012, R Core Team, 
2012).  
3.2.2. Linear Discriminant Analysis 
Linear Discriminant Analysis (LDA) is a linear classification method that attempts to 
maximise the separation between classes. Good separation is found when the 
         4 
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difference between the class mean and the grand mean (mean over all classes) is 
large compared to the standard deviation of a class.  
 
For a two-class system, the Fisher linear discriminant function achieves this by 
maximising the function 
 
 
where   ̃ and  ̃ 
  denote the projected mean and variation of class i and   is the 
vector of coefficients, or loadings, in the linear discriminant function. The function 
J( ) is maximised by maximising the difference between the projected group means 
whilst minimising the projected within group variance. The vector of coefficients   
determines the first linear discriminant function and is one-dimensional projection 
that gives maximal separation between groups. A second discriminant function can 
be obtained that separate the groups in a way that has not already been exploited by 
the first discriminant function. In general, the kth discriminant function Dk 
is chosen 
so that the within-groups covariance between this and each of D1,..., Dk-1 
is zero. Test 
data is transformed using the loadings derived from the training data and the 
transformed points are assigned to the class with the mean closest to them 
(Balakrishnama & Ganapathiraju, 1998).  
 
LDA was employed in Chapter 6 to separate crystallisable and non-crystallisable 
proteins, based on calculated properties. The LDA loadings allow the features that 
are important for class separation to be identified. LDA was implemented in R using 
the lda (Zurich). 
3.3. Feed Forward Neural Network 
An artificial neural network (ANN), such as that indicated by the schematic in Figure 
15, is a machine learning technique inspired by the neurons of the brain. They work 
by being trained to associate particular outputs with particular inputs. Weighted input 
features are combined and the output determined by a transfer function in a threshold 
unit (layer 1). The output values from one layer are then input to the next layer (layer 
  ( )  
( ̃   ̃ )
 
 ̃ 
   ̃ 
  5 
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2 or 3) or output for the user (layer 3). During training if the output is incorrect the 
weights on the network are amended to improve the output. For example, the new 
weight, wnew for a single neuron is defined as: 
           (   )  6 
 
where wold is the weight prior to output, t is the target output, a is the actual output 
and x is the feature associated with that neuron. 
 
There are many types of neural network, with different numbers of layers, training 
functions and transfer functions. The type of network employed in this thesis is a 
feed-forward perceptron network, an example of which is as shown in Figure 15, in 
which each layer passes information to the next. The threshold units in the hidden 
layers are tangent sigmoid functions, where the weighted input is converted by a 
tangent function limited between      and in the final layer is a linear output, 
which, for classification, determines the class. The training method used is the 
Levenberg-Marquardt backpropagation method. This method is designed to train a 
network in a time efficient manner (MathWorks, 2011) by reducing the weights on 
the nodes in proportion to the size of the error (Beale & Jackson, 1990, Hagan & 
Menhaj, 1994).  
 
 
 
Figure 15: A schematic of an artificial neural network. 
An example of a multi-layered perceptron for classification with three layers: two layers 
each with two tangent-sigmoid threshold units and a third layer with a single node giving the 
output. 
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In Chapter 6 a three-layered perceptron is used to classify proteins into crystallisable 
and non-crystallisable, whereas in Chapter 5 a simpler network is used with just one 
layer consisting of 5 nodes. This network is used to predict the pH of crystallisation 
conditions. Neural networks have been shown to be as good as other machine 
learning techniques for classification (Nookala et al., 2013). Neural networks were 
implemented using the Matlab neural network toolbox (MathWorks, 2011). 
3.4. Measuring the Performance of Classifiers 
Determining the success of a classifier requires a metric to measure its performance. 
For Chapter 6 the accuracy is based on the true positives (TP) and the true negatives 
(TN), which here are the number of proteins correctly predicted as crystallisable and 
non-crystallisable respectively, and the false positives (FP) and false negatives (FN), 
here the number of proteins incorrectly predicted as crystallisable and non-
crystallisable respectively. These terms are combined, as follows, to give a measure 
of accuracy as the percentage of correct classifications: 
 
          ( )  
     
           
     7 
3.5. Pearson's Product-Moment Correlation 
The correlation coefficient measures the linear relationship between pairs of 
observations (coordinates) within two variables (x and y). It is obtained by using a 
measure of the deviation of all the points away from the straight line       . 
The coefficient gives a value between 1 and -1, where 1 indicates perfect positive 
correlation; as variable x increases, so does variable y; and -1 indicates perfect 
negative correlation, as variable x increases, variable y decreases. A value of zero 
indicates no linear link between variable x and y. Pearson's Product-Moment 
Correlation, used in this thesis, can be computed using the following equation: 
 
    
∑(   ̅)(   ̅)
√∑(   ̅) (   ̅) 
 8 
 
where  ̅,  ̅ are the means of the populations x and y.  
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The significance of the correlation coefficient can be determined to show whether the 
coefficient is different enough from zero to suggest a relationship. The T statistic  
 
    √
   
    
 9 
 
where r is the correlation coefficient (Equation 8) and n is the number of pairs of 
observations. T is then compared to critical values for a t- distribution (with n-2 
degrees of freedom) in order to determine whether the null hypothesis (there is no 
relationship) should be rejected. In Chapter 4 the correlation coefficient is used to 
indicate the relationship between pH measured with a meter and that obtained by 
spectrophotometry.  
3.6. Regression Analysis 
A regression model shows the relationship of a dependent variable with one or more 
predictor variables. The simplest regression model is a linear relationship between 
one input (predictor variable) and one output (the dependent variable) and is of the 
general form: 
 
  ̂           10 
 
where  ̂ is the modelled dependent variable, β0 is a regression coefficient with no 
predictor variable, β1 is the regression coefficient effecting the predictor variable, X1. 
The model can be extended to include numerous predictor variables, with the general 
form: 
 
  ̂                       11 
 
where the values for βn are obtained so that sum of the squared error between the y 
(observed) and  ̂ (modelled) is minimised. Analysis of the residuals  y-y   can show 
whether the relationship between the predictor variables and the dependent variables 
is nonlinear. The model should have residuals that are independent and form a 
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normal distribution, suggesting that the model is not biased towards particular points. 
If this is not the case, it may be possible to transform the data, by algebraic 
manipulation, so that it is in a linear form.  
3.7. Normality and Significance 
3.7.1. Determining Normality 
Probability plots are used to compare the distributions of two samples. Observed data 
is compared to a theoretical normal distribution that has been generated using the 
observed mean and standard deviation. The quantiles of these two distributions are 
plotted against each other and the closer to the line y = x the distribution is, the more 
similar the distributions. The assessment of this plot is performed manually. 
Probability plotting is performed in R using the functions qqnorm and qqplot from 
the statistics package (R Core Team, 2012). 
 
An extension of this is the Kolmogorov-Smirnov (KS) test, which compares the 
observed distribution to a theoretical distribution with the same mean and standard 
deviation. The largest vertical distance (y-axis) between the two distributions 
(supremum) for any given input (x-axis) provides the statistic, Dmax. This can be 
compared to Dcrit , given by  
 
       
    
√ 
 12 
 
where n is the average sample size of the two distributions, to test the null hypothesis 
that the two distributions are the same. In this thesis n is the same size for both the 
observed and the theoretical normal distribution. KS tests are performed in R, using 
ks.test to compare observed data to a normal distribution (R Core Team, 2012). 
3.7.2. Mann-Whitney-Wilcoxon Test 
The Mann-Whitney-Wilcoxon (MWW) test is a non-parametric test for the 
comparison of two samples, an analogue of the parametric unpaired t-test in which 
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no assumptions about the distribution of the data are required. The MWW ranks the 
observations in the two samples and then calculates the statistic 
 
        
  (    )
 
    13 
 
where n1, n2 are the sample sizes and R1 is the sum of the ranks for the sample with 
the greatest rank sum. U is compared to a critical value to determine whether the null 
hypothesis, that there is no difference between the samples, should be rejected. 
MWW tests are performed in R using the command wilcox.test (R Core Team, 2012) 
3.7.3. Binomial Distribution 
To determine the significance of a binary system, a binomial distribution is required. 
In Chapter 6 a neural network is used to classify protein sequences into crystallisable 
or non-crystallisable. As there are only two options, randomly classifying them 
would result an accuracy of ~50%. A binomial distribution provides a guide to what 
percentage accuracy could have occurred by random chance, depending on the 
sample size, n.  
 
The mean of the binomial distribution can be defined as: 
      14 
and the standard deviation as 
   √(  (   ) 15 
 
where p is the probability of an event being successful. 
 
A sample of 100 sequences with each having probability of 0.5 of being classified 
correctly, would create a distribution (near normal) with a mean accuracy of 50%, 
with a standard deviation of 5%. Assuming that 95% of the data is within 2 standard 
deviations either side of the mean, it is possible to say that any classification with 
40% - 60% could have occurred by chance alone. 
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3.8. Proportional Error 
Proportional error is a measure of the deviation from the true value of a proportional 
success rate, as defined in Equation 16 .  
 
 
The error is dependent on the probability of success, p divided by the number of 
observations, n, therefore, the greater the number of observations the smaller the 
error. It is used in Chapter 7 to provide a margin of error on the success of chemical 
species relative to the number of times they had been trialled. 
3.9. Cross Validation  
Cross validation is a method used in the training and testing of datasets to ensure that 
by chance the random selection originally made does not, in some way, bias the 
results. Here, one quarter of the data was used for training, with the remaining three-
quarters reserved for testing. The training set was then replaced and the process 
repeated four times, as shown in Figure 16. 
 
1 Training Testing Training Testing 
2 Testing Training Training Testing 
3 Testing Testing Training Testing 
4 Testing Testing Testing Training 
 
Figure 16: Venetian blinds cross validation. 
Over 4 iterations 25% of the data is removed for training, the remaining 75% is used for 
testing. The data is then replaced and the next 25% removed and the process is repeated. 
 
 
 
 
 
   √
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4. Determination of pH Using 
Spectrophotometry 
In protein crystallisation, important parameters include the chemical type and 
concentration along with its ionic strength, the inclusion of heavy metals, the purity 
of the reagents and the pH. The pH of the experiment is often a critical parameter. 
Proteins are solubilised, stabilised and crystallised in a specific range of pH 
(McPherson, 1989a, Newman, Sayle, et al., 2012). Crystallisation screens are 
designed to sample pH as well as other parameters such as salts, precipitants and 
other additives in order to find conditions giving initial crystallisation hits. 
Optimisation of the conditions is achieved by finer sampling of the parameter space 
around these initial hits (Jancarik & Kim, 1991, Luft et al., 2003, Luft et al., 2011). 
For successful optimisation it is essential that the properties of the original conditions 
are accurately known and reproduced. The pH of a particular solution is often quoted 
as the pH of the buffer used but this can be highly inaccurate due to the effect of 
other components in the mixture. This is particularly true for high concentrations of 
the salts of weak acids and to a lesser extent any molecule which affects the 
hydrogen ion activity (Kohlmann, 2003). Furthermore, the pH of stock chemicals is 
known to change over time due to chemical decomposition (Bukrinsky & Poulsen, 
2001). As a consequence simply knowing the components of a solution does not 
mean that the resultant pH will always be the same.It has been shown that the actual 
pH of crystallisation conditions can be as much as four pH units away from that of 
the buffer (Newman, Sayle, et al., 2012, Wooh et al., 2003). Figure 17 shows pH 
measurements from 84 crystallisation solutions (conditions) of a custom sparse 
matrix screen, NPCF_4, used at the Collaborative Crystallisation Centre (C3), 
Australia (Newman, Sayle, et al., 2012). The pH of each set of conditions was 
recorded both as the pH of the buffer and as determined using a pH meter. It can be 
seen that most solutions, 73% (61/84), have an actual pH within 0.5 pH units of the 
buffer pH, although 18% (15/84) are between 0.5 and 1 pH units away from the 
buffer pH and 10% (8/84) are over one unit away. 
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Accurate measurement of the properties of conditions is particularly important for 
crystallographers making up their own crystallisation screens. Stock chemicals that 
are prepared or labelled incorrectly or simply placed in an incorrect location in the 
robotic system will be incorporated into screens unnoticed. This can be particularly 
damaging if the chemical is a buffer stock that is included in multiple conditions. 
Although a well-calibrated and well-maintained pH meter can be used to measure 
acidity accurately, it is time consuming and impractical as the solution may also 
require reformatting to accommodate the probe.  
 
 
Figure 17: Measured pH in relation to recorded pH of buffer. 
The buffer pH in comparison to pH measured with a meter for 84 conditions from the 
NPCF_4 sparse matrix crystallisation screen. The data was obtained from supplementary 
information in Newman et al. (2012). Differences between buffer pH and meter pH of <0.5, 
between 0.5 and 1; and >1 are indicated by circles, triangles and squares respectively. 
 
Newman, Sayle, et al. (2012) describe a method for high-throughput measurement of 
pH using the indicator dye Yamada Universal Indicator together with automated 
imaging. The colour information of a dyed crystallisation solution was recorded as a 
single hue obtained from an image of a region of the well. This hue value is 
compared to those obtained for standards prepared from broad-range buffer systems 
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to provide an estimate for the true pH of the solution. For structural genomics centres 
and other laboratories with automated imaging systems in place, the method provides 
a fast, low-cost pH assay with a strong correlation to measurements obtained with a 
pH meter over the pH range 4.0 to 10.5. The need for a suitable imaging system that 
will provide consistent reproducible results, however, makes the method unfeasible 
for many laboratories. Furthermore, Newman, Sayle, et al. (2012) found little 
variation in colour within pH 5.5 to 7.0, a range common in crystallisation trials. 
Although recognising the limitation of UI, they point out the difficulty in producing 
dyes with good discriminatory power over a wide pH range. 
 
In this chapter a method to estimate the final pH of a crystallisation solution is 
described that does not require an imaging system, but instead measures the 
absorbance of solutions using spectrophotometry. We show that the indicator dye 
bromothymol blue gives greater discrimination than UI and other dye systems over 
the pH range 5.5 to 7.5.  
4.1. Material and Methods 
4.1.1. Preparation of pH Gradients 
A 96-point pH gradient (referred to as the 96-point screen) was produced using the 
two part broad range buffer system PCTP (Newman, 2004) supplied by Molecular 
Dimensions. The buffer is made from three chemicals: propionate, cacodylate and 
bis-tris propane in the proportions 2:1:2. One part of the system is created by adding 
hydrochloric acid, to the aforementioned 2:1:2 solution, until a pH of 4 is reached. 
Similarly, the second part is made by adding sodium hydroxide until a pH of 9.5 is 
reached. Ideally the pH would be linearly proportional to the two components of the 
buffer system. It is in fact sigmoidal as shown in Figure 18. This distribution, also 
found by the team who developed the buffer (Newman, 2004), shows that a solution 
containing 70% of the pH 9.5 component (and 30% pH 4 component) should have 
pH of 7.7, whereas it is actually pH 7.5. 
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Figure 18: Measured pH of PCTP. 
The pH of the broad range buffer PCTP measured with a pH meter in relation to an ideal 
linear pH for the proportion of chemicals used. 
 
The 96-point screen of PCTP was dispensed into a 96 deep well block using an 
Emerald Bioscience Matrix Maker at final concentration of 100mM. A second 96 
deep well block (referred to as the short screen) was produced where each row (A1-
A12, B1-B12 etc.) was composed of a 12 point linear pH gradient 4.0-9.5 (PCTP, 
100mM). In order to assess the performance of the spectrophotometric method 
against common crystallisation buffers a third screen was dispensed (referred to as 
the “buffer screen”  containing buffers in a 12 point range spanning ± 1 of their 
respective pKa values with a final concentration of 100mM. The contents of the 
buffer screen were as follows (rows A-H): sodium acetate (pKa 4.75), sodium citrate 
(pKa3 5.40), MES (pKa 6. 10), sodium cacodylate (pKa 6.27), sodium HEPES (pKa 
7.50) and Tris-HCl (pKa 8.30), PCTP pH 4.0-9.5. Row H contained only water which 
was included as a control. The pH of all three screens was measured using a well 
maintained and calibrated Jenway 4330 pH meter (with Jenway probe Catalogue 
Number 924005) calibrated using standards: Fisher phthalate, pH 4.00; phosphate, 
pH 7.00; and borate, pH 10.00. 
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4.1.2. Measuring Absorbance 
Into a 96-well flat-bottomed Costar 3635 UV/vis assay plate, 20μl of stock solution 
(Sigma) was dispensed using a Robbins Hydra 96 robot. To this was added 150μl of 
the 96-point screen using a Thermo Scientific Matrix Hydra II robot and the plate 
mixed briefly using an orbital plate mixer. The plate was then read using a Bio-Tek 
powerwave XS UV/visible plate reader programmed to scan across the visible light 
range from 400nm to 700nm in 5nm increments generating a 61-point absorption 
spectrum for each well, which was exported to Excel (Microsoft) for data processing. 
4.1.3. Curve Normalisation 
It has been observed that different chemicals absorb different amounts of light 
(Silverstein & Webster, 2006, Reusch, 2013). The structure of acid-base indicators is 
modified by excess hydrogen or hydroxyl ions so that they absorb different 
wavelengths of the electromagnetic spectrum. This occurs because of the conjugated 
bonds present in the benzene rings of acid-base indicators. These bonds allow for 
electrons in π orbitals to be moved by photons from the light wave into anti-bonding 
orbitals, therefore, removing energy from light wave - essentially it has been 
absorbed. For example, phenolphthalein when exposed to basic pH has its structure 
modified such that the energy required to move an electron is reduced and this in turn 
means that longer wavelengths are absorbed, allowing only those wavelengths, 
associated with the colour violet (around 400nm) to be seen. In Figure 23, row E 
shows the colour change of phenolphthalein when dissolved in a basic solution. 
Conversely, when the structure is in a neutral or acid solution the energy required to 
move electrons is much greater and so wavelengths associated with ultraviolet are 
absorbed. Variation in volume and concentration can also affect absorbance- as 
defined by the Beer-Lambert Law in Equation 17 (Crouch & Ingle, 1988).  
 
         17 
 
The Beer-Lambert Law states that the absorbance of light, A, is equal to the molar 
absorptivity of the solution,    multiplied by the concentration, c and the length of the 
solution, l, which the light travels through. In short, the further the light has to travel 
  
63 
 
or the higher the concentration of the sample the more light is absorbed, as 
represented in Figure 19. 
 
 
 
Figure 19: Effect of length on the absorbance of light. 
Light is represented as an arrow, where the length of the arrow indicates the amount of 
energy. The further that light has to travel through a solution; the more of it is absorbed. 
 
In order to compensate for variation in measured absorbance due to pipetting and 
mixing errors, Min-Max data normalisation was used. The normalised absorbance at 
wavelength x is given by 
  
  ̂  
       ( )
   ( )      ( )
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where min(a) and max(a), are the minimum and maximum absorbance over the 
range 400nm to 700nm. Figure 20 shows three spectra obtained for PCTP buffer at 
pH 4.5 and pH 7.5 using different volumes of indicator dye before and after 
normalisation. It can be seen that normalisation preserves the overall curve shape. In 
Figure 20(d) the slight translation of the maximum with the addition of 15μl of 
indicator dye corresponds to a difference of just 0.03 pH units. 
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(a) The absorption spectra obtained for PCTP buffer at pH 4.5 with three different 
volumes of indicator dye. 
 
(b) The three spectra from (a) after Min-Max normalisation. 
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(c) The absorption spectra obtained for PCTP buffer at pH 7.5 with three different 
volumes of indicator dye. 
 
(d) The same three spectra shown in (c) but after Min-Max normalisation. 
 
Figure 20: Normalisation of absorbance spectra. 
The effects of Min-Max normalisation on absorbance values for light passing through an 
acid-base indicator solution of pH 4.5 (a) and pH 7.5 (c). 
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4.1.4. Curve Matching 
In order to assign a pH value to a solution using the spectrophotometric method, the 
normalised spectrum obtained for the unknown solution is compared with 
normalized spectra obtained for standard curve solutions of known pH. The best 
match is determined using the smallest Mean Absolute Deviation (MAD) as a 
distance metric. The MAD between two vectors, x and y, of length n is defined by  
 
    (   )  
 
 
∑|     |
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The pH corresponding to the best match is assigned to the solution of unknown pH. 
However, when the MAD value to the best match is above a certain threshold, the pH 
value is still assigned but a warning is given. This threshold was determined as 
follows. 
 
For each column in the 96-well plate, an artificial absorption curve was produced by 
randomly generating 61 numbers to represent values from 400nm to 700nm in 5nm 
increments. This was repeated 100,000 times to represent 960,000 wells in total. 
 
The random absorption values were compared to those obtained for ten 96-point 
screens (used in the results shown in Figure 25). The lowest MAD for each of the 
960,000 in silica wells was recorded and a histogram was produced (Figure 21). The 
distribution for random MAD values was of a normal distribution (confirmed by QQ 
plot and KS test) around a mean of 0.31 with a standard deviation of 0.03. A 
threshold was imposed at 3 standard deviations from the calculated mean of 0.31 
(theoretically covering 99.7% of all data values that could be derived randomly). 
This meant the threshold was imposed at the lower limit of 0.23 and therefore any 
value above this could potentially be obtained from a random distribution of 
absorbance values. 
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Figure 21: Binned MAD for random absorbance curves. 
The distribution of MAD in 0.1 bins for 960,000 artificially generated absorbance curves.  
 
MAD was also used to assess the usefulness of other dyes. A good indicator dye 
system should have a MAD value representative of the pH change between spectra. 
The heat plot in Figure 22a shows the absorbance spectrum obtained for the standard 
solutions using 20 µl of UI. The pH increases from pH 4.5 in well 1 to pH 9.5 in well 
96. The span between pH 5.5 and pH 7.0, shows very little difference between the 
spectral curves, echoing the work of Newman, Sayle, et al. (2012) who found the 
response for UI determined from RGB values to be poor for this range of pH, which 
is important for protein crystallisation (Kantardjieff & Rupp, 2004). Conversely, 
Figure 22b shows that bromothymol blue has large MAD values in the range pH 5.5 
to pH 7.0 and is able to discriminate between similar pH values. However, Figure 
22b also shows that the discrimination between pH values is poorer for the most 
basic (> pH 7.5) and acidic values (<pH 5.5). 
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(a) Universal Indicator. 
 
(b) Bromothymol blue. 
 
Figure 22: Heat plots of absorbance for different indicators. 
Heat plots giving a bird's eye view of the normalised absorbance spectra obtained for the 96 
standard curve solutions using (a) Universal Indicator and (b) bromothymol blue. 
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4.1.5. Testing Other Dyes 
 
(a) Photograph of different indicator dyes in flat-bottomed Costar 3635 UV/vis assay 
plate. 
 
(b) Heat plots showing the difference in MAD values for different indicator dyes as 
pH is incremented. 
 
Figure 23: Discrimination between pH values for 8 indicators. 
(a) A photograph of the short screen buffer gradient plate with various indicator dyes. The 
dyes shown are: A- thymol blue; B- methyl red; C-bromothymol blue; D- nitrazine yellow; 
E- phenolphthalein; F- bromocresol green, G- Universal Indicator minus phenolphthalein; H- 
Universal Indicator. (b) Heat plots of the MAD between the absorbance spectra obtained the 
screen shown in (a). Red indicates the highest MAD values (good discrimination) through to 
blue indicating low MAD values.  
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Owing to the poor performance of UI it was decided to test other indicator dyes using 
MAD analysis. The component dyes of UI along with nitrazine yellow and 
bromocresol green were tested. The component dyes of UI were made up in 100% 
dimethyl sulfoxide (DMSO) at the concentration ratios they are generally used at in 
the indicator solution (thymol blue, 1.1mM; methyl red, 4.6mM; bromothymol blue, 
8.0mM; phenolphthalein, 31.4mM). Nitrazine yellow and bromocresol green were 
made up at 2mM in 100% DMSO. A mixture of the UI dyes excluding 
phenolphthalein was also made by combining the stocks at a 1:1:1 ratio (equivalent 
to UI without phenolphthalein and referred to as UI-p). It was hypothesised that UI-p 
may have a better response over the pH 4 to 9.5 range under investigation as 
phenolphthalein has a sharp colour transition (colourless to fuschia red) above pH 8 
and the colour differs from the other components which are of a blue hue. Using a 
multichannel pipette, 10μl of each dye  20 μl for UI  was dispensed into a separate 
row of a Costar 3635 UV/vis assay plate, after which 150μl of the short screen was 
added.  
 
Figure 23a shows the results for the comparison of indicator dyes with the short 
screen buffer gradient. It can be seen from the photograph of the plate that different 
indicator dyes change colour at different pH values according to the protonation state 
of the dye molecule governed by the pKa of the dye. No single dye covers the entire 
pH range tested (pH 4.0-9.5) and some dyes have a very narrow transition range. UI 
(row H) is a combination of thymol blue, methyl red, bromothymol blue and 
phenolphthalein which capitalises on the complementarity of the dye pKas and colour 
transitions (Foster & Gruntfest, 1937).  
 
Calculation of the MAD values for the eight indicator dyes correlates with the 
observed pattern of colour changes and is shown as heat plots in Figure 23b. The 
ideal indicator dye would discriminate between pH values across the full range from 
pH 4 to pH 9.5. Thymol blue (row A), phenolphthalein (row E) and bromocresol 
green (row F) have narrow response ranges, only changing colour over a small pH 
range with negligible MAD values between the standard curve spectra for most pH 
values. Both thymol blue and phenolphthalein only show a response at our most 
basic pH, giving insignificant MAD values between wells at lower pH. Similarly, 
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methyl red (row B) and bromocresol green only respond to the most acidic pH and 
cannot discriminate between wells of higher pH.  
 
Both bromothymol blue (row C) and nitrazine yellow (row D) show a response 
across a range of pH values with significant differences between the absorbance 
curves indicated by large MAD values. Figure 23a shows that both indicator dyes are 
able to discriminate between wells representing the range pH 5.5 to pH 7.5. Notably 
though, both dyes have very small MAD values at the extremes although 
bromothymol blue changes more across the basic pH range whereas nitrazine yellow 
changes more with acidic pH. UI-p only marginally improved the sensitivity of the 
dye system over the mid-range of pH. Based on these findings it was decided to 
continue experimentation with the simple bromothymol blue dye system. 
 
Phenolphthalein has a colour transition from colourless to fuchsia at a basic pH and 
therefore has a very limited range relevant to crystallisation solutions. Figure 23 
shows that the indicator phenolphthalein is colourless from pH 4.5 to pH 8.5. If 
phenolphthalein is used as an indicator that is only assessed by the human eye the 
only differences detectable would be for crystallisation experiments with pH > 8.5, 
of which there are very few (Kantardjieff & Rupp, 2004). As the spectrophotometer 
used to perform absorbance readings is able to provide ultraviolet (UV) light 
readings too, we are not constrained to those waves of the electromagnetic spectrum 
that we are able to see (400 − 700nm) and can record absorbance for UV 
wavelengths from 100 − 400nm. In a study to determine pka values using 
spectrophotometric methods, Tarn and Takács-Novák (1999) show that nicotinic acid 
and p-aminosalicylic acid have good discrimination between UV light absorbance 
curves for some of the pH range suitable for protein crystallisation. Although we 
have not performed any tests with indicators based on UV light, there is the potential 
to improve upon accuracy and discrimination for certain pH values. 
4.1.6.  Effects of Protein Buffering 
In order to test the effect of protein buffer and protein on the final pH of a standard 
crystallisation experiment, 10ml of lysozyme solution (Sigma) was prepared at 
50mg/ml  in 10mM PCTP, 100mM sodium chloride at pHs 5.0, 7.0 and 9.0. Here, 
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the concentration of the buffer is low so that the buffering capacity of the protein (if 
any) is not seriously compromised. The pH of each protein solution was adjusted 
using 10mM sodium hydroxide after the addition of the lysozyme before making up 
the final volume.  
4.1.7.  Efficient pH Determination 
To improve the applicability of the method, we also investigated miniaturisation of 
the pH assay using a 384 well Greiner UV plate. For each of the 96-point standard 
screen solutions, 25μl was pipetted in quadruplicate with 2ul of bromothymol blue 
indicator dye. The plate was read using the scan function on the plate reader which 
improved the overall turnaround time from 40 minutes for a 96-well plate to less than 
20 minutes for the 384-well plate. 
4.2.  Results 
In order to test the spectrophotometric pH assay with a wider range of crystallisation 
buffers, bromothymol blue was used in conjunction with the buffer screen as 
described previously. It was clear from initial results that the row containing only 
water consistently gave acidic values (Figure 24), possibly due to carbon dioxide 
from air being dissolved into the water. We therefore only consider our method 
suitable for determining the pH of buffered solutions. 
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Figure 24: Testing bromothymol blue. 
Scatter plot showing the spectrophotometric pH in relation to meter pH for eight chemical 
species. The correlation between both methods is 0.99. 
 
Figure 24 shows the spectrophotometric pH values for the 96-point buffer screen 
plotted against the measurements obtained using a pH meter. Only 91 points are 
shown as five points were measured with pH meter to be outside the pH range of our 
system. For the buffers there is a very strong correlation of 0.998 between the 
spectrophotometric and measured pH values. The distribution of deviation is 
positively skewed, with a mean value of 0.16 for the buffered observations.  
 
In order to test the reproducibility, which is more important than accuracy in 
crystallisation trials, 7 trays of the buffer screen were dispensed, measured 
spectrophotometrically and compared with the absorbance values from 10 separate 
96-point buffer screens. Figure 25 shows the reproducibility of the system. 
Correlations of between 0.987 and 0.989 were obtained, with regression slopes 
between 0.90 (intercept 0.43) and 0.94 (intercept 0.26). As five observations were 
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removed due to being outside the range (pH 4.5 – 9.5) of the 96-point screen, the 
graph represents 5,530 observations from 79 buffers and 840 from water. For the best 
and worst models, the distribution of error was positively skewed, with mean values 
of 0.17 and 0.27 respectively. 
 
Figure 25: Repetition of experiments with bromothymol blue. 
Bubble plot showing the pH values obtained for a set of 79 in-house buffer solutions and 12 
containing only water. Bubble size is positively correlated to the number of times a value is 
repeated. 
 
Bukrinsky and Poulsen (2001) tested the pH of the solutions in the Crystal Screen 
(Jancarik & Kim, 1991) and found several differed by more than one unit from the 
pH of the buffer system, with two conditions differing by more than three units. We 
used our method to test three common crystallisation screens: Hampton IndexHT, 
Rigaku Wizard and Molecular Dimensions JCSG-Plus. A total of 247 conditions 
remained after the removal of data points corresponding to wells without buffer and 
those with a spectrophotometric pH of 4.5 or pH 9.5. Data associated with this latter 
group was removed due to being assigned a pH at the edges of the 96-point screen, 
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therefore, there is an increased chance that the true pH could potentially lie outside 
this range.  
 
 
a) Distribution of buffer pH in relation to distance from spectrophotometric pH. 
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b) Percentage summary of the pH change shown in (a). 
 
Figure 26: Spectrophotometric and buffer pH of commercial screens. 
Differences between the buffer pH values and the values obtained by spectrophotometry for 
the 247 conditions in three commercial screens. b) shows whether the pH increased, 
decreased or stayed the same for acidic (<7), neutral (7) and basic (>7) buffered solutions. 
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Figure 26 shows the differences between the buffer pH values and the values 
obtained by spectrophotometry for the 247 conditions in the three screens. For buffer 
pH values less than pH 7.0, 27% differ by less than 0.2 pH units (the estimated error 
in our method) the determined values are higher for 41% and lower for 32%. The 
greatest differences are for the more acidic buffers, some of which differ by more 
than two pH units, being more neutral than the buffer pH would suggest. For buffer 
pH values greater than 7.0, 69% are determined to be more neutral than the buffer pH 
with even more extreme differences. Only 12% had calculated values more basic 
than the buffer pH and 19% differed by less than 0.2 pH units. For solutions with a 
buffer pH of 7.0, 36% were calculated to be more neutral, 19% less neutral and 45% 
differed by less than 0.2 pH units. Overall, we found that the spectrophotometrically 
determined values are often more neutral than buffer values. This is particularly true 
for the most extreme buffer pH values.  
 
Figure 27 shows a histogram for various pH differences with the number of wells in 
each bin. We found 18 conditions with pH values measured by spectrophotometry 
were more than two units away from the pH of the buffer (2 for Index, 10 for Wizard 
and 5 for JCSG-Plus). In the Wizard screen, we determined the pH of a well 
containing 1.2M of sodium phosphate and 0.2M of potassium phosphate to be 6.23, 
4.27 pH units away from the buffer pH of 10.5. In total, 74% of conditions were 
found to differ from the pH of the buffer by more than 0.2 pH units. Other conditions 
with a large disparity between our measured pH and the buffer pH included those 
containing PEGS and ammonium. It is known that PEGs undergo degradation 
overtime (Jurnak, 1986, Ray Jr & Puvathingal, 1985) and that ammonium 
compounds slowly release ammonia (Newman, Sayle, et al., 2012, Mikol et al., 
1989) and could therefore create problems with reproducibility. Our analysis shows 
that screens may not search pH parameter space as systematically or specifically as 
the design intended.  
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Figure 27: Errors in recorded pH for commercial screens. 
Histogram of pH differences between buffer pH and spectrophotometric pH for 247 
solutions used in commercial crystallisation screens. The percentage of the 247 solutions for 
each bin are shown above the bars. 
 
The results described so far relate to the pH of the crystallisation solution, or mother 
liquor, rather than mother liquor mixed with a buffered protein solution. 
Crystallisation occurs at the pH of this mixture, which could differ from that of the 
crystallisation solution due to the effects of any salts in the protein solution, the pH 
of the buffer or the protein itself. The effect of protein buffer and protein on the final 
pH of a standard crystallisation experiment was investigated using lysozyme 
buffered at pH 5.0, 7.0 and 9.0. It was noted that the addition of the lysozyme shifted 
the pH considerably; giving values of 3.8, 4.34 and 4.87 before final adjustment for 
PCTP buffers 5, 7, and 9 respectively. In addition the three buffers were prepared 
without lysozyme to test the effect of the buffer without protein. A selection of 
standard crystallisation conditions was dispensed and the pH was determined by the 
spectrophotometric method. The procedure was then repeated substituting 75μl of the 
screen for 75μl of water, buffer only and buffer with lysozyme at the pH stated. 
Figure 28 shows that there is little change in the pH of a solution after the inclusion 
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of a buffered protein. All three pH levels of buffered lysozyme have a strong 
correlation between the pH before and after the inclusion of the lysozyme. The 
correlation coefficients are 0.98, 0.97 and 0.97, with mean absolute deviations of 
0.23, 0.20 and 0.18 for pH 5, 7 and 9 respectively. As these deviations are within the 
expected error of the method, it is assumed that these differences are caused 
predominantly by the spectrophotometric system and not the buffered lysozyme. 
 
 
(a) Protein buffered at pH 5. 
 
(b) Protein buffered at pH 7. 
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(c) Protein buffered at pH 9. 
 
Figure 28: The effects of protein on buffer pH. 
Scatter plots showing the pH of the crystallisation solution plotted against the pH of a 50:50 
mixture of crystallisation solution and protein in buffer for lysozyme buffered at three 
different pH levels: (a) pH 5, (b) pH 7 and (c) pH 9. 
 
Analysis of the data obtained from the miniaturised assay, using a 384 well Greiner 
UV plate, showed it to be of comparable accuracy to that of the normal volume 
assay, with a correlation of 0.94 and a MAD of 0.35. The unusual value (6.6, 8.9) 
corresponds to the buffer MES, for which 11 other measurements fit the expected 
pattern. When this outlier is removed the correlation increases to 0.97, with a MAD 
of 0.35, the results are shown below in Figure 29.  
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Figure 29: Reduced volume spectrophotometric pH analysis. 
Results for the 384-well buffer screen using reduced volumes. The scatter plot shows pH 
values calculated spectrophotometrically plotted against pH meter measurements, for which 
the correlation is 0.94.  
4.3. Discussion and Conclusions 
While the colour based pH assay of Newman, Sayle, et al. (2012) is suitable for use 
in a high-throughput crystallisation facility where automated imaging is already in 
place, the authors recognised the need for a colour imager as a drawback of their 
method. They suggested that spectrophotometry could provide a more accessible 
assay; however, they found using a UV–Vis spectrophotometer to measure 
absorbance curves unreliable and concluded that the method was not viable. We have 
demonstrated that the use of spectrophotometry via the visible light plate reader 
together with the indicator dye bromothymol blue can be used to determine pH with 
an average absolute deviation of ~0.2 pH units from the pH measured using a pH 
meter. The comparison makes the pH meter the "benchmark" for a pH reading, 
although is well known that pH meters can be inaccurate (Illingworth, 1981). We 
tested the variation between pH meters using three different meters Table 4 and 
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found the overall average error to be 0.09 pH units. Sodium ion interference at high 
pH, acid errors at very low pH and temperature can cause measured values to differ 
from the theoretical pH (Kohlmann, 2003, Beynon & Easterby, 1996). These factors 
are likely to affect pH in crystallisation trials too as many conditions contain very 
high concentrations of salts contributing to changes in the activity co-efficient of 
hydrogen ions and crowding effects. These complex phenomena make relying on the 
buffer pH in crystallisation experiments inaccurate. 
 
 
Table 4: Variance of pH measurement from different meters. 
Variation between pH meters was tested using a Corning 240 pH meter and two different 
Jenway 4330 pH meters. All three meters were equipped with a Jenway pH probe (catalogue 
number 924005). The solutions tested were phthalate, pH 4.00; phosphate, pH 7.00; and 
borate, pH 10.00 bought from Fisher Scientific. The readings for the three meters are shown 
together with the average (absolute) errors for each standard solution.  
 
The indicator dye bromothymol blue gives good discrimination between absorbance 
spectra in the pH range 5.5 to 7.5, where UI shows a flat response. Bromothymol 
blue is less reliable, however, at lower pH and above pH 8.0. The vast majority of 
proteins crystallise within the mid pH range, where bromothymol blue can be used 
reliably and the use of a single dye avoids the potential impact on reproducibility that 
would result from a mixture of components. For other uses, for example the quality 
control of stock solutions where pH falls outside the pH 5.5 to 7.0 range, 
combinations of dyes are likely to be convenient and effective. Rather than mixing 
the components in an attempt to provide an indicator dye that covers the full pH 
range required for protein crystallisation, multiple standard curves could be used. For 
 
pH meter 
Jenway 4330 (1) Jenway 4330 (2) Corning 240 Average error 
pH 4 4.10 4.02 3.96 0.05 
pH 6 6.07 6.02 6.03 0.04 
pH 7 7.07 7.05 7.00 0.04 
pH 9 9.29 9.13 9.20 0.21 
Overall average error 0.09 
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example, separate standard curves could be produced for different dyes and the 
conditions within a screen checked using the appropriate dye and standard curve.  
 
Currently we are only able to provide accurate readings for those solutions with a 
buffer, as the unbuffered solution have their colour modified due the by the solution 
becoming more acidic after absorbing carbon dioxide from the air. However, the 
solution will become saturated with carbon dioxide at a certain point and, therefore, 
cannot become any more acidic. As we know the pH of water and the 
spectrophotometric pH of water it should be possible to compensate for this carbon 
dioxide effect on unbuffered solutions. Even in instances where the compensation is 
too great, the estimate of the pH should still be more reliable than that of the buffer. 
 
We have developed a fast method that is easy to implement and can provide pH 
values with a high correlation (0.98) to the measurement made with a pH meter. The 
pH of crystallisation solutions has been shown to change over time (Jurnak, 1986) 
and the spectrophotometric method can be used provide a simple check on screens 
used repeatedly. The method compares favourably with the RGB method to 
determine pH (Newman, Sayle, et al., 2012) and could be more accessible in that it 
requires a UV–Vis plate-reader to measure absorbance curves rather than an 
integrated imaging system. The time required to dispense and read a 96-well plate 
and calculate the pH values in Excel is approximately 40 minutes, but this was 
reduced to less than 20 minutes for the 384-well plate using the scan function on the 
plate reader. Tailoring the wavelength to specific dyes could increase the speed of 
data acquisition further. For example, it is not necessary to read methyl red at lower 
wavelengths as the dye absorbs in the higher wavelength region. It may also be 
possible to make use of different universal indicators provided they contain methoxy 
reds and phthalein, as these have been shown to be integral to providing good colour 
discrimination in both acidic and basic solutions(Woods & Mellon, 1941). While this 
method is fast and accurate it can only be used at the onset of a crystallisation trial 
and can improve the accuracy of recorded pH going forward. The majority of 
crystallisation data to date is likely to have the pH recorded as that of the buffer, 
however, as we know this is likely to be inaccurate, this data is misleading and 
should be made redundant.   
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5. The Prediction and Use of pH in 
Crystallisation 
We have shown in the previous chapter that accurate measurements of pH can be 
obtained quickly for crystallisation solutions using spectrophotometry. This coupled 
with the knowledge that the buffer pH is sometimes over several pH units away from 
the measured pH suggests that new crystallisation trials could and should have a 
closer estimate of their true pH determined. A more accurate pH would assist in 
accurate reproduction of experimental conditions and provide more meaningful 
results from the data mining that occurs on structural genomics data (Rupp & Wang, 
2004, Hennessy et al., 2000). Conclusions made using data with potentially 
inaccurate pH values could be misleading. In order to make use of previously 
generated data, a better estimate of pH than that of the buffer is required. Here, we 
use the spectrophotometric pH values obtained from numerous experiments to train a 
neural network to assign pH values to crystallisation conditions. These values are 
shown to provide accurate estimates of the pH that can be used, for example, when 
mining databases such as the Protein Data Bank (PDB). Using data obtained from a 
custom experiment, the SGC and the PDB we investigate predicted pH distributions 
and attempt to provide evidence for a link between the isoelectric point of a protein 
and the pH at which it crystallises.  
5.1. Prediction of pH for Buffered Solutions 
An estimate of pH, for a single chemical species solution, can be determined using 
its acid dissociation constant (pKa). These constants are obtained from published 
tables or collected experimentally by chemical titration. The constant is then 
transformed into a pH using the Henderson-Hasslebalch equation, which defines the 
number of hydrogens in an equilibrium, from which a pH can be obtained. However, 
published values are limited to certain chemicals and chemical titration of all 
chemicals used in crystallisation experiments would be extremely time consuming. 
Furthermore, there are limitations to the accuracy of the Henderson-Hasslebalch 
equation (Po & Senozan, 2001) and the constants vary significantly between authors. 
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It is possible that an accurate estimate of pH can be obtained through the use of 
regression modelling. The method described in Chapter 4 to determine pH using 
spectrophotometry was used to determine pH values for buffered conditions in a 
variety of crystallisation screens, including the JCSG-Plus, the Rigaku Wizard, the 
Hampton Index and the JCSG +6. Following the removal of those pHs for solutions 
without a buffer and those at the limit of our system (pH 4.5 and pH 9.5) a total of 
5,161 spectrophotometric pH values were obtained. 
 
The concentrations of the chemical species involved were divided into a training set 
consisting of those conditions with only one chemical species in addition to the 
buffer and a test set of the conditions with multiple chemical species.  
 
 
Figure 30: Organisation of data used for regression modelling. 
The table shows the division of spectrophotometric pH values between training and testing 
sets used in regression modelling. 
 
It was found that a linear regression model of the form: 
 
    ̂                            20 
 
where    ̂ is the predicted pH, B is the buffer pH, C is the concentration and the β 
terms are the regression coefficients, was suitable for each chemical species. 
Inspection of the regression coefficients for individual chemical species revealed 
patterns, such as modifying the buffer pH. Chemicals which we assumed to be 
behaviourally similar (in terms of crystallisation) also had similar regression 
coefficients and the same predictor variables shown to be insignificant. 
 
All conditions: 5,161 
Training set: 1,585 Test set: 3,576 
Buffer plus one chemical: 
1,585 
Buffer plus one 
chemical: 1,189 
Buffer plus two or more chemicals: 
2,387 
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Dihydrogen Salts Ammonias Hydroxide Salts Organics 
 
ammonium 
dihydrogen 
phosphate 
ammonium acetate 
potassium 
phosphate 
dibasic 
1,2-
propanediol 
 
potassium 
dihydrogen 
phosphate 
ammonium citrate 
tribasic 
sodium citrate 
tribasic 
glycerol 
β0 1.74 0.74 -6.55 1.67 
β1 0.80 0.92 1.83 0.71 
β2 0.71 1.06 4.03 0.00 
β3 -0.21 -0.16 -0.48 0.00 
 
 
PEGs Salts 
Salts of Weak 
Acids 
 
jeffamine ed-2001 
cadmium 
chloride 
calcium 
acetate 
 pegs of various 
molecular weights 
lithium 
sulfate 
sodium 
formate 
β0 1.91 1.18 0.20 
β1 0.72 0.87 1.01 
β2 0.00 0.00 1.00 
β3 -0.03 0.00 -0.13 
 
Table 5: Regression models for different types of chemicals. 
Each of the seven groups of chemicals is shown with two example chemical species that 
have been assigned to this group. The lower part of each table shows the coefficients for the 
linear regression models. 
 
Table 5 shows the final regression models for the seven groups of chemicals: salts, 
salts of weak acids, organics, polyethylene glycols (PEGs) of different molecular 
weights and different functional groups, compounds containing ammonia, hydroxide 
and di-hydrogen salts. Regression models were calculated for each group, after 
removing 10% of the data from each group for validation. This grouping of 
chemicals not only provides a more reliable predictive model due to the increased 
sample size but it also allows new chemicals that are not present in the training set to 
be assigned to a group and an estimate of pH obtained. 
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For solutions containing multiple chemical species, pH values were obtained by 
combining the predicted pH values for each individual chemical at the appropriate 
concentration using the formula: 
 
    ̂        (
∑      ̂      
 
) 21 
  
where    ̂ is the predicted pH for the solution containing all elements, n is the 
number of chemical species in the solution and     
̂ is the predicted pH the 
individual species, Si. The formula effectively determines the pH value by averaging 
the number of hydrogen atoms for each chemical in the solution. The ten-fold 
increase in hydrogen ions per pH unit decrease shows that the pH of the solution is 
dominated by the most acidic species, which is modified slightly by more basic 
species. The model requires no weighting of the parameters as the concentration of 
individual chemicals has already been accounted for. 
 
The mean squared error (MSE) between the spectrophotometric and predicted pH 
values is 0.28 in comparison to 0.8 between the values measured by 
spectrophotometry and the buffer pH values. The correlation with the measured 
values is 0.89 for the predicted pH in comparison to 0.77 for the buffer pH. 
 
Linear regression showed that four chemical groups- ammonia, dihydrogen salts, 
hydroxide salts and salts of acids, require the full model including the interaction 
term relating both the buffer pH and the additional chemical concentration to the pH 
of the experiment. The model for PEGs does not include the chemical concentration 
as a separate term, but does include the interaction between chemical concentration 
and buffer pH. Organics and salts have the simplest models, only involving the 
buffer pH as a variable.  
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5.1.1. Modelling pH Using Machine Learning 
An artificial neural network (ANN) implemented in Matlab (MathWorks, 2011) was 
trained to assign a pH value to crystallisation solutions. An ANN was employed as 
they are able quickly to create a richer, non-linear model than that of regression. 
Approximately two thirds of the data for the 5,161 conditions for which pH values 
could be determined by spectrophotometry were used to train a single hidden layer 
network using the Levenberg-Marquardt back-propagation method (Beale & 
Jackson, 1990, MathWorks, 2013). The other third was reserved as an independent 
test set. Chemicals were broadly grouped as suggested by the linear regression 
analysis (Table 5) and stratified sampling used to divide the chemical groups evenly 
between the training and test sets (3524: 1637). The concentration of chemicals in 
each group was calculated for each condition and these values, together with the 
buffer pH, used as inputs to the neural network. We chose a network with a single 
hidden layer of 5 nodes as this was the simplest network that gave a low mean 
squared error between the output pH and the spectrophotometric pH during training 
without over fitting (as assessed by the independent test set).  
 
Figure 31a shows the pH values measured by spectrophotometry plotted against 
those predicted by the neural network for the independent test set. The linear 
relationship between measured and predicted pH can be shown to have an intercept 
close to zero and a gradient close to one suggesting a strong relationship between the 
two methods of obtaining pH. For the same test data the spread of values obtained by 
spectrophotometry for any particular buffer pH is much greater than for the 
corresponding predicted pH, as can be seen in Figure 31b. The correlation of the 
spectrophotometric pH with the predicted pH is 0.92 (MSE 0.25) in comparison to 
0.75 with the buffer pH (MSE 0.97). 
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(a) Measured v predicted pH values.  
 
(b) Measured v assumed buffer pH. 
 
Figure 31: Accuracy of different pH values.  
(a) shows pH predicted using a neural network in relation to the spectrophotometric pH and 
(b) shows the buffer pH in relation to the spectrophotometric pH. 
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Figure 30 shows the distribution of differences between the pH values obtained by 
spectrophotometry and those assigned by the neural network as well as those 
provided by the buffer pH. The histograms show the absolute deviations in 0.1 pH 
unit bins. Whilst 75% of predicted pH values are within 0.5 units of the measured pH 
(i.e. ±0.5 pH units) and 95% are within one unit, only 53% of the buffer pH values 
are within 0.5 units and just 80% are within one unit. 
 
Figure 32: Histogram of errors for different methods of estimating pH. 
Histogram showing errors in predicted (dotted bar) and buffer pH (solid bar) values in 
relation to the spectrophotometric pH.  
 
Closer inspection of the predicted values reveals that six of the 66 individual 
chemicals were involved in the conditions where the deviation from the 
spectrophotometric pH values was unusually high. One of these chemicals, PEG 
2000 DME, should be neutral but spectrophotometry suggested a pH of just over 4.5, 
at the limit of the method’s reliability. It is known, however, that PEGs degrade 
becoming more acidic over time (Hampton, 2012, Jurnak, 1986, Ray Jr & 
Puvathingal, 1985). Indeed, when checked with a Jenway 4330 pH meter, the 
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solution was found to have a pH of just 2.6. The other five chemicals that were 
associated with large errors (jeffamine ed-2003, ammonium phosphate dibasic, dl-
malic acid, sodium malonate, magnesium chloride) were not well-represented in the 
training data. Re-training the network with a larger dataset could therefore improve 
the results further. 
  Protein 
 
 
pH 5 pH 7 pH 9 
B
u
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pH 5 
 
6.3 7.1 
6.3 7.1 
6.2 7.1 
pH 7 
5.8 
 
8.0 
5.8 8.0 
5.9 8.0 
pH 9 
6.5 7.8 
 
6.4 7.8 
6.4 7.8 
 
  Protein 
 
 
pH 5 pH 7 pH 9 
B
u
ff
er
 
pH 5 
 
6.5 7.6 
6.53 7.6 
6.53 7.6 
pH 7 
5.4 
 
8.4 
5.5 8.4 
5.5 8.4 
pH 9 
5.8 7.5 
 5.9 7.5 
5.9 7.5 
 
(a) Ratio of buffer to protein 1: 1. (b) Ratio of buffer to protein 1: 2. 
 
Table 6: The pH within the crystallisation drop. 
The table shows the measured pH of the components of the crystallisation drop for two 
different ratios of crystallisation cocktail: protein solution. The buffer used was 50mM 
PCTP, the protein solution consisted of 40mg/ml lysozyme, 100mM sodium chloride and 
50mM PCTP. The experiments were repeated three times and the pH values measured are 
given in the tables. 
 
Here we have used models to predict the pH of the crystallisation solution although 
only a proportion of this is contained within the drop containing the protein. Using a 
typical lysozyme solution at 40 mg/ml with 100mM sodium chloride and the buffer 
PCTP at 50mM, we have shown that, when mixed with 50mM PCTP at pH 5, 7 and 
9, the final pH could be predicted from the two buffering components with neither 
the salt nor the lysozyme having a noticeable effect. For example, protein solution at 
pH 5 to crystallisation solution pH 7 in the ratio 2:1 gives a predicted pH of 5.66, 
which compares to an average measured pH of 5.46 (Table 6). Only when the ratio of 
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protein solution to: crystallisation solution was increased to 3:1 did we find that the 
lysozyme affected the pH. 
5.2. Isoelectric Point 
It is possible that the use of protein sequence information could assist in 
crystallisation. In 1992, Samudzi and co-workers attempted to answer the question 
'Under which conditions will my protein crystallise?' They studied the BMCD for 
crystallisation trends, which at the time contained 820 macromolecules. Their motive 
was to move from an experimenter’s own experience, which could be based on 
anecdotal evidence to a more scientific approach. Cluster analysis using several 
properties relating to each experiment (such as temperature, precipitant concentration 
and crystallisation method) allowed eight clusters to be determined, each with its 
own features. Using the characteristics of these clusters Samudzi et al. were able to 
provide a recommended strategy for crystallising new proteins. For example, they 
recommend that a protein of relatively high molecular weight should be tried in a 
screen with properties of a typical of cluster 2, 3 or 5. Cluster 2 is dominated by 
entries containing alcohols and high concentration of protein solution, cluster 3 
contains entries that include the use of PEGs and low concentration of protein 
solution and cluster 5 contains entries where the precipitant is ammonium sulfate. 
They also recommend that proteins of low molecular weight should be crystallised in 
conditions similar to those of cluster 2 and 5, suggesting that molecular weight might 
not be useful in determining how to crystallise a new protein. A similar analysis by 
Farr Jr et al. (1998) on 1,500 macromolecules showed less of an overlap in the 
clusters and recommended strategies, but with both low and high weights 
crystallising broadly in the same temperature and pH conditions and with several 
shared chemical species. Despite the fuzzy clustering, the conclusion that protein 
properties can be helpful in determining the conditions under which proteins 
crystallise has since been supported by further studies. Using data from the BMCD, 
Hennessy et al. (2000) were able to provide software that would design a chemical 
screen for use on a specific class of macromolecule. Entering the class of 
macromolecule (enzyme, virus etc.) along with a choice of buffer, temperature, 
precipitating agent and other additives the program uses a Bayesian approach to 
calculate the combinations of parameters that have been most successful for 
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crystallising similar macromolecules. The most successful combinations of 
parameters are output as a design for a crystallisation screen. Hennessy and co-
workers concluded that there are correlations between families of proteins and their 
crystallisation conditions. For example, ligand-binding proteins and enzymes have a 
significantly different distribution of pH values under which they crystallise, whilst 
immunoglobulin-like proteins and enzymes have a significantly different distribution 
of temperatures. It should be noted that these classes are not based on any structural 
classification system such as the Structural Classification of Proteins (SCOP) 
(Hadley & Jones, 1999) and as such, they may have unknowingly introduced their 
own bias. In the most recent study of the BMCD, using 12,765 proteins, Lu et al. 
(2012) were also concluded that different families of proteins have their own 
particular crystallisation conditions. 
 
It has been postulated for some time that the best pH at which to initialise 
crystallisation experiments is one that matches the isoelectric point (pI) of the protein 
(McPherson, 1982). The pI of a protein is the pH at which its overall net charge is 0 
and it determines a protein’s minimum solubility level due to protein-protein 
interactions being favoured over protein-water interactions (Gilliland, 1988, Luft et 
al., 2011). It should therefore follow that a solution with a pH matching the 
isoelectric point would be ideal for crystallisation, although this has never been 
confirmed. One possible reason for this is that the recorded pH is that of the buffer in 
the crystallisation solution rather than the final pH of the crystallisation cocktail 
(Zhang et al., 2013). 
 
An analysis of 9,596 structures obtained from the PDB suggested a link between a 
protein’s pI and the pH at which it would crystallise. It was found that acidic proteins 
tended to crystallise 0 to 2.5 pH units above their pI, whereas basic proteins 
crystallised 0.5 to 3 pH units below their pI (Kantardjieff & Rupp, 2004). The 
authors reported a correlation between pI and pH-pI, that was challenged with claims 
that the predictive statements had been made using a misinterpretation of the data 
(Huber & Kobe, 2004). As a form of data normalisation, there will always be a link 
between pI and pH-pI, but it was also highlighted that no correlation between pI and 
pH had been found previously (Page et al., 2003, Wooh et al., 2003). In defence of 
their work the authors of the original study showed a correlation between the pI of 
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acidic proteins and the pH of successful crystallisation and that a linear model could 
be used to predict the optimal pH for such proteins. They concluded, however, that a 
similar model could not be created for basic proteins because no significant 
correlation was found (Kantardjieff et al., 2004). Since the original study, similar 
relationships between the pI of proteins and the buffer pH of successful 
crystallisation experiments have been noted for both acidic and basic proteins 
(Charles et al., 2006).  
 
Proteins can become more positively or negatively charged by gaining or losing 
protons due to the pH of their environment. The isoelectric point (pI), the pH at 
which a protein has a net charge of zero can be calculated using the charges for the 
specific amino acids in the protein sequence. Estimated values for the charges are 
called acid dissociation constants or pKa values. In the following analysis the pKa 
values used are those used in the EMBOSS software suite (Rice et al., 2000) as 
shown in Table 7.  
 
 
 
 
 
 
 
 
 
 
 
 
Table 7: EMBOSS acid dissociation constants. 
 
For a protein with n− negatively charged amino acids and n+ positively charged 
amino acids, the pI can be determined as the pH for which the net charge given by 
equation 22 is zero. 
 
Amino Acid pKa Charge 
Amine Group 8.6 Positive 
Carboxyl Group 3.6 Negative 
Cysteine (C) 8.5 Negative 
Aspartic Acid (D) 3.9 Negative 
Glutamic Acid (E) 4.1 Negative 
Histidine (H) 6.5 Positive 
Lysine (K) 10.8 Positive 
Arginine (R) 12.5 Positive 
Tyrosine (Y) 10.1 Negative 
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where pKn and pKp are the pK values for negatively charged and positively charged 
amino acids respectively. As an example, consider the small amino acid sequence, 
CRV, with one cysteine (pKn = 8.5), one arginine (pKp = 12.5) and one valine (no 
charge). Including the N-terminal amine group (pKp = 8.6) and C-terminal carboxyl 
group (pKn = 3.6) the net charge for an initial pH of 0 is given by equation 23: 
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The charge for the sequence CRV, therefore, is approximately 23 at pH 0. By 
gradually increasing the theoretical pH, to make the net charge in equation 22 equal 
to zero, it is found that the isoelectric point of CRV is 8.555, as shown in Figure 33. 
 
Figure 33: Net charge of the sequence CRV with varying pH. 
 
In the calculation of a protein's pI from sequence, an assumption is made that all 
residues have the potential to affect its overall charge. This assumption does not 
account for partially buried residues that may not have their pKa modified by the 
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environment. Fortunately, the approximation of pI accounting for buried residues 
(referred to as 3D isoelectric point) is strongly correlated to that of the linear pI. 
Using the PROPKA server (Rostkowski et al., 2011) it has been possible to calculate 
both forms of pI 21,045 different proteins obtained from the PDB in December 2013. 
Figure 34 shows a scatter plot of the isoelectric points calculated using the two 
methods. The correlation between the two groups is 0.9 with 85% of proteins being 
within one pH unit of each other and 94% being within two units. 
 
 
Figure 34: Primary v tertiary isoelectric point. 
The isoelectric point for 21,045 proteins obtained from the PDB is calculated using linear 
sequence (y) and from assumed 3D structure (x). 
 
The PROPKA server calculates the linear and 3D isoelectric point of protein 
sequences using a custom set of pKa values. There is no global agreement on such 
values and several sets exist. However, we found a very strong correlation (~0.99) 
between six sets tested, suggesting they can be used interchangeably.  
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5.3. Relationship between pI and pH  
The investigation into the link between a protein’s isoelectric point at the point at 
which it crystallises was explored using three datasets; the first was a custom 
experiment performed at AstraZeneca, the second used data from crystallisation 
experiments at the SGC and the third utilised data from the PDB. 
 
For the custom dataset, the pI was either obtained from Zhang et al. (2013) or 
calculated as above and was confirmed using isoelectric focusing. The isoelectric 
point for each sequence in the SGC and the PDB datasets was determined in the 
same manner using an Excel spreadsheet with visual basic for applications 
(Microsoft VBA).  
5.3.1. Custom Crystallisation Experiment 
In order to determine the conditions for crystallisation, fourteen proteins (described 
in Chapter 2) were initially screened using sitting-drop vapour diffusion with a 96-
condition sparse matrix screen buffered at 6 different pHs using the multi-component 
buffer PCTP (Newman, 2004, Zhang et al., 2013). This gave a total of 576 
conditions with the buffer pH fixed between pH 4.5 and pH 9.5. The best 
crystallisation conditions were selected for each protein and a finer sampling of pH 
was then performed with these conditions in a 96-well plate buffered between pH 4.5 
and pH 9.5 with PCTP as shown in Figure 35. 
  
98 
 
 
 
Figure 35: Optimisation of conditions in the custom experiment. 
Fourteen proteins were each screened in 6 sparse matrix screens, each screen with a different 
buffer pH. The condition that consistently crystallised each protein across the range of pH 
was then used as the single condition for another screen. This screen had an incremental 
increase of pH from 4.5 to 9.5, which was then measured using a spectrophotometer together 
with the acid-base indicator bromothymol blue. 
 
 
 
  
pH Bin 
 
pI 4.75 5 5.25 5.5 5.75 6 6.25 6.5 6.75 7 7.25 7.5 7.75 8 8.25 8.5 8.75 9 9.25 9.5 
Glycolytic A 7.52 
    
◊ ◊ ◊ ◊ ♦ ♦ ♦ ♦ ◊ ◊ 
      
Glycolytic D 6.75 
     
♦ 
 
♦ 
            
Glycolytic wt 6.75 
    
♦ 
               
α- Chymo A 8.52 
     
◊ ◊ ◊ ◊ ◊ ◊ ◊ ♦ ♦ ♦ 
     
Bovine Catalase 6.79 
      
◊ ◊ ◊ ♦ ♦ ♦ ♦ 
 
♦ ♦ ♦ 
 
◊ 
 
Protease K212A 4.93 
     
♦ ◊ ◊ ◊ ◊ ◊ ◊ ◊ 
       
Protease K234A 5.03 
  
♦ ♦ ♦ ♦ ◊ ◊ ◊ ◊ ◊ ◊ ◊ 
       
Protease K249A 5.03 ♦ ♦ ♦ ♦ ♦ ♦ ◊ ◊ ◊ 
           
Protease E171A 5 
     
♦ ◊ ◊ ◊ ◊ ◊ 
         
Concanavalin A 5.47 
 
♦ ♦ ♦ ♦ ♦ ♦ ♦ ◊ ◊ ◊ ◊ ◊ ◊ 
      
Lysozyme 9.36 
  
◊ ◊ ◊ 
   
◊ 
        
♦ 
  
Kinase 1 5.18 
         
◊ ◊ ◊ ◊ 
      
◊ 
Porcine Trypsin 7 
     
◊ ♦ ♦ ♦ ♦ ♦ ♦ ♦ ♦ ◊ ◊ ◊ 
   
Thaumatin 8.46 
    
◊ ◊ ◊ ◊ ◊ ◊ ◊ ◊ ♦ ♦ ♦ ♦ ♦ ♦ ♦ ♦ 
 
♦ Crystallised within one unit of its pI towards a neutral pH 
♦ Crystallised within one unit of its pI away from a neutral pH 
◊ Crystallised elsewhere 
 
Figure 36: Distribution of crystals in the custom experiment.  
The 0.25 pH bin in which each of the fourteen proteins crystallised is indicated by a diamond. Crystals obtained within one unit of the pI towards a 
neutral pH are shown in green. Similarly, crystals within one unit of the pI but away from a neutral pH are shown in red.  
 
 
The fourteen proteins in the custom dataset were used to further test the relationship 
between pI and the pH of successful crystallisation. Once the best crystallisation 
components had been determined for a particular protein, a fine sampling of pH was 
performed in a 96-well plate with the chosen components buffered between pH 4.5 
and pH 9.5. Figure 36 shows crystals were obtained within one pH unit towards 
neutral from their pI for 11 of the 14 proteins and 13 out of 14 crystallise within one 
pH unit either side of their pI. The glycolytic enzymes D and wt crystallised within 
one unit of their pI but away from a neutral pH. Only one protein, Kinase 1, with a pI 
of 5.18, did not crystallise within two pH units of its pI. The stochastic nature of 
protein crystallisation compounds the difficulties of pattern recognition. Figure 36 
shows that, whilst several proteins crystallise across a wide range of pH values, 
crystals are not seen in every 0.25 bin within that range. Reproducibility in screening 
has been investigated and the results suggest that replication could improve success 
rates in crystallisation experiments (Newman, et al., 2007). 
5.3.2. Structural Genomics Data 
The second dataset, obtained from the SGC (described in Chapter 2), comprised of 
the experimental conditions for 1,039 different protein sequences. Experimental 
results were assessed using the score given by a crystallographer, together with the 
resolution of the diffraction data and whether or not the structure was solved. For 
crystals that were not of diffraction-quality no estimated resolution is given and it 
was assumed that the structure was not determined. In instances where crystals were 
identified as salt, the associated data were removed.  
 
The remaining data were grouped according to the final stage reached in the structure 
determination pipeline as follows: 
Group 1 58 sequences that resulted in structure determination; 
Group 2 48 sequences that resulted in a crystal that diffracted to at least 3.6Å; 
Group 3 210 sequences that result in a least one protein crystal; 
Group 4 723 sequences that were annotated as ‘crystal - to be followed up’. 
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It should be noted that sequences in the final group may not relate to diffraction 
quality crystals or could be salt crystals that had not yet been identified as such. 
Conversely, it is possible that perfectly good crystals may have been overlooked. 
 
These data, all screened using the SGC JCSG +4 sparse matrix screen, were selected 
from the full SGC database and assigned to chemical groups in order to predict pH. 
Although a spectrophotometric pH value was available for some of the conditions in 
the SGC JCSG +4 screen (used either for training the neural network or reserved to 
test the accuracy of the assignments), the pH used here for all conditions was that 
assigned using the trained neural network. In addition to the chemical concentrations, 
the pH of the crystallisation buffer is also input to the network. For those wells 
without a buffer solution (21/96), the pH of the purification buffer was used instead. 
Data for any wells where neither buffer pH nor purification pH were available were 
removed. In Chapter 4 we showed that the buffering capacity of the protein itself is 
negligible in vitro and this has also be demonstrated in vivo (Poznanski et al., 2013). 
 
For each well in which a crystal was observed, the calculated pI was then compared 
to the assigned pH. The protein sequences were considered in groups, as defined in 
section previously, reflecting the maximum stage in the structure determination 
pipeline that was attained. The protein structure was determined and deposited in the 
PDB for the 58 protein sequences in Group 1. In addition to the conditions that led to 
the final structure, we also have information about other conditions that produced 
crystals. Analysis shows that crystals are only obtained in conditions with a pH 
within one unit of the pI for 9 of the 58 sequences. A total of 28 sequences only 
result in crystals within two pH units of the pI, 45 sequences only result in crystals 
within three pH units, 57 sequences only result in crystals within four pH units and 
the final 4 proteins crystallise up to five pH units away from the pI. Thus, for over 
70% of these protein sequences, crystals are only obtained in experiments buffered 
within 3 pH units of the pI. 
 
Particularly in cases when available protein is limited, it is important to identify 
suitable conditions in as few trials as possible and restricting screening to a particular 
pH range would reduce the number required. Promising initial conditions (including 
the pH), could then be optimised to obtain crystals suitable for crystallographic 
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studies (Jancarik & Kim, 1991). For the 58 proteins in the SGC dataset that resulted 
in a structure deposited in the PDB, we found a correlation of 0.8 between the pH of 
any crystalline result and the pH at which the final structure was obtained. We 
therefore investigated the differences between a protein’s isoelectric point and the 
closest pH value for any conditions producing crystals. Again the proteins were 
considered in the four groups according to the stage reached in the crystallisation 
pipeline. For those proteins in group 1, 84% crystallised within one pH unit of their 
pI and 95% crystallised within two pH units of their pI. Crystals were found within 
one pH unit of their pI for 78% of proteins in group 2 and within two pH units for 
88%. In group 3, 74% of proteins crystallised within one pH unit of their pI and 90% 
within two pH units and for group 4 proteins, 55% produced crystals within one pH 
unit of their pI and 82% within two pH units. Overall, 85% of proteins produced 
crystals within two pH units of their pI. Histograms showing the distribution of the 
absolute difference between the pI and the closest pH at which crystals were obtained 
for each group are given in Figure 37. It is worth noting that those proteins for which 
no crystals were found within three pH units of their pI (6% of all protein sequences 
here) tended to have more extreme isoelectric points. Of the 64 such proteins, 46 had 
a pI outside the range 5 to 9 and of the 18 protein sequences with a pI in this range, 
only one with a pI of 7.9 is within the range 6 to 8. 
 
(a) Group 1- structure determined. 
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(b) Group 2- diffraction to at least 3.6Å. 
(c) Group 3- at least one protein crystal.  
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(d) Group 4- crystal to be followed up. 
 
Figure 37: Distribution of differences between pI and pH. 
Histograms showing the absolute difference between the pI and the closest pH at which 
crystals were obtained for proteins in the SGC dataset.  
5.3.3. Protein Data Bank Snapshot 
Using a snapshot of the PDB with standardised crystallisation conditions courtesy of 
Fazio et al. (2014) we were able to calculate for 23,949 proteins their pI and the pH 
of the crystallisation solution in which is crystallised. A full overview of the structure 
of the data obtained from the PDB is described in Chapter 2.  
 
Figure 38 shows a pattern in the relationship between the pI of proteins and the pH at 
which they have been crystallised. Acidic proteins, i.e. those with a pI below 7, tend 
to crystallise about one pH unit above their pI, whereas basic proteins tend to 
crystallise below their pI by around 1.5-3 pH. These results support those found in 
our custom experiment and those derived from the SGC data along with those of 
other studies (Kantardjieff et al., 2004, Kantardjieff & Rupp, 2004, Charles et al., 
2006). 
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Figure 38: The relationship between pH and pI for PDB proteins. 
The distribution of the difference between the pH from which a structure was obtained and 
the isoelectric point for 23,949 proteins in the PDB-UNIQUE dataset. The distributions are 
shown separately for proteins with a pI less than 7 (acidic) and those with a pI greater than 7 
(basic). Those with a pI of precisely 7 (of which there were 4) were grouped with the basic 
proteins. 
5.4. Discussion and Conclusions 
Linear regression modelling revealed groups of chemicals with similar effects on the 
pH of a crystallisation experiments. The simplest models were obtained for salts with 
no hydrogen ions and neutral organic compounds. Although a simple linear 
regression model can be used to relate the pH of the experiment to the buffer pH for 
both of these chemical groups, the model is different for each group, with the 
constant offset larger for organics than that for salts. For other groups the effect of 
the additional chemical on the buffer pH depends on the concentration of that 
chemical. In the case of PEGs, the chemical concentration does not appear as a 
separate variable, but the interaction term between buffer pH and the chemical 
concentration is significant. It is known and we have shown (Appendix C) that PEGs 
degrade over time (Hampton, 2012, Jurnak, 1986, Ray Jr & Puvathingal, 1985), 
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increasing the acidity of the solution. Similarly, ammonia-containing compounds 
slowly release the ammonia and affect the pH of a condition (Mikol et al., 1989, 
Newman, Sayle, et al., 2012). Ammonia containing compounds are more acidic than 
PEGs, which when fresh and correctly stored are close to neutral pH, and like the 
final two groups (acids and basic) require the full linear regression model including 
the interaction term to represent the pH of the experiment. The last two groups either 
contain hydrogen ions that have a large impact on pH or contain a hydroxide group, 
with a large but opposite effect on pH. The largest errors in prediction are due to 
chemicals that undergo degradation. The deterioration of chemicals, such as PEGs, 
cannot be predicted but should be considered and storage conditions such as light 
exposure and temperature could perhaps be controlled. 
 
The grouping of chemicals according to their effect on the pH of a solution means 
that individual models are not required for each chemical and the effect of chemicals 
for which there are no examples in the training set can be predicted from the model 
for the appropriate group. Moreover, the increase in the number of examples 
available for each model reduces the possibility of over-fitting of the training data 
and provides more robust models for prediction.  
 
Using the chemical grouping suggested by linear regression modelling, the most 
accurate results were obtained using a single-layer neural network with five nodes 
but the method is less intuitive, and similar results were obtained using the regression 
equations. 
 
The ability to predict the effect of different combinations of chemicals on the pH of 
an experiment allows information in databases such as the PDB to be used in data 
mining studies that aim to reduce the number of crystallisation trials required. Over 
the last decade a number of investigations have considered a possible link between 
the pI of a protein and the pH at which it will crystallise (Charles et al., 2006). Such 
a link has also been disputed, with Zhang et al. (2013) suggesting that "the pI value 
of a protein should be avoided when choosing the pH for a protein solution". Zhang 
and co-workers also discuss the issue of the recorded pH not necessarily being the 
pH of the experimental conditions. Previous findings have been based on the pH of 
the buffer solution, which can differ from the actual pH by more than 3 pH units 
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(Bukrinsky & Poulsen, 2001, Newman, Sayle, et al., 2012). Using more accurate pH 
values that take into account how the concentrations of the various chemicals in the 
crystallisation cocktail affect the pH of the buffer solution, we have shown that a 
relationship between a protein’s pI and the pH under which it will crystallise does 
exist. In addition to data for the conditions leading to protein structure solution we 
have considered the pH of experiments producing crystals that may not have been 
confirmed as diffraction quality. We found that proteins frequently crystallise within 
one pH unit of their pI and that 85% of the proteins produced crystals within two pH 
units of their pI. In most cases, proteins tended to crystallise at a more neutral pH 
with acidic proteins crystallising above their pI and basic proteins below their pI, 
confirming those results found previously (Charles et al., 2006, Kantardjieff & Rupp, 
2004). As the majority of proteins that crystallise are of an acidic pI (Figure 39), we 
therefore suggest that a useful initial pH for crystallisation trials can be obtained 
from the pI of the protein in question, but this pH should not simply be taken as that 
of the buffer solution but, if not measured, should be adjusted to take into account the 
effect of any additional chemicals. 
 
It may also be possible to distinguish between whether the pH of the solution is 
imperative for crystal nucleation, crystal growth or both. This could be performed 
with two experiments, one where a crystal/seed is added to a solution of a desired pH 
and the growth, maintenance or degradation of the crystal is monitored and compared 
to the same set of conditions but without the seed. This strategy could then be used to 
improve microcrystals or use artificial seeds to grow protein crystals around. 
Distribution of Isoelectric Points 
Figure 39 shows a trimodal distribution for isoelectric points with modes of 
approximately 4.8, 6.6 and 9 and the majority of crystallisable proteins having an 
acidic isoelectric point. This distribution contradicts the findings of others who show, 
for smaller sample sizes, that the isoelectric points of proteins are bimodally 
distributed with one peak representing acidic pIs and another basic pIs (Canaves et 
al., 2004, Kantardjieff & Rupp, 2004). Analysis of the BMCD shows that the most 
successful buffer pH is normally distributed around pH 7 (Samudzi et al., 1992) 
which is supported by a later study of the PDB (Fazio et al., 2014). These are reports 
of the buffer pH and not of predicted or measured pH and therefore it is difficult to 
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untangle which of these pH values are accurate and which proteins (and isoelectric 
point) they are associated with. 
 
 
 
Figure 39: Histogram of isoelectric point for PDB proteins. 
The distribution of pI for 23,949 significantly different proteins obtained from the PDB. 
5.4.1. Prediction of Crystallisation Group 
As some proteins do not crystallise close to their pI, we investigated protein 
properties to determine whether or not such proteins could be predicted. In addition 
to pI, the GRAVY (Kyte & Doolittle, 1982) and the number of D, C, G, H, M, F, P, 
S, T, W, Y residues (Overton et al., 2008) were calculated for each sequence in the 
SGC dataset. A Euclidean distance matrix was created between each sequence based 
on the difference in their scaled features. This distance matrix was then used for 
multidimensional scaling k-means clustering, which is described in Chapter 3. PCA 
was also performed, a plot of which is shown in Figure 40, it can be seen that there is 
no discrimination between the groups. 
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Figure 40: PCA of 1,039 sequences represented by 13 features. 
The plot shows the four groups (1- structure determined, 2- diffracted to at least 3.6 Å, 3- 
protein crystal, 4- annotated by eye as crystal) of the SGC data plotted with respect to their 
first and second principal components. 
 
MacQueen k-means clustering was implemented, with k=4 (MacQueen, 1967) and 
Figure 41 shows the confusion matrix obtained. Each group had around 25% of its 
targets classified correctly overall due to the differences in group's sizes the accuracy 
is 25%. Without clustering the overall accuracy increases to 30%. These results 
suggest that experimentation may be the only way of determining whether a 
sequence will result in a determined structure. A possible explanation for this is that 
the properties used do not give any indication of the complex intra- and 
intermolecular interactions. Differences in physical crystallisation conditions such as 
temperature, use of ligands and whether the protein sample was frozen were not 
taken into account. 
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Figure 41: Confusion matrix for k-means clustering. 
These are the results of k-means clustering for the SGC data. The overall accuracy of the 
clustering was just 19%. 
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6. Predicting a Protein's Propensity 
to Crystallise 
Using parameters derived from the amino acid sequence, a number of researchers 
have tried to predict whether a protein is suitable for structure determination by X-
ray crystallography. In 2006, a SEquence-based CRystallisability EvaluaTor 
(SECRET) created by Smialowski et al. (2006) was developed using two classes of 
protein sequences from the PDB. The first class, proteins solved by X-ray 
crystallography and the second, proteins solved by NMR. As proteins solved by 
NMR are small, the classifier is limited to sequences 40 to 200 amino acids in length. 
This ensures that the separation of the classes is not dependent on length. They 
calculated properties such as single amino acid frequency, dipeptide frequency and 
hydrophobicity of the amino acids (using 3 hydropathy scales (Rose et al., 1985, 
Kyte & Doolittle, 1982, Engelman et al., 1986)). After reducing the number of 
properties using wrapper feature selection (Kohavi & John, 1997), Smialowski et al. 
(2006) were able to accurately classify 62.7% of proteins in their sample with 
support vector machines. When Overton et al. (2008) assessed a new dataset with 
this classifier, they reported an accuracy level of 58.1%. 
 
The work of the team who developed SECRET was challenged by Chen et al. (2007) 
who claimed that SECRET used many features and yet has relatively low prediction 
rates, as 50% accuracy should be achieved by the flip of a coin. They proposed a new 
classifier, named CRYSTALP, which uses features such as a count of all the 
individual amino acids in a sequence divided by the length of the sequence as well as 
the collocation of amino acid pairs. Their final predictor with 46 features is also 
limited by the size of the proteins that can be classified as to make it directly 
comparable to SECRET. When tested with the same dataset as SECRET an accuracy 
rate of 77.51% was reported (Chen et al., 2007), although Overton et al. (2008) 
report that, on one of their restricted length datasets, CRYSTALP only achieved an 
accuracy level of 46.5%, a percentage that would be expected by a random guess. 
Jahandideh and Mahdavi (2012) reported the accuracy of CRYSTALP to be 68.40% 
and 75.69% in two separate trials. An improvement on the classifiers came with 
  
113 
 
CRYSTALP2, which had no upper length restriction (Kurgan et al., 2009). New 
features include the use of collocated tripeptides, pI and Grand Average of 
Hydropathy (GRAVY). In total 1,103 features were used. Results show a 
classification accuracy of between 69.3% and 77.5% depending on the dataset 
(Kurgan et al., 2009).  
 
In 2006, the same year as the publication of SECRET, the OB-Score was published. 
The OB-Score “ranks potential targets by their predicted propensity to produce 
diffraction-quality crystals”. A high OB-Score suggests that a protein is likely to be 
successfully crystallised; a low one suggests it is unlikely (Overton & Barton, 2006). 
The OB-Score was trained using the predicted isoelectric point and the GRAVY of 
the 5,545 amino acid sequences from the PDB with a diffraction quality of <3.0Å. 
The accuracy of the OB-score predictor has been reported as 69% by Kurgan et al. 
(2009) and 73% by Jahandideh and Mahdavi (2012). In a similar manner to the OB-
Score, XtalPred provides a guide on how likely a protein is to crystallise, using 
protein properties derived from the sequence such as molecular weight and GRAVY. 
XtalPred was developed on the back of comments from as early as 1984 suggesting a 
“crystallisation feasibility score”. From the 2007 publication it is unclear how the 
score is derived. Like SECRET, OB-Score and CRYSTALP2, XtalPred is freely 
available online and has accuracy levels of 76% and 72.40% that have been 
published by Kurgan et al. (2009) and Jahandideh and Mahdavi (2012) respectively.  
 
There have since been several other classifiers and predictors all using properties 
derived from the protein sequence with statistical pattern recognition methods. 
ParCrys uses Parzen Window probability density estimators with a measure of 
randomness of the sequence (Wan & Wootton, 2000), pI and hydropathy values; an 
accuracy of 79.1% was reported (Overton et al., 2008). RFCRYS uses the machine 
learning method of random forests to predict crystallisability. In their own tests they 
report 80.4% accuracy (Jahandideh & Mahdavi, 2012). The CRYSpred predictor, 
uses a set of sequence derived properties that are described in the Amino Acid Index 
Database (Kawashima et al., 2008). They include several methods for calculating 
disorder, hydrophobicity, disorder and charge. In total they use 15 features, achieving 
an accuracy of 73.4% on a test set of 2,000 proteins (Mizianty & Kurgan, 2012).  
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Name Year Prediction Method 
TEST 
Accuracy 
(%) 
TEST-RL 
Accuracy 
(%) 
 
SECRET RL 2006 
Support Vector 
Machine 
- 58.1 1 
The OB-Score 2006 Z-score Matrix 64.6 69.8 1 
CRYSTALP RL 2007 Naïve Bayes - 46.5 3 
Xtalpred 2007 
Logarithmic Opinion 
Poll Method 
79.2 76.7 1 
ParCrys 2008 Parzen Window 71.5 79.1 1 
CRYSTALP2 2009 
Radial Basis Function 
Network 
75.7 69.8 1 
Metappcp 2009 Logistic Model Tree 81.0 - 2 
MCSG 2010 
Support Vector 
Machine 
- - 4 
Hyxg-1 2010 
Regression 
Partitioning 
- - 4 
Xannpred 2010 Neural Network - - 4 
SVMCRYS 2010 
Support Vector 
Machine 
86.8 89.53 3 
RFCRYS 2012 Random Forest 81.25 - 2 
CRYSpred 2012 
Support Vector 
Machine 
79.9 80.2 1 
 
- 
 
RL 
test set was not tried with the named predictor  
 
the predictor was trained on sequences of restricted length 
 
Table 8: The accuracy of different predictors. 
Accuracy rates are shown for the two independent test data sets, TEST and TEST-RL. 
1
 Figures for accuracy were obtained from the CRYSPred paper (Mizianty & Kurgan, 2012).  
2 
Figures obtained from the RFCYRS paper (Jahandideh & Mahdavi, 2012).  
3 
Figures obtained from the SVMCRYS paper (Kandaswamy et al., 2010).  
4 
These predictors were not evaluated on the named test sets. 
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This accuracy rate was surpassed by Kandaswamy et al. (2010) using a support 
vector machine, but this classifier had a large discrepancy between the accuracy rates 
on training and test data sets, which suggests that their results might be unreliable 
due to over fitting (Mizianty & Kurgan, 2012).  
6.1. Datasets 
Two particular datasets, TEST and TEST-RL, originally introduced by the 
developers of the ParCrys predictor (Overton et al., 2008) have since been used by a 
number of authors to allow comparisons to be made. The TEST dataset contains 144 
sequences obtained from TargetDB, 72 of which had been given the annotation 
‘diffraction quality crystal’ and the other 72 had been given the annotation ‘work 
stopped’. TEST-RL contains 86 sequences of proteins that are less than 200 amino 
acids in length. The 43 crystallisable sequences in TEST-RL are a subset of those in 
TEST that have been filtered by length. The 43 non-crystallisable sequences were 
selected at random from a larger dataset, which again had a length restriction, and 
had the TargetDB status of ‘work stopped’. TEST-RL was introduced to compare the 
performance of those predictors with a length restriction to those without. A 
summary of the prediction accuracies for the various classifiers is shown in Table 8. 
 
Other researchers used the FEAT or TEST-NEW dataset. The FEAT dataset, again 
introduced by the developers of the ParCrys predictor, contains entries from the 
TargetDB: 728 entries with status ‘diffraction quality crystal’ and 728 entries with 
status ‘work stopped’ (Overton & Barton, 2006, Overton et al., 2008). The TEST-
NEW dataset, introduced by (Kurgan et al., 2009), was also obtained from TargetDB 
and contained 1000 entries with status ‘diffraction quality crystals’ and 1000 entries 
with status ‘work stopped’ (TargetDB, 2010, Kurgan et al., 2009).  
 
Using data obtained from the Structural Genomics Consortium (SGC) Oxford we 
derived our own list of sequences with a crystallisable or non-crystallisable outcome. 
A positive data set was obtained from the 69 protein structures that had been 
determined from a single sparse matrix screen, the SGC JSCG +4. Some of these 
structures were obtained from the same sequence, for example, the structures with 
PDB IDs 2IZR, 2IZS and 2IZU are all from the same sequence. After removing the 
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repeated sequences, the positive data set, SGC61POS, comprised 61 entries. To 
ensure that proteins that were not successfully crystallised in the SGC JCSG+4 
screen were unsuccessful due to properties intrinsic to the sequence and not the 
screening conditions, it was necessary to determine whether they had been 
crystallised in any other screen. If they had been crystallised in other screens at the 
SGC they were not included in the negative data set, SGC382NEG, which finally 
comprised 382 sequence entries. Table 9 shows the number of entries in the 
commonly used data sets together with the custom data set introduced here. As our 
datasets are different sizes they are reported separately.  
 
Dataset Name 
Number of Successful 
Sequences 
Number of Unsuccessful 
Sequences 
TEST 72 72 
TEST-RL 43 43 
FEAT 728 728 
TEST-NEW 1000 1000 
SGC61POS 61 - 
SGC382NEG - 382 
 
Table 9: Datasets used for predicting a protein's crystallisability. 
The number of successful and unsuccessful sequences in various datasets used for predicting 
the crystallisability of proteins. 
6.2. Protein Sequence Properties 
During the development of the various predictors described above, at least 34,500 
features have been calculated from protein sequences in order to determine whether a 
protein would indeed crystallise. These features include counts of di- and tripeptides, 
separated by up to four other amino acids (Chen et al., 2007, Kurgan et al., 2009), 
features given in the AAIndex (Kawashima et al., 2008) and many others. It is 
difficult to determine which features harness the most predictive power as every 
predictor uses a different set. We investigated this using features previously used by 
others as well as new features. 
 
  
117 
 
The core features calculated for our data matrix are defined on ExPASy’s ProtParam 
web tool. This online Bioinformatics Resource Portal from the Swiss Institute of 
Bioinformatics provides access to scientific databases and software tools (Artimo et 
al., 2012). One tool available on the ExPASy server is ProtParam created by 
Gasteiger et al. (2005). This tool computes physical and chemical parameters of a 
protein from its amino acid sequence.  
 
Proteins are compositions of 20 amino acids in various frequencies with an amino 
group at one end (the N-terminal) and a carboxyl group (the C-terminal) at the other, 
as shown in Figure 42. Each amino acid has different properties that can be 
combined to provide a feature for the whole sequence. The following section 
describes the various features used in our analysis. The number in parentheses 
following the feature type indicates the number of parameters calculated for this 
feature.  
 
 
 
 
 
 
Figure 42: Standard protein sequence structure. 
A standard amino acid sequence has an N-terminal and a C-terminal (shown in red). 
Between these two terminals are the amino acid residues (orange) connected by peptide 
bonds (blue).  
 
The Molecular Weight (1), M, is the sum of the molecular mass of each atom making 
up the protein. This can be calculated by summing the molecular masses of the 
amino acids (aa) in the sequence after adjusting for the dehydration reaction, as 
shown in Equation 24. For each peptide bond formed between amino acids one water 
molecule (~18Da) is lost. The water is lost as a combination of a hydroxide (OH) 
from the carboxyl group of one amino acid and hydrogen (H) from the amine group 
of another amino acid. If the mass of one water molecule is subtracted for each 
amino acid in the sequence, then the mass of one water molecule should be added to 
N 
Terminal 
 
Residue 
 
Residue 
 
Residue 
 C 
Terminal 
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account for the remaining hydroxide on the C-terminal and the remaining hydrogen 
on the N-terminal.  
 
    ( ∑ (      )
      
)      24 
 
The Net Charge (15) is a summation of the individual charges of certain amino acids 
in the sequence. The amino acids arginine, histidine and lysine are known to have a 
positively charged side chain and the amino acids aspartic acid and glutamic acid are 
known to have a negatively charged side chain. The other 15 amino acids have a side 
chain with neutral charge. In calculations for net charge the charge of the N-terminal 
and the C-terminal is also included. The N-terminal is affected by pH in the same 
way as positively charged side chains and the C-terminal acts in the same way as 
negatively charged side chains. Charged side chains are affected by pH. Amino acids 
with a positively charged side chain remain positively charged while their pKa value 
is above the pH of the solution. If the pH is greater than the pKa value, then the side 
chain becomes neutral. Similarly, negatively charged side chains remain negatively 
charged while the pH of the solution is of greater value than their associated pKa 
value. If the pKa value is greater than the pH they become neutral. 
 
The Isoelectric Point (pI) (1) is the pH at which the net charge of the protein is zero 
and its calculation from seven key amino acids (Kozlowski, 2012) is described in 
detail in Chapter 5. We implemented the computational algorithm of Sillero and 
Maldonado (2006) in VBA (Microsoft Excel) to calculate pI. 
 
The Sequence Length (1) is simply the total number of each of amino acids in a 
sequence. 
 
The Amino Acid Composition (20) is given by the number of each of the 20 different 
amino acids contained within a sequence. 
 
The Amino Acid Frequency (20) is the number of the 20 different amino acids within 
a sequence divided by the sequence length. 
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The Atomic Composition (6) is the number of each atom type within the sequence. 
This can be calculated from the number of carbon, oxygen, nitrogen, hydrogen and 
sulphur atoms in each amino acid multiplied by the number of each amino acid, 
accounting for the loss of water through the dehydration reaction. The total number 
of atoms in a sequence is also used. 
 
 
Figure 43: A Venn diagram of amino acid types. 
The 20 amino acids, indicated by their single letter code, are divided into groups with other 
amino acids that share the same properties.  
 
Amino Acid Types (8) are different properties of amino acids due to by the particular 
side chain. There are eight different types, as shown in Figure 43. The eight types are 
small, aliphatic, hydrophobic, aromatic, negative, polar, positive and proline. For 
each sequence, a count of the number of amino acids with this property provides a 
feature. 
 
The Extinction Coefficient (4) can be used to determine protein concentration. Using 
the method provided by Pace et al. (1995), the extinction coefficient for proteins in 
water is calculated as 5,500 times the number of tryptophan residues plus 1,490 times 
the number of tyrosines plus 125 times the number of cysteine pairs.  
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The Half-Life (3) of a protein is the length of time it takes for half of the protein to 
disappear within a cell. The method to determine the half-life is referred to as the 'N-
end rule', which refers to which amino acid is on the N-terminal of the protein 
sequence (Varshavsky, 1997). The ProtParam documentation provides a list of half-
lives for mammalian, yeast and e.coli cells for each amino acid (Gasteiger et al., 
2005). For example, for a protein with an alanine as N-terminal amino acid, the half-
life would be 4.4 hours, >20 hours and >10 hours for mammalian, yeast and E.coli 
cells respectively.  
 
The Instability Index (1) is a value assigned to a protein sequence based on dipeptide 
combinations. It has been reported that proteins containing certain proportions of 
some dipeptides undergo rapid degradation and that proteins containing high 
frequencies of proline, glutamic acid and serine can be unstable (Guruprasad et al. 
(1990). The latter was also found by Rogers et al. (1986), who reported a similar 
affect for methionine and glutamine. On the other hand, asparagine, lysine and 
glycine are reported to occur in high frequencies in stable proteins (Guruprasad et al. 
(1990). Guruprasad and coworkers have provided a table of instability values for 
each dipeptide within a sequence. These can be summed to provide the instability 
index for a protein sequence, where an instability index > 40 suggests the protein is 
unstable.  
 
The Aliphatic Index (1), suggested by Atsushi (1980), is a metric for a given protein 
sequence based on the quantity of four specific amino acids: alanine, valine, 
isoleucine and leucine. Atsushi reported that proteins derived from thermophilic 
bacteria are known to have significantly higher frequencies of these aliphatic amino 
acids. A protein with a high index may be regarded as having high thermostability.  
 
The Grand Average of Hydropathy (GRAVY) (1) is the average hydropathy value for 
an amino acid sequence. The sum of the hydropathy values for each individual amino 
acid, provided by Kyte and Doolittle (1982) is divided by the number of amino acids 
in the sequence to give the average hydropathy value. A positive GRAVY value 
suggests a hydrophobic sequence, whereas a negative GRAVY value indicates a 
hydrophilic sequence. Rose et al. (1985) and Engelman et al. (1986) have also 
defined a set of amino acids that they consider to be hydrophobic or hydrophilic 
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although they do not provide a method to calculate a score. Note that hydropathy and 
hydrophobicity are used interchangeably. 
 
The Mean Side-Chain Entropy (3) is the average amount of entropy for each protein 
sequence, based on estimations of entropy provided by Creamer (2000). In general, 
entropy is a measure of the amount of energy in a system that is unavailable in a 
particular state. In folded proteins this energy is unavailable due to protein folding.  
 
 
Class 
 Non- crystallisable ○ Crystallisable 
 
Figure 44: Scores plot for first two principal components. 
The fsOur87 features were calculated for the FEAT dataset and then scaled. Principal 
components analysis was performed and the scores obtained within respect to the first two 
principal components are shown here.  
 
Here we refer to the set of 87 features described above as fsOur87. This set of 
properties was calculated for the sequences in the FEAT dataset, which we use as 
training data. Principal components analysis (PCA) was implemented for data 
reduction in R on the FEAT dataset (Zurich, 2012). The data were scaled to prevent 
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large variables dominating the analysis. The top 5 principal components only account 
for 67% of the variance, with 40% of this in the first principal component. The scores 
plot in Figure 44 that this variance is not due to a difference between groups. Each 
subsequent component adds little to the cumulative variance with 22 principal 
components being required for 95% of the variance. As PCA showed that most of the 
variance in the data was not related to any difference between the two groups and the 
method did not offer effective data reduction, it was not pursued further. Instead a 
feature selection method, which does not require any transformation of the variables 
was used. 
 
It has been shown that the removal of highly correlated features (correlation >0.9) 
can improve the performance of neural networks (Wendemuth et al., 1993, Hall & 
Smith, 1997) and therefore we produced a second feature set, referred to as 
fsUncorrelated, consisting of 54 features. We also used the feature sets used to test 
previous predictors, which we refer to by the name of the original predictor preceded 
by fs for feature set. For example, fsCRYSTALP is the set of features used in the 
CRYSTALP predictor. A summary of the size of the feature sets and their source is 
shown in Table 10. A full list of the features in each of the named sets is listed in 
Appendix A. 
 
Feature Set Source Feature Count 
fsOur87 Original Features 87 
fsUncorrelated Original without correlated features 54 
fsOB The OB-Score 2 
fsCRYSTALP CRYSTALP 46 
fsParCrys ParCrys 13 
fsCRYSTALP2 CRYSTALP2 88 
 
Table 10: The number of features in the various datasets. 
The feature sets fsOur87 and fsUncorrelated were compiled specifically for this 
study, whereas the other features sets correspond to those used by other researchers 
to develop prediction tools for determining the propensity of a protein to crystallise. 
 
  
123 
 
6.3. Classification 
Various machine-learning algorithms have been used to predict a protein’s 
propensity to crystallise, but as Table 8 shows, no particular method stands out as the 
most successful. Using data on gene expression in cancers, it has also been shown 
that many of the machine learning methods can be equally successful in 
classification (Nookala et al., 2013, Caruana & Niculescu-Mizil, 2006). Here we 
chose an artificial neural network (ANN).  
 
The ANN model is inspired by the neurons in the brain and is trained to associate a 
particular output with certain input features. A weighted combination of the input 
features is passed through transfer function in a threshold unit to determine the 
output of a neuron, as described in detail in Chapter 3. This output is then sent to the 
next layer or output to provide the class. Here the input features are protein 
properties and the final output is given as 01 representing uncrystallisable (failure) 
and 10 for crystallisable (success). 
6.3.1. Validation 
Figure 45 shows a binomial distribution for a sample of 382 experiments, with each 
experiment having a 0.5 probability of being classified correctly. Only the range 
from 40% to 60% accuracy is shown, as this is the range of accuracies most likely to 
occur if each sequence had a 0.5 probability of being classified accurately. The 
probability of accurately classifying precisely half (191/382) of the sequences by 
random chance would be 0.04. The probability of classifying more than 207/382 
sequences (54.2%) by random assignment is less than 5%. For most purposes, this 
would be the accuracy at which the null hypothesis (the distributions are the same) 
would be rejected in favour of the alternative hypothesis (the distributions are 
different). Similarly, the probability of classifying fewer than 162/382 (42.4%) of 
sequences by random assignment is less than 5%. The value of 5% is the probability 
of making a type 1 error, rejecting the null hypothesis when it is true. Similar random 
distributions were created for different numbers of experiments. In each instance the 
distribution was normally distribution around a mean of 50% accuracy with a 
varying standard deviation (increasing for smaller samples and vice versa). 
  
124 
 
 
Figure 45: Accuracy for random probabilities. 
The binomial distribution for 382 experiments with the probability of success of 0.5 gives a 
mean accuracy of 50% with a standard deviation of 2.5%. There is 99.9% probability that the 
accuracy rate for 382 random experiments, with a 50% chance of success for each 
experiment, lies between 40% and 60%. 
6.3.2. Training 
 
 
 
 
 
 
 
 
Table 11: The accuracy during training for different feature sets. 
The features from the named feature sets were determined for each sequence in the FEAT 
dataset and used to train a neural network. During training, 15% was used as an internal test 
set and the results for each feature set are shown. 
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Feature Set  15% Testing Set Accuracy (%) 
fsOur87 75.7 
fsUncorrelated 79.4 
fsOB 69.7 
fsCRYSTALP 74.3 
fsParCrys 75.2 
fsCRYSTALP2 74.3 
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In order to compare the results of the neural network with reported results using 
other machine learning algorithms, we trained the network with different feature sets. 
In each case, the FEAT dataset was used and was split into training, validation and 
test data sets in the ratio 70:15:15. Using a feed-forward network with the 
Levenberg-Marquardt training method, various architectures were trialled for each 
feature set using the Neural Network Toolbox in Matlab (MathWorks, 2011).The 
optimal architecture was used in each case, where the simplest model with greatest 
accuracy on the test set was considered as optimal. The difference between training 
and testing accuracies was used to check for over-fitting. For all feature sets the 
optimal architecture was found to have two nodes on each of two hidden layers. The 
accuracy of the training test set is shown in Table 11. 
6.3.3. Testing 
In order to compare the results from our neural network with those of others, we used 
our trained network with the previously used independent test data sets, TEST-RL, 
TEST and TEST-NEW. The results for each set of features from each test data set 
are shown in Table 12. The results for each test set, using for our own feature sets are 
also shown Table 13. 
 
Feature Set 
TEST-
RL 
TEST TEST-NEW SGC61POS SGC382NEG 
fsOur87 77.9 78.5 68.8 29.5 85.8 
fsUncorrelated 74.4 77.1 71.0 57.3 68.3 
fsOB 70.9 67.4 68.3 62.3 39.5 
fsCRYSTALP 60.5 55.6 60.9 57.4 56.8 
fsParCrys 75.6 76.4 73.9 49.2 68.8 
fsCRYSTALP2 59.3 60.4 63.2 39.3 60.5 
 
Table 12: Accuracy of testing sets. 
A comparison of the accuracy achieved using different feature sets on five different test data 
sets. Overall the most successful feature sets are fsParCrys (bold) and our own 
fsUncorrelated. 
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Table 12 shows the accuracy for different feature sets ranges from 29.5 to 85.8%. 
Using publicly available datasets, the features used in the ParCrys predictor provide 
the best results with our own uncorrelated feature set giving comparable results. The 
46 features from CRYSTALP perform worse with the neural network than the OB-
Score features, of which there are only two. This shows that the success of the 
predictor does not depend on the number of features used.  
 
Table 13: Comparison of results. 
The results are shown for the standard test data sets obtained using a neural network trained 
the fsParCrys feature set in comparison with the results for other predictors (obtained from 
Mizianty and Kurgan (2012)). 
 
Table 13 shows the results for the neural network trained with the fsParCrys feature 
set in comparison to other published predictors. Although CRYSPred performs best 
for two datasets, TEST-RL and TEST, both contain duplicate entries and are smaller 
than the TEST-NEW dataset. In fact our network trained with the fsParCrys feature 
set outperforms CRYSPred on the larger TEST-NEW dataset and uses fewer and 
simpler features. Again, there appears to be no connection between the number of 
features and the accuracy of the predictor. 
  
We also used the trained networks to predict the crystallisability of the SGC data and 
obtained mixed results. For most feature sets the results seem to be biased towards 
either positive or negative outcomes and are generally lower than those obtained for 
the publicly available data. In some instances, fsOur87 for example, the result is 
Predictor Number of Features TEST-RL TEST TEST-NEW 
fsParCrys 13 75.6 76.4 73.9 
CRYSpred 15 80.2 79.9 73.4 
XTALPred 9 76.7 79.2 70.0 
CRYSTALP2 88 69.8 75.7 69.3 
ParCrys 13 79.1 71.5 70.6 
OB-Score 2 69.8 64.6 Unreported 
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worse than randomly choosing between success and fail. This suggests that the data 
used for training is not representative of the data being tested.  
6.4. Biochemical parameters 
In the previous analysis it has been demonstrated that a selection of features derived 
from a protein sequence can, to some extent, be used to predict whether a protein can 
be crystallised. The nature of the neural network with two hidden layers, each with 
two nodes, makes it difficult to determine which features are most important for the 
separation of the two groups. The features (pI; GRAVY; counts of the amino acids: 
D, C, G, H, M, F, P, S, T, W and Y) from the most successful feature set, ParCrys, 
were used to further explore the properties than can be used to determine 
crystallisability. 
6.4.1. Individual Parameters 
The thirteen features in the ParCrys feature set were used separately in linear 
discriminant analysis (LDA) to determine the discriminatory power of individual 
features. The LDA was created in R using the entire FEAT dataset for training. 
 
LDA results show the features pI and GRAVY to be the most powerful when it 
comes to predicting the outcome of a crystallisation experiment. This might be 
expected as these features have been used with several predictors (Overton & Barton, 
2006, Overton et al., 2008, Kurgan et al., 2009), Isoelectric point shows notably 
different rates of accuracy across the different datasets (Table 14), showing a bias 
towards positives on the SGC data. It might be expected that features involving the 
amino acids used in pI calculation (D, C, H and Y) would have better discriminatory 
power than the other amino acids. Similarly, it might be expected that the 
hydrophobic phenylalanine (F) and hydrophilic aspartic acid (D) would have greater 
discriminatory power than demonstrated because of their close link to average 
hydrophobicity. However, this is not the case. The use of the different amino acid 
counts as a feature varies across the different test sets and no single amino acid count 
stands out as particularly useful for classification. For the SGC datasets some of the 
amino acid features give results that are worse than random guessing.  
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Feature TEST-RL TEST TEST-NEW SGC61POS SGC382NEG 
pI 66.3 66.0 69.9 57.3 32.9 
GRAVY 53.5 52.1 57.7 52.4 66.8 
D 53.5 47.9 64.6 50.8 57.6 
C 53.5 62.5 56.2 44.3 72.0 
G 53.5 43.1 58.8 42.6 67.5 
H 50 43.1 55.1 59.0 30.1 
M 50 45.1 57.3 50.8 56.0 
F 50 38.9 57.5 45.9 59.7 
P 51.2 35.4 53.0 41.0 65.2 
S 54.7 64.6 46.5 59.0 41.6 
T 53.5 38.2 59.5 44.2 61.3 
W 53.5 47.2 52.7 39.3 66.5 
Y 47.7 46.5 60.7 47.5 48.4 
 
Table 14: Accuracy of individual features for prediction. 
The percentage accuracy is shown for the different test sets when using each feature 
individually in LDA to classify as either crystallisable or non-crystallisable. The FEAT 
dataset was used for training and TEST-RL, TEST and TEST-NEW for testing.  
6.4.2. Combinations of Parameters 
The thirteen features from ParCrys were also used together in LDA. Discriminant 
functions were identified using the FEAT dataset and four fold venetian blind cross-
validation. In each fold 25% of the data was used as the training set and the 
remaining 75% was used as the test set. The results from each of the four (non-
overlapping) subsets are shown in Figure 46. On average the LDA achieved 70% 
accuracy across the four test sets, with only marginal differences between them. 
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Figure 46: Summary of cross-validation results. 
LDA was performed using the ParCrys features on the FEAT dataset with four fold cross-
validation. The figure shows the percentages of correct (dark) and incorrect (light) 
classifications on the test data. 
 
 
Figure 47: LDA loadings for the FEAT dataset with ParCrys features. 
The loadings of the four linear discriminant functions obtained for the FEAT dataset show 
that GRAVY, pI and the number of cysteines are the dominant features in determining 
whether a protein will crystallise for each of the four testing sets. 
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Not only were the results similar for each of the four test sets, but in each model the 
linear discriminant created from 25% of the data was dominated by GRAVY, 
followed by pI and the number of cysteines as indicated by the loadings in Figure 45. 
The other ten features had loadings of 0.1 or less showing that they contribute little 
to the discriminant functions. In the analysis of individual features, C (the cysteine 
count) did not appear to be useful for discrimination, but when combined with 
GRAVY and pI, it does seem to have some discriminatory power. This is also true to 
some extent of Y (the tyrosine count), it has the fourth highest loading when used in 
combination with other variables. Although GRAVY, the sum of hydropathy values 
scaled by residue count, has the greatest discriminatory power, the features F 
(phenylalanine count) and D (aspartic acid count), which are closely associated with 
hydrophobicity, do not appear to be useful. It may be that these features cannot add 
to the discrimination due to their high correlation with GRAVY.  
 
When the three parameters, GRAVY, pI and the number of cysteines, are plotted 
against each other, some separate areas corresponding to crystallisable and non-
crystallisable sequences can be seen (Figure 48). It can be seen that the crystallisable 
proteins are clustered in an acid to neutral pI, with a slightly negative GRAVY value 
and a low cysteine count. The number of crystallisable proteins outside of this zone 
decreases to a handful, although the opposite is not true. The non-crystallisable 
proteins are spread across a large area in all three parameters.  
 
The model was used to categorise the sequences in the TEST-NEW set and achieved 
a correct classification rate of 73%. However, none of the neural network models, 
trained using the fsParCrys or other feature sets, were able to classify both the 
positive and negative sequences in the SGC data well. 
 
Figure 49 shows the three parameters, GRAVY, pI and the number of cysteines, 
plotted against each other, for the SCG data. As with the TEST-NEW data, the 
uncrystallisable proteins are spread across a large area of this parameter space. 
Although many sequences corresponding to proteins that crystallise are in the zone 
identified for the TEST-NEW data (acid to neutral pI, with a slightly negative 
GRAVY value and a low cysteine count), they are also spread across a larger area, 
making the overlap greater for the SGC data than for the TEST-NEW data. 
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◊ Crystallisable ○ Non- Crystallisable 
 
Figure 48: TEST-NEW data based on the most discriminatory variables. 
The TEST-NEW data is plotted for the variables GRAVY, pI and the number of cysteines. 
Crystallisable proteins are represented by blue diamonds and non-crystallisable proteins by 
red circles.  
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◊ 
Crystallisable 
SGC61POS ○ 
Non- Crystallisable 
SGC382NEG 
 
Figure 49: SGC data based on the most discriminatory variables. 
The two SGC datasets plotted for the variables GRAVY, pI and the number of cysteines. 
Crystallisable proteins (SGC61POS) are represented by blue diamonds and non-
crystallisable proteins (SGC382NEG) by red circles.  
 
As the data for each of the three properties pI, GRAVY and cysteine count was not 
normally distributed for the FEAT dataset, the non-parametric Mann-Whitney-
Wilcoxon test (MWW) was performed and revealed differences in the populations 
between the positive and negative sequences of the FEAT data for all three 
properties. However, the difference between positive and negative populations for 
SGC data was not so well defined. For the isoelectric point and cysteine count the 
null hypothesis (there is no difference between positive and negative populations), 
could not be rejected with p-values of 0.23 and 0.95 respectively. A p-value of 0.001 
provided evidence against the null hypothesis for the variable GRAVY, suggesting a 
difference between the distributions of the hydrophobicities of the positive sequences 
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and the negative sequences. The problem in classification occurs because, although 
the negative SGC dataset has a similar distribution to the negative FEAT dataset used 
for training, the positive SGC data has a different distribution to the positive FEAT 
dataset. Furthermore the positive SGC data has a similar distribution the negative 
FEAT dataset. The distributions are shown in Figure 50. 
 
 
Figure 50: Boxplots of GRAVY values for the FEAT and SGC datasets. 
The four boxplots show the distribution of the GRAVY values for the positive and negative 
sequences in the FEAT and SGC datasets datasets. The line in the centre of the box 
represents the median, the lower and upper bounds to the box represent the first (25%) and 
third (75%) quartiles. Each whisker is drawn to the most extreme value within 1.5 box 
lengths of its respective box boundary. Circles are representative of data points more than 
1.5 box lengths away from the closest box quartile and stars are 3 box lengths away. It can 
be seen that the SGC61POS and SGC382NEG populations both have median values closer 
to that of FEAT negative than that of FEAT positive. 
 
The overall homology of the sequences was also inspected, as strong homology 
would compound the number of incorrect classifications. The correlation between the 
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properties of each pair of sequences was found to be non-significant (at 5%). The 
sequences were also separated into their families (determined by the SGC) and the 
standard deviation calculated for each feature, this again revealed that there was no 
similarity between sequences, as suggested by standard deviations that were large 
with respect to the mean. To further test the classification, a much larger set from the 
PDB was used. The ParCrys features were calculated for 25,316 sequences from the 
PDB. The neural network using these features, that had previously achieved an 
average of 75% accuracy on three test datasets, was used to classify this PDB data 
and only achieved 55% accuracy. Restricting the PDB data to sequences submitted 
between July 2006 and December 2008 to reflect the dates of the TEST-NEW data 
did little to improve the accuracy with just 58% (3180/5453) correctly predicted as 
crystallisable. As shorter sequences are not well represented in the FEAT dataset, we 
also tried restricting the PDB data to sequences more than 99 amino acids in length. 
Again an accuracy of just 58% (13,233/22,829) was achieved. To ensure our 
methodology was not the cause of the low prediction rate we used another predictor. 
Taking a random sample of 1,000 sequences from the PDB with length between 100 
and 1,000 residues we were able to use the CRYSTALP2 online predictor (Kurgan et 
al., 2009). Again the accuracy was low, with only 60% of sequences correctly 
classified as crystallisable'  
 
 
Predicted  
Crystallisable Non-Crystallisable  
A
ct
u
a
l 
PDB 13,955 
55.1% 
11,361 
45.9% 
 
    55% 
45% 
 
Figure 51: Confusion matrix for the prediction of PDB sequences. 
The classification results are shown for 25,316 sequences from the PDB, of which the neural 
network correctly predicted just 55%. 
 
The original training and test datasets were both obtained from TargetDB and no 
PBD data was included in either (FEAT or TEST-NEW). Kurgan et al. (2009) 
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specifically state that crystallisable proteins in the TEST-NEW dataset were chosen 
if they were annotated as having "Diffraction-quality Crystals", but not annotated 
with In PDB in the Status field. No motivation for excluding sequences resulting in 
PBD structures is given. The reason for sequence differences between proteins 
designated as producing diffraction-quality crystals in TargetDB and those that result 
in a structure deposited in the PDB is not clear. One possible explanation is the fact 
that only structural genomics targets are included in TargetDB and may be restricted, 
for example by particular medical interests, whereas structures deposited in the PDB 
are from a wider, and potentially more difficult to crystallise, range of proteins. On 
the other hand, proteins for which diffraction data is collected, but the structure is not 
solved are presumably the most different from known protein structures. Diffraction 
data is collected for about a third of the structural genomics targets for which crystals 
are obtained and only two-thirds of these result in a protein structure in the PDB 
(Westbrook et al., 2003). Sequences from these proteins with diffraction-quality 
crystals, but no PDB entry are precisely those included in the training and test 
datasets producing models that do not generalise to PDB data.  
6.5. Discussion and Conclusions 
It has been stated that the use of several predictors together could allow accurate 
classification of 90% of sequences (Mizianty & Kurgan, 2009). The datasets used are 
sufficiently large to overcome any difficulties with accuracy caused by data size 
(Cunningham, 2000) and the number of features searched is large, 34,618 (including 
34,000 from n collocated amino acids). However, the number of features that could 
possibly be calculated from a protein sequence is unknown. For example, the user 
could potentially determine that the oligomeric state (determined through PDB 
search for protein similarity) or the amount of n collocated amino acids could 
determine the difference between the positive and negative datasets.  
 
Several values of n, for n collocated amino acids have been used in previous 
predictors to determine a protein's crystallisability (Chen et al., 2007, Kurgan et al., 
2009, Charoenkwan et al., 2013). In our search, however, we find like others that 
isoelectric point and grand average of hydrophobicity are the properties that hold the 
most predictive power (Goh et al., 2004, Overton & Barton, 2006, Mizianty & 
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Kurgan, 2009). A search for further features is likely to involve complex properties 
and be based on predictions such as secondary structure or molecular interactions, 
which are currently limited to 80% accuracy (Dor & Zhou, 2007), but are already 
included in some predictors (Mizianty & Kurgan, 2012, Smialowski et al., 2006).  
 
We aimed to find out, not only 'will my protein crystallise?', but 'why will my protein 
crystallise?' and the information provided from the black box method of a neural 
network cannot answer this. We therefore also used linear discriminant analysis 
(LDA), which is easier to interpret, but was unable to classify as accurately. From 
this, we were able to show that just three features, pI, GRAVY and cysteine count, 
were providing the majority of the discrimination between classes. 
 
The use of pI and GRAVY has been shown before to have predictive power when it 
comes to determining the crystallisability of a sequence. In a study of 500 proteins 
from the Thermotoga maritima proteome, Canaves et al. (2004) were able to show 
that that crystallisable proteins are located in a cluster, similar to ours, in the 
GRAVY-pI parameter space. The results of other predictors also demonstrate the 
usefulness of GRAVY and pI (Overton & Barton, 2006, Kurgan et al., 2009). 
 
Artificial neural networks have been shown to be as good as any other classifier 
(Nookala et al., 2013) and indeed we were able to produce a classifier that is 
comparable to the best of those already available when applied to the same datasets. 
Our results show that neural networks can be used to predict whether a sequence will 
crystallise, at least as successfully as any other machine learning method. Over three 
publically available test sets our neural network successfully classified more 
sequences than any other predictor. Although the percentage accuracy is a marginal 
improvement over the previous best classifier, CRYSpred (Mizianty & Kurgan, 
2012), the model is simpler. Our classifier uses two calculated values: isoelectric 
point and grand average of hydrophobicity along with 11 counts of amino acid 
frequency. In comparison, the features used in CRYSpred include the sum of 
predicted disorder scores and the distribution of amino acids in alpha helices in 
thermophilic and mesophilic proteins. As CRYSpred requires features obtained from 
a predicted secondary structure, it follows that if this prediction is wrong any 
classification using this information is also likely to be wrong. Occam's razor 
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suggests that a simpler model should be selected over a more complicated model 
without strong evidence to support its use. In classification, a simpler model also 
helps to prevent over-fitting.  
 
The use of sequence-derived variables as useful indicators of a proteins propensity to 
crystallise must be questioned, given that these are optimised to identify the most 
promising crystallisation targets from particular protein families. The problems in 
classification of the SGC and PDB data must be caused by properties intrinsic to the 
proteins in these datasets. Difficulties in predicting whether a protein will crystallise 
may arise due to the purification process, or to chemical and physical parameters 
which are not considered in sequence-based predictors (Smialowski et al., 2006). In 
order to re-train classification algorithms, data on unsuccessful experiments would be 
needed as well as data on successful experiments, such as can be obtained from the 
PDB. Information on failed experiments is also necessary to investigate the 
relationship between protein properties and the conditions that result in crystals 
(Hennessy et al., 2000). This could potentially allow properties that can be measured 
or calculated before crystallisation trials begin to be used to predict the best initial 
conditions to try. 
 
PPCpred (Mizianty & Kurgan, 2011) and PredPPCrys (Wang et al., 2014), both 
available online, have not only determined protein crystallisability but also whether it 
will pass certain stages of the structure determination pipeline. Once the decision has 
been made to progress with crystallisation it is then necessary to determine under 
which conditions a protein will crystallise. 
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7. The Propensity of Chemicals to 
Promote Crystallisation 
Once a crystallographer has decided to attempt to crystallise a protein, whether or not 
persuaded by the outcome of a predictor, it is necessary to determine suitable 
conditions. In 1962 Max Perutz and John Kendrew were awarded the Nobel Prize for 
Chemistry for being the first people to solve the structure of a complex protein, 
specifically equine haemoglobin (MFPL, 2012). Perutz once said "crystallisation is a 
little like hunting, requiring knowledge of your prey and a certain low cunning" 
(Fink et al., 2009), which caused Hennessy et al. (2000) to pose the question "are 
there good hunting grounds?", or less poetically, are there favourable regions of 
crystallisation parameter space? The search for successful regions of parameter space 
using complete factorial sampling is not possible. This problem is further 
compounded by physical properties such as pressure, gravity and biochemical 
properties such as the protein itself and any ligands. 
 
One method for optimal searching of crystallisation parameter space uses regions of 
known success. For example, Jancarik and Kim (1991) describe the design of a 
sparse matrix screen which used the most popular conditions found in the literature. 
However, determining the success of individual chemicals from frequency counts in 
the literature and online repositories can be problematic. Repositories such as the 
PDB (Berman et al., 2000) and the BMCD (Tung & Gallagher, 2008) provide no 
negative examples and therefore give no indication of relative success rates, i.e. how 
many times a chemical is used before successful crystallisation (Newman, Bolton, et 
al., 2012). Consideration of the properties of the proteins to be crystallised, together 
with the success rates of the chemicals for particular types, would allow greater 
optimisation in crystallisation. This may be achieved using anecdotal evidence 
(Samudzi et al., 1992) or the use of statistical analysis. 
 
In 2004 Rupp and Wang provided a broad overview of some of the issues in 
crystallisation and suggested generic techniques that could be used to improve the 
attrition rates of protein crystallisation. They suggest a method of normalised 
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frequency analysis known as crystallisation propensity to provide relative success 
rates. This takes into account both positive (crystalline) and negative (non-
crystalline) outcomes and may provide support for the reduced use, or even removal 
from screens, of less successful chemicals and allow focus on those with higher 
success rates.  
 
Propensity is an intra-property comparison, for example, pH 6.5 can be compared 
with pH 7.5, and provides a statistic that ranges from 0 upwards. It provides an 
indication of how a specific property of parameter space (chemical, pH or protein) 
relates to the average property. For example, a propensity value of 2 suggests that 
protein x is twice as likely to crystallise as the average protein, whereas a value of 
0.5 suggests that protein y is only half as likely to crystallise as the average. 
Throughout this chapter a trial refers to the data associated with one particular well 
from one specific screen. 
 
The crystallisation propensity for a parameter is defined as follows: 
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Figure 52: Visualisation of propensity. 
As a whole, the circle (A + B + C + D) represents all trials. The section beneath the 
horizontal chord (C + D) represents those trials that resulted in crystalline material and the 
section to the right of the vertical chord (B + D) represents trials with the property for which 
the propensity is being calculated. A represents those trials without the property or result in 
crystalline material; B represents trials with the property but do not give crystalline material; 
C represents trials without the property but do result in crystalline material; and D represents 
those trials with the property resulting in crystalline material. 
 
Re-writing equations 26 and 27 to correspond with Figure 52 gives:  
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In demonstrating the usefulness of propensity, Rupp and Wang analysed data from 
the TB structural genomics consortium on 230,000 crystallisation trials, sampling 55 
chemical species across 5 unit intervals of pH from pH 4.5. They found that the 
propensity of all chemical species in their data was normally distributed which 
allowed them to define 'supercrystallisers' - the chemical species in the top 5% of the 
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distribution. At the other end of the spectrum, although not discussed by Rupp and 
Wang, this allows 'awfulcrystallisers' to be defined- the chemical species with a 
propensity in the bottom 5% of chemicals. 
 
The results of Rupp and Wang show that just under half (45%) of their chemicals 
have a propensity greater than one, with the top ten chemicals, the supercrystallisers, 
including PEG 2000 MME, PEG 5000 MME, PEG 2000, PEG 6000, PEG 4000 PEG 
400, calcium chloride, sodium formate, potassium sodium tartrate and MES. The 
eight awfulcrystallisers are 2-butanol, isopropanol, MPD, EDTA, ammonium 
phosphate and acetate, ethanol and DMSO. 
7.1. Results 
We have investigated crystallisation propensity with new data and compared our 
results with those in the literature. The AstraZeneca dataset has information on 
573,786 crystallisation trials. This includes 13,550 (2.4%) successful trials, where a 
trial with any crystalline result is deemed a success. In this analysis we only consider 
the chemicals in the crystallisation screens as variables and do not consider 
temperature, purification method, or the use of ligands due to the extent of missing 
data in these fields. The proteins include human, bacterial, virus and other 
mammalian targets. Although propensity cannot be calculated for data in the PDB, 
due to the lack of negative results, it is still possible to perform frequency analysis to 
determine the chemicals that are used most often. We show that the chemicals 
contained within a well are interdependent and that the propensity of one chemical is 
affected by another, but that propensity does provide more information than simple 
frequency counts. 
 
Propensity analysis for the 37 chemicals in nine screens at AstraZeneca (Figure 53) 
suggests that slightly more than half (55%) of the chemicals perform better than 
average. The propensities were not normally distributed (as verified with a QQ plot 
and a KS test) so it was not possible to define supercrystallisers. The top 10 includes 
four salts (lithium sulfate, magnesium chloride, calcium acetate and ammonium 
sulfate), two buffers (TRIS and PCTP) and one organic (ethanol).  
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Figure 53: The propensity of chemicals in AstraZeneca screens. 
The propensity of 37 chemicals used in the nine screens of the AZ dataset. Propensities were 
calculated using 13,550 crystalline results from 573,786 trials. Error bars are not shown, as 
they are negligible after normalisation due to the large sample size. 
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The top ten chemicals with the highest propensity also includes three PEGs of 
varying weights (3350, 2000 MME, 8000). To the best of our knowledge, PEG 
(6000) was first used to crystallise alcohol oxidase in 1968 (Janssen & Ruelius). It 
was not until ten years later that PEGs became the reagent of choice, following an 
endorsement from McPherson Jr (1976) who concluded that 
 
'[PEG] may be the best initial trial reagent for crystallisation'. 
 
A summary of 44,063 crystallisation conditions from the PDB dataset also suggests 
PEG to be a successful crystallisation reagent, appearing three times in a list of the 
top ten chemical species (Table 15). Like Figure 53, this also includes the buffer 
TRIS and the salts magnesium chloride and ammonium sulfate along with five other 
chemicals. 
 
Rank Chemical Count 
1 PEG 3350 9,264 
2 TRIS 8,375 
3 Ammonium sulfate 8,225 
4 HEPES 5,795 
5 PEG 4000 5,637 
6 Sodium chloride 5,248 
7 Sodium acetate 5,194 
8 PEG 8000 4,095 
9 Magnesium chloride 3,845 
10 MES 3,664 
 
Table 15: The ten most prevalent chemicals reported in the PDB. 
The ten most prevalent chemical species are shown together with the number of entries in the 
PDB-BLAST-reduced dataset, consisting of 44,063 PDB entries. 
 
Subsequent studies of crystallisation data have provided evidence to support 
McPherson’s claim (Hui & Edwards, 2003, McPherson, 1999). In 1984 PEG was 
ranked second in a list of species used to induce crystallisation (Gilliland & Davies, 
1984) and in 1991 PEGs were included in half (25/50) of the wells of Jancarik and 
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Kim's popular sparse matrix screen. PEGs have also been previously reported to be 
amongst the most prevalent chemicals in the PDB (Fazio et al., 2014, Peat et al., 
2005) and have shown to be more successful in crystallising protein-protein 
complexes than ammonium sulfate (Radaev & Sun, 2002). Although the mechanism 
that allows PEGs to be successful crystallization reagents is not well understood, it 
appears that they compete with water molecules to interact with the protein, forcing 
it out of solution (McPherson, 1989a, Lee & Lee, 1981). The varying weights and 
lengths enable a steric exclusion mechanism to occur that excludes protein from 
zones of the solution and increases local activity and solubility (Laurent, 1963, Ward 
et al., 1975). A further advantage is that since they are of neutral pH they do not 
require large concentrations of buffer, however, we have shown previously that they 
become acidic over time (Ray Jr & Puvathingal, 1985) and as a result it might not be 
possible to reproduce certain crystallisation experiments. 
 
A study of one protein, Aspergillus flavus urate, showed that modification of the 
concentration and the weight of PEG included in a crystallisation solution can 
modify chemical parameter space in such a way that the thermodynamic parameter 
A2 is changed and moved into the 'crystallisation slot', where crystallisation is more 
favourable. A2, the second virial coefficient, is used to provide corrections to the 
ideal gas law. In practice A2 is a number obtained by interpreting Static Light 
Scattering (SLS) output (Kratochvíl, 1987) or through self-association 
chromatography (Tessier & Lenhoff, 2003). It has been shown by George and 
Wilson (1994) that proteins which successfully crystallise have an A2 value between 
-1 x 10
-4 
and -8 x 10
-4
. With this knowledge, Vivares and Bonneté (2002) were able 
to show that different crystallisation parameters such as pH, temperature and the 
volume and weight of PEG in the crystallisation solution could affect the experiment 
such that A2 was in the range in which crystallisation had been shown to occur. 
 
Other successful chemicals are either salts or buffers used to control pH and assumed 
to be otherwise chemically inert with respect to crystallisation (although this is 
contestable (McPherson, 1995). The salts have a similar effect to PEGs in 
crystallisation solutions, by competing with the protein for water molecules 
(McPherson, 1989a). In some instances metal cations (and anions) from salts, such as 
those of calcium and magnesium, bind to proteins and can stabilise the crystal lattice 
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(Kretsinger, 1976, Jayachandran et al., 2007). Whilst sodium chloride and 
ammonium sulfate increase solubility, magnesium chloride has been suggested to 
decrease solubility by binding to the protein and freeing up water (Arakawa & 
Timasheff, 1985, Kretsinger, 1976, Jayachandran et al., 2007). Many of these salts 
have been identified in successful crystallisation conditions before, using data from 
the PDB (Peat et al., 2005) and the BMCD (Lu et al., 2012), but the literature is 
inconclusive as to whether they do encourage crystallisation. Two studies reported 
sodium chloride to be a poor crystallisation reagent, but suggested ammonium sulfate 
to be successful (McPherson, 2001, Rupp & Wang, 2004). In their analysis of 
crystallisation propensity, Rupp & Wang also found that magnesium chloride was 
less likely to produce crystals than the average chemical.  
 
Surprisingly, analysis of the AZ data shows ethanol and lithium sulfate to be 
successful crystallisation reagents. The success rate of lithium sulfate was previously 
shown to be average (Rupp & Wang, 2004, McPherson, 2001) and ethanol has been 
reported amongst the least successful groups of chemicals in crystallisation (Hosfield 
et al., 2003, Page & Stevens, 2004, Rupp & Wang, 2004). Ethanol is included as a 
cryoprotectant and has been shown to have to no ill effect (Tran et al., 2004, Farley 
& Juers, 2014). As it occurs in many successful solutions in the AZ data, it does 
appear that ethanol does not adversely affect crystallisation. Organic chemicals tend 
to evaporate from the crystallisation solution to the sitting drop, causing the 
concentration in the drop to fall rather than to increase to a supersaturated state 
(Kimber et al., 2003). To compound this, certain concentrations of some organic 
chemicals denature the protein by acting like a detergent (where part of the molecule 
binds with the protein and the other part binds with water) (McPherson, 1989a). 
 
In contrast to the highly successful chemicals, some additives appear in very few 
successful crystallisation solutions. In analysis of the PDB data, 268 chemicals have 
been used fewer than five times, with 108 leading to a single protein structure. For 83 
of these 108 chemicals (76%), a protein structure was obtained for the same BLAST 
group using alternative conditions. The other 25, of which 8 are ligands, are 
chemicals that did lead to a unique protein structure and might be considered a last 
resort list. The chemicals with the lowest propensities in our data contained the set of 
custom chemicals, referred to as AZ crowns, which were designed to contribute 
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similar effects to crystallisation as PEGS. As these chemicals were not used for many 
projects and do not appear in the literature, it is not possible to give a reason for their 
low propensity. Another group of chemicals with low propensity are pH amending 
chemicals, including potassium and sodium dihydrogen phosphates and some PEGs 
(possibly degraded). It is possible that, due to their structure, these chemicals have an 
effect on pH in addition to their effect on crystallisation as a salt. 
 
 
Figure 54: The effect of pH on propensity. 
The propensity of 25% v/v PEG 3350 with 0.2 M magnesium chloride is shown for different 
pH values (as determined using spectrophotometry). Data was obtained from one filter 
screen with 809 crystalline results in 33,828 trials. Errors shown are normalised proportional 
errors. 
 
Figure 54 shows that the propensity of PEG 3350 varies with pH, with values 
between 0 and ~2.75 and potentially up to 3.3 when allowing for error. Thus 15% v/v 
PEG 3350 could be considered more than twice as effective in crystallisation as the 
average chemical, but the variation in propensity means that it could also be viewed 
as a chemical that does not result in crystalline material. Propensity can therefore 
only be useful if pH is taken into account in the calculation. Furthermore, the results 
shown here are for magnesium chloride and PEG 3350 together, so these trials count 
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positively towards the propensity of both chemicals, even though one may have had 
no effect on crystallisation.  
 
 
Figure 55: The propensity of PEG 3350 with different chemicals. 
The propensity for 15% v/v PEG 3350 with 0.1 M ammonium sulfate is compared to 15% 
v/v PEG 3350 with 0.1 M magnesium chloride. Data was obtained from the Filter 2 screen 
with 497 crystalline results out of 22,712 trials.  
 
Figure 55 shows how varying the chemical combination within a screen can affect 
the propensity. The two graphs show that propensity changes when PEG 3350 is 
combined with different chemicals. Near pH 5.5 the propensity of PEG 3350 with 
either chemical is roughly similar, but near pH 7, PEG 3350 with ammonium sulfate 
has a propensity of ~0.75 (less than average) whereas PEG 3350 with magnesium 
chloride has a propensity of ~2.75 (almost 3 times the average). Thus, we must 
consider combinations of chemicals rather than individual components within a 
crystallisation solution.  
 
The C6 distance metric (Newman et al., 2010) provides a similarity measure between 
crystallisation conditions and gives the distance between PEG 3350 with ammonium 
sulfate and PEG 3350 with magnesium chloride as 0.66, provided the pH is the same 
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for both solutions. However, the observed difference between these two solutions 
does not show the same result. 
 
 
 
Figure 56: The effect of proteins on propensity. 
Propensity was calculated for 15% v/v PEG 3350 with 0.1 M ammonium sulfate across a 
range of pH for two screens. The propensity for the Filter 2 screen was calculated based on 
497 crystalline results out of 22,712 trials and the propensity for the Filter 4 screen was 
calculated from 701 crystalline results out of 33,048 trials.  
 
We must also consider the proteins involved in the propensity calculations. Figure 56 
shows data for the same experimental condition, 15% v/v PEG 3350 with 0.1 M 
ammonium sulfate, calculated from two different screens, Filter 2 and Filter 4. As the 
projects being screened are different, the two sets of proteins are mutually exclusive. 
The variation shown in Figure 56 is predictable; if all proteins crystallised in the 
same conditions, then parameter space could be reduced to a set of core conditions 
and resource-consuming exploration would no longer be required. It also shows that 
all proteins that crystallised in the Filter 2 screen have a better than average 
propensity to crystallise in these conditions whereas proteins that crystallised in the 
Filter 4 screen only ever perform below or close to average. For example, at pH 6.5 it 
0.0
0.5
1.0
1.5
2.0
2.5
5.5 6 6.5 7 7.5 8 8.5
P
ro
p
en
si
ty
 
Spectrophotometric pH 
Filter 2 Filter 4
  
149 
 
is possible to see a propensity of ~2.5 for Filter 2 and ~0.7 for Filter 4. As the 
conditions are the same, the difference must be due to the proteins being screened. 
This shows that quite different results can be obtained, depending on the proteins 
involved. In fact the results here contradict those displayed in Figure 51 which shows 
pH 4.5 to have a propensity well below average, whereas here it can be seen that for 
some proteins pH 4.5 has twice the average propensity. 
 
 
Figure 57: Success rates for AZ screens. 
The rate of success for five evolutions of a filter screen and four evolutions of a sparse 
matrix screen used in initial screening at AstraZeneca are shown. The figures shown are as 
follows: (1) the number of projects crystallised; (2) the number of projects attempted; (3) the 
number of wells containing crystalline material; and (4) the number of wells in total. 
Proportional error bars are shown. 
 
The screens at AstraZeneca have evolved over time as poor chemical combinations 
have been identified and removed. This should mean that the more recent the screen 
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is, the more successful it should be. Screen evolution is indicated by the number 
following the screen type, so that, for example, Filter 3 has evolved from Filter 2. 
The success rates for evolutions of the filter screen are shown in Figure 57. It can be 
seen that, in most cases, later screens are indeed more successful and the slight 
modifications to the screening conditions in the filter screen have been beneficial 
overall. The rate of success for Filter 2 is ~2% which falls to 1% for Filter 3. 
However, Filter 3 was only used with three projects so the sample size is too small to 
determine whether the modification to the screen was really detrimental or whether 
the result is just due to the proteins involved. Conversely, it is known that Filter 5 has 
an artificially high success rate of ~12% due to a particular project involving proteins 
that tended to crystallise easily. A similar pattern can be seen for the sparse screen, 
with the initial Sparse 0 having a success rate of 1.5% and this being gradually 
improved to 4% for the latest version, Sparse 3. 
7.2. Discussion and Conclusions 
7.2.1.  Average Success Rate  
One issue with the use of the propensity formula is how to calculate the average 
success rate (AS) and from what data. The problem is that AS is described as the 
number of successful trials divided by the total number of trials. The total number of 
trials could include screens that have had no success and failed projects or just 
include those that have been successful on at least one protein. If a specific screen is 
being considered, then the total number of trials may mean the number of trials for 
that particular screen.  
 
The AstraZeneca screens selected for analysis were those that were commonly used. 
The removal of screens that were only used once or had no positive (successful) 
results means that we have, therefore, modified our AS. 
7.2.2. Hypersensitivity 
As most crystallisations trials are unsuccessful, the number of successful trials for 
each set of conditions is very small. This affects the reliability of the calculated 
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propensity, which is sensitive to small changes. For example, 2 successful trials out 
of 15 would give a RS of 0.133 (3 sig. fig.), divided by the average success rate of 
0.02 giving a propensity of 6.67 (3 sig. fig.). Having 3 successful trials out of 15 
gives a RS of 0.2, divided by the average success rate (0.02) gives a propensity of 10. 
By our definition of propensity this means that something that was 6 times more 
likely to crystallise than average is now rated 10 times as likely due to one crystalline 
result. It is also important to note that the rate of success is calculated from an 
observed rate and therefore changes from screen to screen.  
7.2.3. Protein Dependent Success Rate 
The average rate of success calculated depends on the number of trials with specific 
proteins and can be artificially raised by repeated experiments with those that 
crystallise easily in many different conditions. For example, one screen involved 7 
projects in a total of 4,473 trials, 5 of the projects were successful in 542 of the trials. 
The rate of success for this screen is therefore ~0.12 (542/4473), which is 
significantly higher than the ~0.02 obtained for all other screens. Further 
investigation revealed that one of the 5 successful projects crystallised in 432 of 646 
trials. This project has such a high success rate (~0.66) that the overall rate of success 
for the screen is artificially high. If data related to this project is left out of the 
calculations, the screen has an average ~0.02 success rate. 
 
A higher rate of success for a particular screen, therefore, does not necessarily mean 
that it has a significantly higher chance of crystallising a new protein, but can simply 
mean that a particular project was crystallised numerous times in it. 
7.2.4. Conclusion 
A comparison of the results obtained for the propensity of pH and chemical species 
in our study shows some differences with those obtained by Rupp and Wang. For 
example, PEG 2000 MME is their most successful chemical with a propensity of ~ 
2.4, but our results show a propensity of ~ 1.5. Of the 10 chemicals with the lowest 
propensities in our dataset, only one, MPD, is in the 10 lowest propensities of Rupp 
and Wang. The top 10 are broadly similar groups, highlighting the fact that PEGs are 
  
152 
 
highly successful chemicals. However, their presence in a solution can artificially 
boost the propensity other chemicals in the crystallisation solution. 
 
The complex nature of crystallisation means that changes in one parameter affect the 
results of another in a nonlinear way. As our data is limited to only specific 
combinations of chemicals/pH/protein it is difficult, using the propensity metric, to 
make any solid conclusions about revising the AstraZeneca screens to make them 
more successful. In order to provide a reliable measure, propensity calculations 
would need to involve combinations of chemicals, requiring much more data. As 
well as understanding the properties of the parameter space, it is clear that the 
properties of the protein also require analysis. As this data was not available to us it 
was not possible to link specific protein properties with patterns in crystallisation 
parameter space. 
 
The use of a statistic such as propensity provides an insight into success rates of pH 
and chemicals within a screen. It can provide statistical evidence that certain 
chemicals with anecdotal evidence of success, do not actually work. Conversely, it 
can provide support for chemicals with known success. The AZ crowns were 
removed from screen because they were observed as poor crystallisation reagents. 
However, due to the interdependence between chemicals and pH, the poor 
performance of chemical x might simply be because more buffer is required.  
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8. Minimal Set of Conditions 
Crystallisation screens cover a large range of crystallisation parameter space using 
different methods of sampling, many of which are described in the section below. 
Some are a systematic sampling of the space and some are designed with a target in 
mind. Here, we describe our method for a multi-target initial screen, which samples 
space in a non-systematic manner. We are able apply our algorithm to data from 
AstraZeneca and the PDB to design screens that, if used from outset, would have 
crystallised the maximum number of proteins while using the minimal number of 
conditions. In 1937, Laufberger crystallised ferritin by adding cadmium salts directly 
onto slices of the horse spleen (Laufberger, 1937, McPherson, 1991). Unfortunately, 
not all proteins crystallise so readily and are usually screened against various 
combinations of chemical species at different concentrations and pH in order to 
identify suitable crystallisation conditions. Carter and Carter (1979) used a factorial 
approach (Fisher, 1942) to rationalise the process of protein crystallisation screening. 
A complete factorial design is the systematic sampling of every combination of 
parameters. For protein crystallisation the number of possible salts, polymers, 
organic and non-organic solvents, detergents and other additives, at different 
concentrations, pH and temperatures, makes such a search impossible. Therefore, a 
method of incomplete factorial design was devised to sample a subset of parameter 
combinations. Carter and Carter explored 6 parameters: precipitating chemical, pH, 
temperature, divalent cation, counter anion and counter cation, further broken down 
into specific chemicals or units. For example, pH was investigated at just 4 levels: 
pH 4.5, 5.5, 6.5 and 7.5. In total, 35 combinations were used whereas a complete 
factorial design would have required 4,032. The volume of ethanol is the only 
difference between the two combinations in the example below and, therefore, only 
one of them would be included in the incomplete factorial screen: 
 
Combination 1 
pH 5, 289K, 15% PEG 3350, 200mM sodium chloride, 
100mM ammonium sulfate, 5% ethanol. 
Combination 2  
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pH 5, 289K, 15% PEG 3350, 200mM sodium chloride, 
100mM ammonium sulfate, 10% ethanol. 
Carter and Carter found polyethylene glycol (PEG) to be favourable for crystal 
growth, whereas they found sodium and ammonium salts detrimental. This latter 
conclusion was reached based on one protein, for which the best results were 
reported as ‘single, three-dimensional crystal showing little or no diffraction’. A 
later, more comprehensive study showed that the best crystals were actually obtained 
in ammonium sulfate with the previous apparent negative effect on crystallisation 
explained as misidentification of crystalline precipitate (Carter et al., 1988). 
 
 
 
 
Footprint 
 
Grid 
 
Random 
 
Figure 58: Crystallisation parameter space sampling. 
Representations of crystallisation screens that use different sampling methods are shown. 
The footprint screen is represented by blocks of three rows of three blue cubes spread across 
parameter space, the grid screen is shown as a block of nine red cubes on the centre left and 
the random screen is represented by nine yellow cubes spread randomly across parameter 
space. 
 
The sparse matrix screen was designed to sample those conditions known to be 
favourable for crystallisation rather than provide a systematic sampling of 
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crystallisation parameter space. Jancarik and Kim (1991) compiled a list of 50 
favourable crystallisation conditions, as determined from their own and others’ 
experience. This sampling of crystallisation parameter space is similar to random 
(non-systematic) sampling as shown in Figure 58. The rationale for the screen design 
is that, provided approximate crystallisation conditions are found for a particular 
protein  i.e. result in some form of crystalline material , it is then ‘relatively easy to 
optimise the conditions’ to obtain a diffraction quality crystal (Jancarik & Kim, 
1991). As more crystallisation experiments are performed, more information 
becomes available about conditions that can then be used to update the screen. The 
original screen of Jancarik and Kim included the use of ammonium and sodium salts 
and half of the conditions contained PEG of various weights. A total of 46 proteins 
were trialled in this initial screen and all 15 proteins that had previously been 
crystallised with other screens produced crystals. Of the 31 proteins that had not been 
crystallised before, 26 produced crystals, giving a success rate of 84%. However, no 
crystal quality is reported and it is not known whether structures could have been 
determined from the crystals obtained.  
 
The grid screen is described by McPherson (1989b) as a 24-well screen in which the 
concentration of precipitant is varied across six columns, with the pH varied down 
four rows (centre left grid, Figure 58). A pH range between 3.5 and 9.0 is suggested, 
to be reduced or extended as appropriate, with ammonium sulfate or PEG 4000 as the 
initial precipitant. If sufficient protein is available it is recommended that an organic 
solvent, specifically ethanol or MPD, also be tested. They also recommend that all 
conditions be tested at both 4
º
C and 25
º
C for comparison. Should a protein still not 
crystallise the use of complexes, ligands or alternative forms of the same protein 
could be tried. The screen can be used to determine how precipitant concentration 
together with pH affects the growth of protein crystals. In contrast to the incomplete 
factorial screen, which aims to sample crystallisation space as widely as possible, the 
grid screen involves a very detailed and systematic search of particular regions. A 
combination of the two methods, i.e. the identification of a region followed by an in-
depth search, is thought to be the best approach (Jancarik & Kim, 1991, McPherson, 
1992). To achieve this the PACT screen was developed (Newman et al., 2005) as 
part of a two-screen strategy. The first screen, a sparse matrix, was followed by the 
PACT screen - a systematic sampling of pH, anions, cations and PEG. Such 
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sampling allows for insights into regions of parameter space which are favourable to 
crystal growth, for specific proteins, without obtaining a crystal. The results serve to 
prove this strategy is successful, crystallising 20/34 (58%) proteins that had never 
been crystallised before. 
 
Another type of screen, the footprint screen (Stura et al., 1992), is a 24-well screen 
utilising six different precipitants across the columns with pH varied over the four 
rows (represented by three separate blocks of three blue cubes in Figure 58). 
Although the choice of precipitants includes PEG 4000 and ammonium sulfate, the 
authors note that ammonium sulfate is usually avoided at high pH as the release of 
ammonia can change the pH. The precipitants chosen are those used ‘successfully in 
the crystallisation of many proteins’ (Stura et al., 1992). 
 
In the years following the publication of the sparse matrix screen several 
complementary screens were designed to sample the parameter space not covered by 
the sparse matrix screen. The screen of Cudney et al. (1994) is one such screen 
designed to use novel chemicals, suggested by their own experience, to ‘uncover new 
additional leads for further optimisation’. In trials with the novel chemicals, crystals 
were obtained for previously uncrystallised proteins as well as those that had been 
crystallised before.  
 
The MORPHEUS screen developed by Gorrec (2009) is intended to be used as an 
alternative initial screen. Gorrec reports that even with 40 commercial screening kits 
covering over 1,500 conditions many proteins still do not produce diffraction-quality 
crystals. Even so, many of the conditions are repeated across commercial screening 
kits (Wooh et al., 2003). The MORPHEUS screen contains ligands and additives 
such as amino acids in the crystallisation solution, although Gorrec also notes that 
the inclusion of ligands and additives can sometimes have a detrimental effect. With 
successful crystallisation trials reported for previously uncrystallised proteins, the 
MORPHEUS screen shows that there is still potential for alternative initial screens. 
 
Others have tried to improve the efficiency of crystallisation screens particularly for 
situations where limited protein is available. Brzozowski and Walton (2001) created 
a pair of screens both containing just 24 wells, a reduction of 75% of the standard 96-
  
158 
 
well plate. Their first screen was designed to improve crystallisation success for 
enzymes, the main protein group studied in their laboratory. Using this screen, they 
crystallised proteins that had not previously crystallised in commercially available 
screens. In their second screen they developed a complementary set of conditions 
with different sections of the screen containing a specific chemical species. The 
screens are designed to allow the user to incorporate any available information about 
the protein or to include particular preferred conditions. 
8.1. The Most Efficient Screening Method 
The rate of success, that is the number of proteins crystallised divided by the number 
trialled, varies from screen to screen. A comparison of the three different major 
screening methods was undertaken by Segelke (2001) who tested the random, 
footprint and grid screens with five proteins. The results of five proteins (four of 
which are commercially available) suggest that the most successful screen type is the 
random screen. Results from the TB SGC show that random screening can also be 
used to obtain diffraction quality crystals without optimisation (Rupp, 2003).  
 
Here a similar analysis of the AstraZeneca dataset was performed to investigate the 
efficiency of their different screen types. Using data from two screen types - filter (a 
mix of footprint and grid screens) and sparse (a sparse matrix screen) we show that 
sparse matrix sampling is also the most efficient method for the proteins studied at 
AstraZeneca (Table 16). 
 
 Screen  
Projects 
Trialled 
Projects 
Resulted in 
a Score of 
4, 5 or 6 
Projects 
Resulted in 
a Score of 
6 
RS  
Score of 
4, 5 or 6 
(%) 
RS  
Score of 6 
(%) 
C1 
Sparse 151 131 80 86.75 52.98 
Filter 88 60 37 68.18 42.05 
C2 
Sparse 87 77 53 88.51 60.92 
Filter 87 58 37 66.67 42.53 
 
Table 16: Comparison of screens' success. 
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Here, we show the rates of success (RS) for each screen type, filter and sparse. Comparison 
one (C1) accounts for the projects used in the named screening type; comparison two (C2) 
only takes into account projects used within both screen types. The rates of success are 
calculated by the number of projects with a particular crystalline annotation (4, 5, 6) divided 
by the number of projects trialled in that screen type.  
The first comparison (C1) involved any project that had been trialled in the named 
screen type, whereas in the second comparison (C2), only projects tried in both 
screen types was included in the analysis. Both comparisons show that the sparse 
screens produce crystalline results for about 20% more proteins than the filter 
screens. Furthermore, high quality crystals are obtained for between 10% and 20% 
(for C1 and C2 respectively) more proteins with the sparse screens. 
 
3 3 3 3 3 3 3 4 4 3 3 3 
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6 9 9 9 7 6 5 5 10 9 7 5 
1 7 12 14 12 8 2 7 11 10 11 8 
 
Figure 59: Heat plot of proteins crystallised in Filter 6 (59). 
The figure shows the number of projects crystallised by each condition in the Filter 6 screen, 
for which the mean number of projects crystallised is 5.28. The most successful (shown in 
yellow) crystallised 16 projects and the least successful conditions (shown in white) did not 
crystallise any projects.  
 
As sampling in a non-systematic manner is the most efficient method for initial 
protein screens, the question becomes how to select such conditions. Jancarik and 
Kim (1991) observed that many proteins would crystallise in several conditions and 
so it follows that many conditions could be used to crystallise several proteins. 
Analysis of a set of 59 projects that were trialled in every condition of the Filter 6 
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screen also shows this (Figure 59). The mean, median and mode number of projects 
crystallised in each condition are 5.28, 4.5 and 2 respectively. A total of 16 projects 
were crystallised in the most successful conditions whereas some conditions did not 
produce crystals for any projects. It comes as no surprise, following propensity 
analysis, that the most successful condition contains PEG 3350 and ethanol buffered 
at pH 8.5. Generally the most successful rows of the screen (shown in red) are rows 6 
to 8, all of which contain PEG. Conversely, the least successful conditions contain 
either MPD buffered at pH 9.5 or tetramethylene sulfone at varying pH. Rows 2 and 
5 containing these chemicals are shown in the palest colours in Figure 59. 
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No
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All proteins accounted 
for?
Identify condition that 
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List all proteins accounted 
for.
Minimal set complete.
Remove condition
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Figure 60: Flowchart for implementation of the minimal set algorithm.  
 
As some conditions crystallise numerous proteins, the minimal number of conditions 
in which all the successful projects have crystallised can be calculated. This NP-hard 
problem can be solved using mathematical minimal set theory (Karp, 1972). A 
problem is NP-hard if the algorithm for solving it can be translated into one that 
could solve an NP-problem. NP refers to nondeterministic polynomial, which means 
is can be solved by a nondeterministic Turing machine in polynomial time (the time 
taken to provide a solution is a polynomial function of the number of inputs). 
 
 Project ID  
Well  A B C D E F G H Sum 
1 ♦ ♦ ♦ ♦     4 
2 ♦     ♦   2 
3  ♦   ♦   ♦ 3 
4    ♦     1 
5   ♦ ♦   ♦  3 
 
♦ Crystal 
 
Figure 61: Example of a minimal set algorithm. 
The figure shows which of the five conditions (wells 1-5) the eight projects (A-H) produced 
crystals. The algorithm to find the minimal set of conditions is as follows: 
1. Identify the well in which most projects crystallise: this is well 1 for projects A, B, C 
and D. 
2. Find the well in which most projects not already crystallised in well 1 crystallise: 
this is well 3 for projects E and H. 
Six of the eight projects are now accounted for (A, B, C, D, E and H). Conditions only need to be 
found for project F and G. 
3. Add well 2 in which project F crystallises and well 5 in which project G crystallises 
and the set is complete. 
4. Remove any members of the set that do not contribute something unique: remove 
well 1 as projects A, B, C and D also crystallise in wells 2, 3 and 5.  
The minimal set required for crystallisation of the 8 projects consists of wells 2, 3 and 5. 
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A greedy algorithm, for which the flowchart is shown Figure 60, was employed to 
ensure a solution in a reasonable amount of time. A greedy optimisation algorithm 
chooses the optimal solution at each step but may not result in the overall optimal 
solution, as this may not be the sum of the optimal parts. The example in Figure 61 
shows the implementation of a minimum spanning set across conditions in which 
proteins crystallise. The first step in the algorithm is to identify the condition that 
crystallises the most proteins and save this to a set MSET. The next step identifies 
the condition that crystallises the most proteins not already accounted for by MSET 
and is repeated until (a) either there are enough conditions to fill a crystallisation 
screen or (b) all possible proteins are accounted for. At this stage, each condition in 
MSET is checked to ensure it crystallises at least one protein that another condition 
in the set does not.  
8.2. AstraZeneca Minimal Sets 
For each screen (96 conditions/wells) used to produce the AstraZeneca data, a 
minimal number of conditions that gave crystals for all projects that could be 
crystallised was found. 
 
Table 17(a) shows that the minimal set that gave crystals for the most projects per 
condition, is that of Sparse 0 with an average of 4.33 projects crystallising in each 
condition and one condition (containing PEG 8000 and calcium acetate) giving 
crystals for 33 different projects. Conversely, just one project crystallised in each 
condition in the Sparse 1 screen. Table 17(b) shows the results for minimal sets 
calculated over those projects that were trialled in every condition. This also shows 
that, on average, the Sparse 0 screen minimal spanning set gives crystals for the most 
projects per condition (4.8) and again Sparse 1 is shown to be the least efficient with 
one condition per project in the minimal set. This result could be expected as there 
are fewer projects and therefore a smaller minimal set with higher redundancy. For 
each screen, at least one condition produced crystals for ~40% of the projects 
trialled. In the most extreme case of Filter 4, one condition gave crystals for 7 out of 
the 11 proteins (~64%). Kimber et al (2003) also showed that a single condition 
could give crystals for a high percentage of proteins, with 99 successes out of 338 
(~29%). The redundancy rate is the percentage of wells not included in the minimal 
  
163 
 
and ranged from 81% for Sparse 0 up to 98% for Filter 3. Page et al. (2003) also 
reported high redundancy rates of up to 77%, with 23% of conditions giving crystals 
for all proteins trialled (Page et al., 2003). 
 
Screen Minimal Set Size Maximum* Redundancy (%) 
Filter 2 4 8 96 
Filter 3 2 2 98 
Filter 4 3 7 97 
Filter 5 3 3 97 
Filter 6 10 16 90 
Sparse 0 18 33 81 
Sparse 1 2 1 98 
Sparse 2 6 6 94 
Sparse 3 16 20 83 
(a) The minimum number of conditions required for crystallisation of all projects. 
 
Screen Minimal Set Size Maximum* Redundancy (%) 
Filter 2 3 7 97 
Filter 3 2 3 98 
Filter 4 3 8 97 
Filter 5 2 4 98 
Filter 6 8 36 92 
Sparse 0 15 73 84 
Sparse 1 2 2 98 
Sparse 2 6 16 94 
Sparse 3 16 56 83 
(b) The minimum number of conditions required for crystallisation of all projects 
that were trialled in every condition of the named screen. 
 
Table 17: Minimal sets for AstraZeneca projects. 
Tables (a) and (b) show the size of the minimal sets and redundancy rates for AZ screens. 
The results for Table (a) included any project that had been trialled in that screen, whereas 
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the results for Table (b) were calculated using projects that had been trialled in all 96 wells 
of the screen. 
* This is the maximum number of projects that could be crystallised in one condition.  
To improve efficiency, the number of conditions trialled within the screen could be 
reduced by only including a minimal set of conditions. Replacing the other 
conditions with new ones could improve the chances of crystallising more proteins. 
The number of projects crystallised has a strong correlation with the size of the 
minimal set. As the number of projects trialled with a screen increases, the number of 
conditions included within the minimal set also increases (redundancy decreases). To 
investigate how successful the conditions within the minimal spanning might be with 
a new project, it is necessary to test the stability of the size of the minimal spanning 
set. Stability is defined as the percentage of projects required for the minimal set size 
to stop changing i.e. the fewer proteins required for the size of the minimal set to 
stabilise, the greater its reliability. It is likely that project n and project n+1 are 
proteins which are chemically similar, as typically each protein modification is 
assigned a new project number and this may bias the stability of the set. To reduce 
any such bias, the order in which the projects were included was randomised.  
 
For the first project on the project list we randomly select the condition in which it 
crystallised and form the list of conditions, MSET. The remaining projects for the 
same screen are checked to see if they crystallise in this condition. If they do, they 
are removed from the project list. Another project is then randomly selected from the 
project list and the conditions in which this project crystallised are added to MSET 
and checked to see if projects already removed from the project list crystallise in 
these conditions. If this is not the case then the project is simply removed from the 
project list. Otherwise, the minimal set algorithm is run on MSET, to determine the 
smallest subset of MSET that will crystallise all projects removed from project list. 
This process is repeated until all projects are removed from the project list. The size 
of MSET might stop increasing before all projects are removed from the project list. 
The percentage of projects that have been removed at this point is indicative of 
MSET stability. 
 
Table 18 shows that a high percentage of projects is required for the size of the 
minimal set to stabilise. The percentage of projects required ranges from 75% for 
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Filter 5 up to 100% for Filters 2 and 3 and Sparse 1. It is highly probable that the 
order of testing affected the percentage of projects required for the size of the 
minimal set to stabilise. This can be demonstrated by the following example: 
consider ten projects of which nine crystallise in one condition and one project 
requires a separate condition. Starting the minimal set derivation with the project that 
requires a unique condition gives an initial of one condition. The other nine projects 
do not crystallise in this condition and so a project from the remaining nine is added 
and the size of the minimal set is increased to two. It would then be found that the 
remaining eight projects crystallise in these two conditions so that the percentage of 
projects required for the size of the minimal set to stabilise is two out of ten (20%). 
However, if the order was changed so that each one of the nine projects that 
crystallise in the same conditions, were added before the project that requires unique 
conditions, all ten projects would need to be tested before the minimal stabilised and 
produced crystals all projects. 
 
Screen Projects Required Projects Crystallised Projects Required (%) 
Filter 2 7 7 100 
Filter 3 3 3 100 
Filter 4 7 8 88 
Filter 5 3 4 75 
Filter 6 35 36 97 
Sparse 0 60 73 82 
Sparse 1 2 2 100 
Sparse 2 15 16 94 
Sparse 3 54 56 96 
 
Table 18: Number of projects required for minimal set size to stabilise. 
The minimal set of conditions changes depending on which projects are sampled. It is 
possible that a minimal set to crystallise all projects is found before all projects have been 
trialled. Here, the number of projects required for the minimal spanning set to stop changing 
size is shown in Projects Required. 
  
Further analysis was undertaken to determine the number of projects that could not 
be crystallised with a minimal set of conditions derived from the other projects 
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within the same screen. For every screen, each project was removed in turn and a 
minimal set of conditions found for the remaining projects. It was then determined 
whether or not the removed project could be crystallised in this minimal set. Table 19 
shows the number of projects, S, for each screen that when removed could be 
crystallised in the minimal set of conditions derived from the remaining projects. 
 
To establish whether it would be more efficient to adopt a minimal set for all 
projects, then use an extra screen to crystallise those that will not crystallise in the 
minimal set, requires calculation of how many conditions would be needed to use 
this method in comparison to screening everything with the standard 96 conditions 
(the standard screening protocol). 
 
For the minimal set to be the most efficient method, the following condition has to be 
met: 
 
 
where P is the number of projects, S is the number of projects that can be crystallises 
in a minimal set derived from other projects and M is the number of conditions 
within the minimal set. Rearranging equation 30 gives: 
 
 
which shows that it is more efficient to use the minimal set provided its size, when 
divided by 96, is less than the number of successes divided by the number of 
projects. 
 
Table 19 shows that, for eight out of nine screens, it is more efficient to use a 
minimal set of conditions as the crystallisation screening protocol. Sparse 1, with 
only two projects trialled, is the only screen where this is not the case, no single 
condition gave crystals for both projects. 
 
 
      (   )      30 
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Screen Successes (S) Projects (P) P-S  (%) Minimal Set Size Apt* 
Filter 2 3 7 4 57 3 Yes 
Filter 3 1 3 2 67 2 Yes 
Filter 4 4 8 4 50 3 Yes 
Filter 5 2 4 2 50 2 Yes 
Filter 6 30 36 6 17 8 Yes 
Sparse 0 58 73 15 21 15 Yes 
Sparse 1 0 2 2 100 2 No 
Sparse 2 11 16 5 31 6 Yes 
Sparse 3 43 56 13 23 16 Yes 
 
Table 19: Minimal set of conditions efficiency. 
The number of projects that can be crystallised in a minimal set derived from the other 
projects trialled with the same screen. If a project would not crystallise in a minimal set 
derived from other projects, then standard screening protocol is resumed. *Apt means is it 
more appropriate to use the minimal set?  
8.2.1. Minimal Set for Combined Screens 
At AstraZeneca, nine crystallisation screens, covering 281 conditions were used with 
152 projects. Of these 152 projects, 134 were successfully crystallised. Using a 
greedy algorithm, as described previously, we were able to obtain a set of 27 
conditions in which the 134 projects could be crystallised. Where two or more 
conditions contribute the same number of projects, the algorithm chooses the one it 
finds first. To examine the effect this might have the algorithm was run 1,000 times. 
For 583 runs the minimal set was of size 27, for 382 runs the size was 28 and for 35 
runs the size was 29. 
 
The minimal set with conditions in which the most projects could be crystallised was 
taken as the optimal minimal set. As Figure 62 shows, two different minimal sets 
(Set One and Set Two) can be used to crystallise all six projects with three wells. The 
sum of the parts for Set One is 2+4+3=9 and the sum of the parts for Set Two is 
2+2+3=7. In this instance Set One would be chosen as the sum of the parts is greater. 
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Figure 62: Comparison of two minimal sets. 
An example of two minimal sets, both consisting of 3 wells where one set (Set One) gives 
more crystals overall than the other. 
 
For the all projects minimal set, the sum of parts was 640 projects, with two very 
successful conditions each giving crystals for 48 projects and the least successful 
condition producing crystals for eight projects. Over 50% of projects can be 
crystallised using just two conditions (one containing PEG 8000 and calcium acetate 
and the other PEG 3350 and ethanol), 75% in six conditions, 85% in ten conditions 
and 95% in 21 conditions. Of the 27 conditions, 15 only contributed one project. Of 
the 134 projects, 14 crystallised in only one condition, and 10 of these 14 are the 
only project associated with this condition in the minimal set. Similarly Kimber et al. 
(2003) found that 27% of their proteins would crystallise in 6 conditions, 36% in 12 
and 42% in 24.  
 
Some conditions are found to have components that are over-represented in the 
minimal set or under-represented in the original 281 conditions from which the 
minimal spanning set is derived. For example: PEG 10000 is used in 16 of the 281 
conditions and therefore, in a minimal set of 16 conditions, one might expect PEG 
10000 in two (16/(281/27)), but it is only observed once. Conversely, sodium 
chloride is found in 21 of the 281 conditions and might be expected to be in 2 
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conditions of the minimal set. It is, however, found in 4 conditions of the minimal 
set.  
 
Chemicals included more frequently in the minimal set than might be expected are 
PEGs-400,500 MME, 2000MME and 8000, ethanol and isopropanol and calcium 
acetate among others. In Chapter 7 the properties of such chemicals was discussed. 
Their inclusion in successful conditions is due, for example, to the precipitating 
effects of PEGs, the bonding of calcium-based compounds and the inclusion of 
additives such as ethanol as a cryoprotectant. Some of the chemicals found to be 
under-represented are: MPD, PEGs 10000, 6000 and 1500, magnesium acetate, 
ethylene glycol and tetramethylene sulfone. 
 
A new screening protocol at AZ might allow crystallisation space to be sampled in a 
manner that maintains the same ratios of chemicals in the minimal set. For example, 
it is known that sodium chloride is associated with conditions that crystallise 
numerous projects or ones that do not crystallise elsewhere, therefore, the inclusion 
of more conditions containing sodium chloride might prove beneficial. 
8.2.2. Filling Up the Screen 
As crystallisation plates are typically made up of 96 wells, the use of a 27-condition 
screen leaves 69 wells empty. These wells could be used to repeat the 27 conditions 
twice more as it is known that repetition is beneficial in crystallisation as nucleation 
is a stochastic process (Newman et al., 2007) or used to further explore chemical 
parameter space. Previously we showed that the more sparsely spread across 
parameter space the chemical conditions are, the more successful the screen is. To 
fill the remaining 69 positions of the screen it would be ideal to use conditions that 
are as chemically different as possible, in terms of their influence on crystallisation.  
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Figure 63: Identifying new crystallisation conditions. 
The flowchart shows the process to identify new conditions to improve the sampling of 
crystallisation space. 
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The C6 metric (Newman et al., 2010) and CDcoeff (Bruno et al., 2014) are two 
measures that provide a similarity metric between the contents of a crystallisation 
solution. We can use such a metric to determine the most diverse conditions in the 
281 conditions used at AstraZeneca. However, this might identify two solutions that 
are chemically different, but they may not be useful as crystallisation reagents, used 
only where the outcome was unsuccessful. Our best measure of how similar 
conditions were in terms of their propensity to crystallise is given by which projects 
crystallise in which conditions. 
 
A data matrix X was formed in which xij = 1 if project i crystallised in condition j, 
and xij = 0 otherwise. This allowed the Hamming distance between conditions to be 
calculated, giving the most similar conditions a score closer to zero and the most 
different a score closer to one. With a core screen made up of 27 conditions obtained 
through the minimal set algorithm, the other 69 conditions could be chosen as 
follows. The next condition would be the one that (a) crystallised a project and (b) 
was most different, according to the sum of Hamming distances, to the 27 conditions 
already identified. The process of identifying the new conditions for the screen is, 
again a greedy process, shown in Figure 63. After obtaining 96 conditions, the C6 
metric can be used to analyse the diversity of the new screen in comparison to 
previous screens. The 'internal diversity score’ on the C6 web tool can be used to 
determine the spread of conditions (Newman et al., 2010). This score is obtained 
from the average of the pairwise C6 distance scores for conditions within a screen 
and ranges from 0 (identical) to 1 (completely different). The new screen scored 
0.75. To put this in perspective, the internal diversity scores for commercially 
available sparse matrix screens are around 0.9. It is, therefore, possible that drawing 
from a limited sample of conditions and with one quarter (27/96) of the screen being 
fixed, contains bias towards highly similar conditions. 
8.3. Minimal Set for the Protein Data Bank 
Analysis of the PDB data shows that one crystallisation solution (30% PEG 4000, 
0.1M tris pH 8.5, 0.2M magnesium chloride,) occurs 90 times, with the successful 
crystallisation of 69 different proteins (i.e. from different groups in the PDB-BLAST 
dataset). Minimal set analysis of the PDB dataset shows that only 5,683 unique 
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conditions are required to crystallise all proteins, whereas 35,389 different conditions 
were actually used, giving a redundancy rate of 84%.  
 
 
 
Figure 64: The number of proteins required for minimal set. 
The number of proteins in the PDB is plotted against the numbers of conditions used to 
crystallise them. The growth of the minimal set becomes linear after 768 conditions have 
been included. 
 
Figure 64 shows the number of proteins that can be crystallised by different numbers 
of conditions. After 768 conditions are included, each protein not already accounted 
for requires its own conditions (according to the data in the PDB) so that the minimal 
set grows linearly with the number of proteins. The solutions in the minimal 
spanning set of 96 conditions (one screen) determined from the PDB data are listed 
in Appendix B. These conditions have been used to crystallise 1,905 of the 8,937 
proteins in the PDB (~21%). The similarity of sets of conditions can be assessed 
using the C6 metric (Newman et al., 2010). The C6 score has been used to show that 
1,795 entries in the PDB have similar conditions to those in the MCSG_1 screen, 
making this the most successful commercial screen. The 96 conditions in the 
minimal set derived here together match 2,929 entries in the PDB. The minimal set 
screen obtained from the PDB data has an internal diversity score of 0.93, suggesting 
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a very good sampling of crystallisation parameter space. This compares with the 
Hampton Index, MCSG_1 and Rigaku Wizard screens with diversity scores of 0.91, 
0.91 and 0.94 respectively. Currently (Spring 2015), the screen designed using data 
from the PDB is in trials in the York Structural Biology Laboratory at and AZ. 
8.3.1. Minimal Sets for Acidic and Basic Proteins 
Separate minimal sets were developed for proteins with acidic and basic isoelectric 
points. Proteins associated with BLAST groups that contained both acidic and basic 
proteins were removed, leaving 4,695 acidic and 2,125 basic proteins. Of these, the 
96 condition minimal set for the acidic proteins could crystallise 19% (915/4,695) 
and the basic, 16% (350/2,125). The average predicted pH for the minimal sets were 
6.73 and 6.67 for acidic and basic respectively. The most productive solution for 
acidic proteins contained magnesium chloride, PEG 3350 and bis-tris with a 
predicted pH of 5.5, whereas for basic proteins, ammonium sulfate, PEG 400 and 
HEPES with a predicted pH of 7.35 was the most productive. The most productive 
condition in the acidic minimal set is the eleventh in the basic minimal set; the most 
productive condition in the basic minimal set is the seventeenth in the acidic minimal 
set. 
 
Figure 65 shows the composition of the minimal sets when divided into the chemical 
groups described in Chapter 5. The type most sampled group for both sets is PEGs 
(27.6% for acidic and 20.9% for basic) and the least sampled group is the dihydrogen 
salts (0.4% for acidic and 2% for basic). The largest difference between the groups 
sampled in the two minimal sets is for the organics, with 14.2% of chemicals 
sampled in the basic minimal set being organic but only 2.9% in the acidic minimal 
set. Conversely, salts account for 17.6% of the species used in the acidic minimal set 
but only 10.1% in the basic. The acidic minimal set samples 56 different chemical 
species and the basic, 49. For the chemical species that the two sets have in common, 
54 are sampled at the same concentration, the acidic set samples 40 concentrations 
that the basic does not and the basic set samples 54 concentrations that are not in the 
acidic set. 
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(a) Types of chemicals for acidic minimal spanning set. 
 
 
 
(b) Types of chemicals for basic minimal spanning set. 
Figure 65: Types of chemicals occurring in different minimal sets. 
The chemical species found in two minimal sets (a) acidic and (b) basic are shown 
grouped as described in Chapter 5. 
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8.4. Discussion and Conclusions 
We have been able to confirm that non-systematic sampling of protein crystallisation 
chemicals is the most efficient method of initial screening. With this information, 
new initial screens were designed using minimal set theory, one for data at 
AstraZeneca and three for the PDB. 
 
There are, however, alternative methods of obtaining a minimal spanning set. Some 
of these provide exact solutions. One such solution for was obtained using SCIP 
(Achterberg, 2009) for the AstraZeneca data. This solution was 26 conditions, 
whereas the custom algorithm suggested 27 conditions. Of 26 conditions, 20 were 
identical to those in the custom solution and another 3 contained the same species but 
a different buffer pH. For larger datasets, if the problem cannot be solved exactly 
there exist other approaches that approximate the solution (Paschos, 1997). 
 
Minimal set screens could be particularly useful when the amount of protein purified 
is limited. The use of conditions that crystallise most proteins first should maximise 
the chances of crystallisation success. Using a minimal screen followed by a more 
specific screen for any proteins that do not produce crystals, could provide an 
efficient method of screening. Since the number of conditions required never stops 
growing, minimal sets can only be developed post-crystallisation with the hope they 
will work for a new protein.  
 
It has been observed that conditions are sometimes missed due to dispensation errors 
and those on the edge of a plate are vulnerable to desiccation if they are not sealed 
properly before being stored in a temperature controlled unit. Using repeated 
experiments it may be possible to determine any long term effects of these physical 
parameters. Minimal sets should also be updated perhaps every couple of years to 
account for changing tastes in crystallisation reagents (Jancarik & Kim, 1991) due to 
the requirement for more and more complex proteins (Aloy & Russell, 2006). It is 
possible to determine bespoke minimal sets for particular subsets of proteins, for 
example, minimal sets for acidic and basic proteins. There is the potential to create 
different minimal sets for specific protein families as it has been reported previously 
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that certain families prefer certain conditions (Samudzi et al., 1992, Hennessy et al., 
2000). 
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9. Shrinking Crystallisation 
Parameter Space 
The “instant physician” is a neural network that was trained using data from patient 
records, including their symptoms, diagnosis and treatment. When new patient 
symptoms are entered, the network returns the diagnosis and recommended treatment 
(Maithili et al., 2011). The symptoms are analogous to protein features and the 
diagnosis represents the conditions in which a protein will crystallise. Many of the 
protein features are redundant through being highly correlated with others or having 
little-to-no discriminatory power. It has been shown that a set of 13 features can 
provide good discrimination between crystallisable and non-crystallisable proteins. 
The assumption that the protein features and the list of conditions are all inputs and 
that the output is either successful or unsuccessful crystallisation creates a problem. 
As most crystallisation data (98% of the AstraZeneca data) is associated with 
experiments where the outcome is unsuccessful, a large bias is introduced. A 
classifier could perform well in terms of accuracy simply by predicting that every 
combination of protein and crystallisation features would fail crystallisation but this 
would not be very useful. Ideally, a classifier would be trained using equal class 
sizes.  
 
By defining which chemical combinations we consider to be chemically similar, 
meaning that they give similar experimental outcomes, it is possible to cluster 
conditions. Provided one condition in the cluster crystallises a protein we can assume 
the other ones would if the experiment was repeated. Using custom crystallisation 
experiments we are able to investigate the theoretical distance, C6 metric, for 
defining similarity in crystallisation chemical parameter space. Using data from AZ 
and the SGC we test the C6 against a modification, C8. 
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9.1. The C6 Metric 
The C6 web tool (Newman et al., 2010) includes a distance metric, referred to as C6, 
to compare the contents of crystallisation conditions i and j, providing a theoretical 
distance, Dij, between the two in chemical parameter space. Where Dij = 0 if 
conditions are identical and Dij = 1 if the two conditions have no chemical species in 
common. In all other cases it is defined by: 
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In every applicable term, max[x], is the maximum concentration of x obtained from a 
collection of commercial crystallisation screens. In the normalising factor, (1/T+3), 
in Equation 32, T is the number of distinct chemical species in conditions i and j. The 
first term, α (Equation 33), compares the concentrations of matching species, where 
[sti] is the concentration of chemical t in condition i. The molecular weights of any 
PEGs in both conditions are taken into account in the second term, β  Equation 34). 
If the molecular weights are within a factor of two, they are considered similar. For 
example, PEG 400 and PEG 600 are considered similar, but PEG 400 and PEG 4000 
     
 
   
(       ) 32 
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are not. Here, [PEGi] is the PEG concentration of PEG in condition i. The penalty, 
0.2 is added to compensate for the fact the distant metric is qualitative. If this term is 
greater than one then, then β is set to one. If the two conditions contain an anion or 
cation in common, they are considered to be more similar. This is accounted for by 
the third term, γ (Equation 35). For example, sodium chloride and lithium chloride 
are considered similar as they both contain chloride. Similarly, ammonium sulfate 
and ammonium acetate both contain ammonium. In this term, [ioni] is the 
concentration of the ion in condition i and 0.3 is the added penalty. Again, if γ > 1 
the term is set to one. The final term, ∂  Equation 36) is the absolute difference 
between the pH of both solutions (taken from the buffer pH or that of the 
predominant component) divided by the pH range for crystallisation.  
 
Manually entering every pair within 96 conditions into the C6 online web tool was 
impractical. Moreover, some of the distances obtained were not as expected given 
the equation. After obtaining the code from the authors, it was possible to see that the 
implemented distance measure differed somewhat from the published equation 
(Newman et al., 2010). Along with the four terms discussed above, the measure 
implements further penalties for differences between conditions. 
9.1.1. Investigation of the C6 Terms 
To investigate any similarities between PEG weights and various ions used in 
crystallisation, custom crystallisation screens were created. Each screen was trialled 
with 11 of the proteins described in Chapter 2 (excluding the glycolytic proteins). All 
of the proteins were obtained from the same batch, which had been frozen and were 
defrosted to room temperature immediately before use. The conditions were buffered 
using PCTP at a pH close to that of the protein's isoelectric point. The crystallisation 
method was vapour diffusion, sitting drop, stored at room temperature. The screens 
were manually assessed after 21 days. 
 
To investigate similarities between PEGs, a custom screen was produced with PEGs 
of various molecular weights, various functional groups (mono-, di- methyl ethers), 
ethylene glycol and tetramethylene sulfone, each in various concentrations. Ignoring 
pH and molecular weight, the most successful concentrations were found to be 14%, 
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20% and 26%, each crystallising 9 of the 11 proteins. The same nine proteins 
crystallised at both 20% and 26%, and eight of these also crystallised at 14%. 
Conversely, the most extreme concentrations were the least successful, with just one 
protein being crystallised in any condition with PEG concentrations of 1%, 52%, 
77% or 90%. Grouping PEGs according to the maximum concentration at which they 
are soluble, shows that PEGs with a weight of 10,000Da or 20,000Da, soluble to a 
concentration of 27% (w/v) are more successful at concentrations of 8%, 12% and 
15%. Those PEGs that have a molecular weight less than 10,000Da, soluble up to 
45% (w/v), are more successful at 20% and those that can be used up to 
concentrations of 90% are more successful at 26%. In all instances no single 
concentration could be used to crystallise all proteins but a selection of 14%, 20% 
and 39% would ensure that all proteins were crystallised.  
 
 
Figure 66: Success of PEG conditions in relation to their pH and concentration. 
Crystallisation results for 11 proteins across 552 conditions containing buffered PEG 
solutions. Successful crystallisation is indicated by blue diamonds and unsuccessful 
experiments by red circles. 
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Hierarchical clustering of the PEG results suggests that concentration and pH are the 
dominant parameters defining the difference between success and failure. Linear 
discriminant analysis and a one-layered ANN gave similar results. 
 
Figure 66 shows the distribution of the conditions from custom screening using their 
spectrophotometric pH, PEG concentration and whether they crystallised. Most 
crystals are obtained between pH 5.5 and pH 9, and at concentrations between 5% 
and 35%. This zone contains PEGs of different molecular weights and functional 
groups. Of the 24 PEG-like chemicals trialled, 19 are found at least once within this 
zone. The other five chemicals are two non-PEG chemicals, tetramethyl sulfone and 
ethylene glycol, the highly acidic PEG 2000 dimethyl ether (pH ~2), and the low 
molecular weighted PEG 200 and PEG 400. These latter two have been found 
previously to crystallise a different set of proteins to other PEGs, (Kimber et al., 
2003). We have also observed that the pH of PEG 400 is not stable under any storage 
conditions. 
 
This distribution suggests that the different weights of PEGs does not affect their 
similarity in terms of which proteins they crystallisation. These findings are also 
supported by those of Zhu et al. (2006) who describe the phase diagram for PEG 
3350 at 21
o
C (the temperature at which we crystallised our proteins). They state that 
the concentration range in which nucleation would occur being from 18%w/v to 
30%w/v. 
 
A potential modification to C6 would take the concentration of PEGs into account 
rather than molecular weight. In this modification, the β term is only included where 
PEGs are within 5% to 40% concentration. For any concentration outside this range, 
the β term is not used. So for example: 15% PEG 400 and 39% PEG 600 are 
considered similar and the β term would be used, but for 4% PEG 400 and 39% PEG 
600 or 12% PEG 400 and 41% PEG 600, the β term would not be used. 
  
A set of similar experiments to that of the PEGs was performed for salts. A total of 
30 salts with anion sand cations of different valences, were trialled at different 
concentrations with 11 proteins. 
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Unlike the results of the PEGs, however, there was no obvious pattern in 
crystallisation results. Even ignoring variables such as pH and concentration did not 
suggest that salts with shared ions were the same in terms of what they crystallised. 
The results of the three buffer levels 5, 7 and 9 were combined as there were few 
successful crystallisation results. The most successful chemical was potassium 
bromide, crystallising 9 out the 11 proteins. The least successful were potassium 
phosphate, ammonium fluoride and sodium bromide all crystallising just one protein, 
thaumatin. The fact that thaumatin crystallised in 25 of the 30 salts, means that it is a 
property of the protein rather than the salt that allows crystallisation in these three 
salts. The average salt crystallised four proteins and the average protein crystallised 
in 11 salts. All proteins crystallised in three salts, potassium bromide, calcium 
chloride and sodium phosphate. Interestingly, these three salts all have a different 
cation and anion group which might suggest that different protein properties have 
different interactions with different chemicals in the crystallisation solution. Using 
the results of McPherson (2001) study of salts, we performed cluster analysis and 
found that few chemical species giving similar crystallisation results had matching 
ions. As a consequence, the ion term, γ, of the formula can be removed. 
 
The final term in the C6 metric is related to pH. We modified this term by limiting 
the normalisation range to two pH units so that solutions that are not within two pH 
units of each other are considered to be significantly different. We showed earlier 
that when pH is carefully controlled and measured, most crystals for a particular 
protein are found within a narrow pH range.  
 
In the modified metric we used the more accurate pH predicted by a regression 
model from the concentrations of the chemicals and the buffer pH to obtain a more 
accurate value for the true pH, rather than simply using the buffer pH. In instances 
where the buffer pH is not stated the pH term is not used, as in the original C6. 
 
We refer to the modified C6 metric as C8. 
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9.2. Comparison of the C6 and C8 Metrics 
In order to compare the results of experimental data to the theoretical C6 and C8 
distances, we initially used the Hamming distance to provide experimental distances. 
A 39 × 96 matrix of 1’s and 0’s was created from 39 projects that had been trialled in 
all 96 conditions of the Filter 6 screen. The element on the ith of the jth column was 
set to 1 if the project i crystallised for in condition j and 0 otherwise. The Hamming 
distance was then calculated from this matrix for each pair of conditions. It became 
apparent that the clustering (not shown) was predominantly grouping together 
conditions that were similar due to being highly unsuccessful. To overcome this, the 
use of a different distance metric was employed, the Jaccard distance. However, a 
dendrogram of the results showed very little structure in the clusters, with many 
clusters consisting of just one pair of conditions.  
 
 
 
 
Figure 67: Two example dendrograms for comparison. 
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To determine objectively how well the C6 and C8 metrics reflect the observed data 
we used the Bk measure of dendrogram similarity (Fowlkes & Mallows, 1983). This 
allows two dendrograms to be compared at each cluster level. The dendrograms are 
cut to give k = 2, 3…, n-1clusters, where n is the total number of items. A matrix, m 
is defined in which the element mij is the number of objects that occur in the same 
cluster in both dendrograms for any given k.  
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Bk is calculated for every value of k to create a plot of Bk versus k. A Bk value of 1 
indicates the two dendrograms are identical, whereas a value of 0 indicates they 
share no common element. 
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For dendrogram D1 with objects 1 and 3 in cluster one (C1) and objects 2, 4 and 5 in 
cluster two (C2) and dendrogram D2 with objects 1 and 4 in C1 and objects 2, 3 and 
5 in C2. The matrix, m is: 
 
  
 D2 
 
  C 1 2  
[mij] = D1 
1 1 1 2 
2 1 2 3 
   2 3 5 
 
From Equations 38 to 40, we have 
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For small dendrograms it is possible to interpret the Bk by visual inspection. 
Simulations were performed in order to interpret Bk values for large numbers of 
objects. For our data with 96 different conditions (objects), k ≤ 95.  
 
For each k, simulations of the matrix m were produced to model varying similarity, 
where between 0 and 100% of the objects were in the same cluster (the leading 
diagonal) and the rest evenly spread across the off diagonal terms. For example, 
when Bk = 1, 100% of the data lies on the leading diagonal.  
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A2 
 
   1 2 3  
[mij] = A1 
1 24 4 4 32 
2 4 24 4 32 
3 4 4 24 32 
   32 32 32 96 
 
Figure 68: Example of Bk modelling. 
A matrix obtained from three clusters is shown where 75% of the 96 objects are in the same 
cluster. 
 
Figure 66 shows a matrix corresponding to k = 3, with 75% of the data on the leading 
diagonal, for 96 objects. This means 72 objects occur in the same clusters in each 
dendrogram, with 24 in each. The remaining 24 objects are found in other clusters 
and are evenly spread over the other 6 elements of the matrix. For this example B3 
would be calculated from: 
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A score of 0.58 for 3 clusters, therefore, corresponds to 75% of the data being in the 
same cluster in both dendrograms. Repeated simulations produce the surface shown 
in Figure 69. 
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Figure 69: Surface of Bk values for 96 data points. 
The surface shown is obtained from the Bk values for 96 objects with varying numbers of 
objects in the same cluster. Cardinal directions are given for ease of description. 
 
Figure 69 shows how the Bk values change with different numbers of clusters and 
distribution of objects within these clusters. For two clusters (running from north to 
west) the value falls steeply from 1, where 100% of the objects are in the same 
cluster, to a minimum of 0.49 when the objects are evenly distributed. This value 
then increases until 100% of the objects are once again in the same cluster. For all k, 
when 100% of the objects are in the same cluster (from north to east) the Bk value is 
1. The value of Bk decreases from north to south as the number of clusters increases 
and the number of objects are found in different clusters. Provided that at least 90% 
of the objects are away from the leading diagonal, from k = 11 onwards, the value of 
Bk is 0. This percentage drops by 1%, per increase of 1 in the value of k until at k = 
95, when 99% of the objects are in different clusters giving a Bk value of 0. This can 
be seen by a plateau of value 0 running from west to east for the majority of the 
southern part of the surface, where south is defined in relation to a bisection of the 
South 
West 
East 
North 
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objects running from west to east. It is possible to obtain Bk values between two 
clusters and find their corresponding value on this surface to determine how many 
objects are in the same cluster. 
 
 
Jaccard C6 C8 
Jaccard 1.00 
  
C6 0.40 1.00 
 
C8 0.46 0.63 1.00 
 
Figure 70: Correlations between methods assessing the similarity of conditions.  
The correlation matrix is shown for three methods of determining similarity between 
conditions in the Filter 6 screen. The Jaccard distance is obtained from observed 
experimental results, while C6 and C8 are theoretical distances. 
 
Figure 70 shows the correlation for the two methods, C6 and C8, of measuring 
distance in crystallisation chemical parameter space, in comparison to the Jaccard 
distances calculated from the crystallisation results for 39 projects in the Filter 6 
screen. C6 and C8 have a similar structure, as might be expected, which is reflected 
in the 0.63 correlation coefficient between them. Neither C6 nor C8 have a strong 
correlation with the observed Jaccard distance as neither model can reflect the 
stochastic nature of crystallisation experiments (Newman et al., 2007). It should be 
noted that the Filter 6 screen (a grid footprint hybrid) provides a systemic sampling 
of pH, chemical species and concentration.  
 
Data from the SGC was introduced to provide further test data. This data was 
obtained from 1,039 proteins crystallised in the JCSG +4, a sparse matrix screen. 
Figure 71 shows the correlation between Jaccard and C6 is 0.63 for this data and 
between Jaccard and C8 is 0.71. Although both metrics have higher correlation with 
the observed data than seen for the Filter 6 screen, they are not as highly correlated 
with each other. Figure 71 also shows the Bk metric used to determine the similarity 
of the clustering. The Bk values can be interpreted by comparison with the surface 
shown in Figure 69. For both metrics, when two clusters are used, 99% of the objects 
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are in the same cluster as obtained using the Jaccard distance. The C8 metric gives 
more similar clusters to the observed data until k = 28. With 24 clusters, 68% of the 
conditions are in the same cluster for C8 and the Jaccard metrics whereas Jaccard 
and C6 had 53% of conditions within the same clusters. 
 
 
 
Jaccard C6 C8 
Jaccard 1.00 
  
C6 0.63 1.00 
 
C8 0.71 0.46 1.00 
 
(a) Correlation matrix between C6, C8 and Jaccard distances. 
 
 
(b) Bk value between C6 and Jaccard clusters and C8 and Jaccard clusters. 
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(c) Summary of Bk values derived from the graph shown in (b). 
 
Figure 71: Comparison of C6 to C8 for the JCSG +4 screen. 
The similarity of the C6 and C8 clustering is compared to patterns observed (Jaccard) for 
1,039 proteins trialled in the JCSG+4 sparse matrix screen. (a) shows the correlation between 
Jaccard, C6 and C8. (b) shows the Bk measure for comparing dendrograms, between the 
clustering of the distances C6 (red dots) and C8 (blue line), with the observed distance 
(Jaccard). (c) shows the percentage of conditions that have been clustered together for each 
metric using different numbers of clusters. 
9.3. Conclusions 
Crystallisation chemical parameter space is large and often populated with regions 
that are chemically similar to other regions but do not always crystallise the same 
proteins. The C6 distance metric (Newman et al., 2010) provides a method of 
grouping regions by assuming that certain chemical species and pH are similar, 
however, this may not be correlated to the patterns obtained by experimental data 
due the stochastic nature of crystallisation. The C6 metric was deliberately designed 
without the use of empirical data due to difficulties in obtaining a globally 
representative sample of proteins. Here, we have investigated the accuracy of this 
metric with real datasets obtained from different screen types (custom, filter one and 
sparse matrix). After comparing the clustering of conditions obtained from 
experimental data with the theoretical clusters obtained from C6 and the new C8 
metric, we show that the new metric provides a more accurate reflection of the 
observed patterns. This new metric, obtained via modifications to the terms in C6 
involving PEGs, ions and pH, allows efficient design and assessment of 
C8 0.97 0.81 0.63 0.36 
Percentage in same cluster 
C6 99 74 55 53 
C8 99 91 76 68 
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crystallisation screens and conditions. The repeated analysis of crystallisation data 
should allow this metric to be updated to more accurately reflect crystallisation 
parameter space. 
  
  
192 
 
10. Conclusions and the Future 
Crystallisation is essential for the determination of protein structures by X-ray 
crystallisography. In this thesis some of the problems associated with protein 
crystallisation are discussed along with methods to potentially reduce the high 
attrition rates for this process.  
 
Protein crystallisation solutions are typically recorded in terms of severable 
variables, the chemicals species, the chemical concentration and the pH of the buffer 
or a component that has had its pH modified. The pH is known to be an important 
variable but it is well known that the recorded buffer pH can be inaccurate 
(Bukrinsky & Poulsen, 2001, Newman, Sayle, et al., 2012). Using spectrophotometry 
and the acid-base indicator bromothymol blue, we have shown that the pH of 
crystallisation solutions can be determined accurately, efficiently and quickly. This 
allows conditions to be replicated without the requirement for a pH meter. 
 
The inaccurate recording of pH in databases has meant that any analysis of such data 
is also likely to be erroneous. Inaccurate entries were recorded in data at 
AstraZeneca, the Structural Genomics Consortium, Oxford and the world's largest 
repository of successful crystallisation data - the Protein Data Bank. Many studies 
have reported the distribution of buffer pH (Samudzi et al., 1992, Rupp & Wang, 
2004, Bonneté, 2007), however, drawing conclusions from these distributions could 
be misleading. Kantardjieff and Rupp (2004) also reported a link between the pH at 
which a protein would crystallise and its isoelectric point (pI). We were able to 
develop a method to predict a pH as accurate as that of the spectrophotometric pH 
from the buffer pH using linear regression and machine learning. Using neural 
networks to associate input combinations of chemical with output pH values, it has 
been possible to achieve a more accurate prediction of the true pH than that of the 
buffer. We were then able to reinvestigate some of the results that have been 
previously reported. 
 
Using the newly modelled pH, with custom experiments, data from the SGC and the 
PDB it has been possible to examine the fiercely contested link between a protein's 
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pI and the pH of crystallisation. A lack of correlation between pI and pH was 
confirmed, however, some patterns were observed. Such information could aid the 
identification of suitable initial conditions and, therefore, could help reduce attrition 
rates. 
 
Proteins can be grouped into distinct categories according to the stage of 
crystallisation they reached. Some protein crystals were of sufficient quality to be 
used for structure determination while others crystallised and were never followed 
up. Although attempts to classify proteins into these categories were not successful, 
it was possible to classify proteins as crystallisable or non-crystallisable based on 
properties intrinsic to their sequence. Three properties were deemed to have the most 
predictive power: pI, GRAVY and the number of cysteines. This analysis involved 
the use of data from TargetDB (TargetDB, 2010), which provided both positive and 
negative data. Using a neural network we achieved a correct classification rate of 
around 70%, comparable to other published results. However, when the trained 
classifier was using data from the PDB we found that the classification algorithm 
only returned the correct result for 55%, a percentage that could have been achieved 
through guessing. We suggest that this is because the data used to train the network 
included proteins that were annotated as having "Diffraction-quality Crystals", but 
not annotated with "In PDB" in the "Status" field. The structural genomics targets in 
TargetDB may be restricted, for example due to interest in particular medical 
interests (human proteins, for example, which do not over-express in bacteria), 
whereas structures deposited in the PDB are from a wider, and potentially more 
difficult to crystallise, range of proteins. 
 
Chemical parameters were also explored and, using data from AstraZeneca and the 
PDB, it was possible to confirm that PEGs, especially PEG 3350, were the 
crystallisation reagents that were the most successful. Other successful crystallisation 
reagents include ammonium sulfate and buffers (assumed to be chemically inert). We 
obtained these results through the use of a previously proposed metric, propensity 
analysis (Rupp & Wang, 2004) and minimal set analysis. The minimal set of 
conditions, obtained by mining the Protein Data Bank, builds on the work of Jancarik 
and Kim and could help increase the number of proteins crystallised. 
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Using minimal spanning analysis of a set of approximately 9,000 proteins and their 
crystallisation conditions in the PDB it was possible to create a screen that if used 
from the onset of time would have crystallised over 2,000 of these proteins. The 
conditions for this screen were analysed using the C6 metric, giving an internal 
diversity score of 0.9, which is comparable to other commercially available screens. 
Initial trials have proven successful at AstraZeneca and YSBL, where crystalline 
material has been obtained for 23/31 (74%) of the proteins trialled. There is the 
potential for it to become an integral part of their initial screening protocol. The 
conditions of the screen are hosted on the C6 web tool (Newman et al., 2010). 
 
We also explored the possibility to reduce the number of variables in crystallisation 
parameter space by determining which chemical species are similar when 
crystallising biomolecules. This would help in the development of screens. It was 
possible to develop further the C6 metric, which compares crystallisation conditions 
and provides a distance between 0 and 1 (Newman et al., 2010). Using custom 
experiments and data from AstraZeneca, analysis was performed on the similarity of 
PEGs and ions. It was possible to develop the C6 metric, using this analysis, to fit the 
patterns observed in crystallisation screens more accurately. 
 
The development of a high-throughput method of measuring pH highlighted 
problems with a common acid-base indicator, Universal Indicator. This indicator 
covers a large pH range, but has very little colour change over neutral pHs- those 
most used in crystallisation. We found that the indicator Bromothymol Blue does 
show differences over this range, but has no observable colour change for pH values 
below 5 or above 8. Further experiments with combinations of indicators or the use 
of a multi-well tray to test several indicators simultaneously would allow an even 
more accurate method of determining pH. 
 
Using models to predict the effect of various additives within a solution provides a 
more useful estimate of the measured pH than that of the buffer. This work could be 
extended to further groups of chemicals to build more models and allow subtler 
effects to be taken into account. With regards to buffers, it might also be possible to 
determine which buffers maintain pH when placed in solution with an increasing 
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concentration of strong acid or base. It may also be possible to determine the 
different effects that buffers have on crystallisation other than controlling pH. 
 
The difference between the proteins and their properties at Structural Genomics (SG) 
centres and the Protein Data Bank needs to be explored further in order to explain 
why some proteins can be classified as crystallisable or non-crystallisable whereas 
some cannot. There have been several studies using SG data (Page & Stevens, 2004, 
Chen et al., 2004, Kimber et al., 2003) and it seems that machine learning algorithms 
trained on data from these centres does not generalise to other more varied proteins 
being explored elsewhere. Although the use of such properties has been shown to 
provide information on a proteins propensity to crystallise, it is known that even 
slight modifications to a protein sequence can affect crystallisability. 
 
The standardised PDB facilitates data mining studies and could be used to investigate 
further indicators of a proteins ability to crystallise including, for example, molecular 
weight and domain structure. Is low molecular weight better than high molecular 
weight, are single domain proteins more likely to crystallise than multi-domain 
proteins and is an oligomeric state multimer better than a monomer? We have seen 
that the most widely used crystallisation agents include both ‘salting-in’ and ‘salting-
out’ chemicals and further investigations could explore any links between protein 
properties and salt types. Where similar proteins have been crystallised in multiple 
conditions, potentially in different crystal forms, any link between the resolution of 
diffraction and the crystallisation conditions could be investigated.  
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Appendix A 
Features for Predicting a Protein’s Propensity to Crystallise 
 
Feature Set  Features 
fsOur87 Length, molecular weight, isoelectric point, instability index, 
aliphatic index, Grand Average of Hydropathy (GRAVY), 
count of 20 standard amino acids, count of 20 standard amino 
acids normalised by sequence length, mean entropy (3 
features), total number of charged residues (2 features), number 
of different types of amino acids (8 features), number of atom 
counts (6 features), extinction coefficient (4 features), half-life 
(3 features), net charge (15 features). 
fsUncorrelated Isoelectric point, instability index, aliphatic index, GRAVY, the 
amino acids A, R, N, D, C, Q, G, H, I, K, M, F, S, T, Y, the 
number of sulfurs each sequence had, the number of small, 
aromatic, aliphatic and proline amino acids, extinction 
coefficient (1 feature), half-life (3 features), count of 20 
standard amino acids normalised by sequence length, mean 
entropy (1 feature), the net charge at pH, 4,6,10,12 and 14. 
fsOB Isoelectric point, GRAVY. 
fsParCrys Isoelectric point, GRAVY, count of amino acids S, C, G, F, Y, 
M, T, H, D, W, P. 
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fsCRYSTALP The following amino acids, where - is indicative of another 
unnamed amino acid. 
Y, DL, EH, LR, PD, RI, RT, SS, WC, YT, H-H, I-C, L-E, Q-L, 
T-E, T-T, Y-F, E--C, F--Q, I--P, L--E, Q--S, S--L, T--G, W--V, 
Y--N, A---G, C---L, E---L, E---Q, H---S, L---D, M---A, N---I, 
N---Q, C----S, D----N, F----T, G----R, I----G, M----A, M----Y, 
N----H, T----G, T----Y, V----T. 
fsCRYSTALP2 The following amino acids, where - is indicative of another 
unnamed amino acid. 
Isoelectric point, GRAVY, L, Y, RI, DL, QG, QM, ES, GL, 
HH, IR, LF, LS, PP, SS, SV, WC, WM, WW, WV, YI, YT, R-
S, D-L, C-A, Q-L, H-R, H-G, H-H, I-R, L-E, F-S, T-K, T-S, T-
T, D--M, H--C, H--H, L--N, K--W, S--L, T--G, W--W, Y--N, 
R---D, Q---C, E---Q, E---S, G---H, L---D, L---L, F---T, Y---I, 
V---Y, C----E, C----H, C----S, E----Q, E----F, G----R, I----E, L-
---L, M----Y, M----V, S----H, W----H, W----M, V----T, EFV, 
IVV, TKV, R-PS, Q-QQ, K-TV, M-DS, F-TK, P-PE, DP-V, 
LR-F, MG-S, SA-D, YV-E, VT-G, N-P-G, K-I-R, F-E-F,S-T-S. 
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Appendix B 
List of conditions for PDB Minimal Spanning Screen 
 
A Number of proteins contributed 
B Predicted pH 
C Buffer pH 
  
A B C Conditions 
69 8.0 8.5 30% (w/v) polyethylene glycol 4000; 0.1 M tris chloride; 0.2 
M magnesium chloride 
56 7.9 8.5 0.1 M tris chloride; 0.2 M sodium acetate; 30% (w/v) 
polyethylene glycol 4000 
52 6.7 7.5 20% (w/v) polyethylene glycol 4000; 10% (v/v) 2-propanol; 
0.1 M hepes 
45 5.5 5.5 25% (w/v) polyethylene glycol 3350; 0.1 M bis-tris 
43 5.5 5.5 0.2 M magnesium chloride; 0.1 M bis-tris; 25% (w/v) 
polyethylene glycol 3350 
43 7.7 8.5 2 M ammonium sulfate; 0.1 M tris chloride 
42 6.5 6.5 20% (w/v) polyethylene glycol 8000; 0.1 M sodium 
cacodylate; 0.2 M magnesium acetate 
39 5.2 4.6 30% (w/v) polyethylene glycol 4000; 0.1 M sodium acetate; 
0.2 M ammonium acetate 
38 6.5 6.5 1.6 M ammonium sulfate; 0.1 M mes; 10% (v/v) dioxane 
37 5.7 5.5 0.2 M ammonium acetate; 0.1 M bis-tris; 25% (w/v) 
polyethylene glycol 3350 
35 5.5 5.5 25% (w/v) polyethylene glycol 3350; 0.2 M sodium chloride; 
0.1 M bis-tris 
34 5.5 4.6 0.1 M sodium acetate; 2 M ammonium sulfate 
32 5.5 5.5 0.1 M bis-tris; 0.2 M lithium sulfate; 25% (w/v) polyethylene 
glycol 3350 
29 6.5 6.5 12% (w/v) polyethylene glycol 20000; 0.1 M mes 
28 6.3 6.5 0.2 M magnesium chloride; 0.1 M bis-tris; 25% (w/v) 
polyethylene glycol 3350 
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28 7.4 7.5 2 M ammonium sulfate; 2% (v/v) polyethylene glycol 400; 0.1 
M hepes 
27   2 M ammonium sulfate 
27 5.2 5.6 20% (w/v) polyethylene glycol 4000; 20% (v/v) 2-propanol; 
0.1 M sodium citrate 
27 5.2 4.6 0.2 M ammonium sulfate; 0.1 M sodium acetate; 25% (w/v) 
polyethylene glycol 4000 
27 6.4 6.5 30% (w/v) polyethylene glycol 8000; 0.1 M sodium 
cacodylate; 0.2 M ammonium sulfate 
27 5.7 5.5 0.2 M ammonium sulfate; 0.1 M bis-tris; 25% (w/v) 
polyethylene glycol 3350 
26 6.3 6.5 0.1 M bis-tris; 0.2 M ammonium sulfate; 25% (w/v) 
polyethylene glycol 3350 
26 8.0 8.5 30% (w/v) polyethylene glycol 4000; 0.2 M magnesium 
chloride; 0.1 M tris 
25 5.7 5.6 0.2 M ammonium acetate; 0.1 M sodium citrate; 30% (w/v) 
polyethylene glycol 4000 
24 7.2 7.5 0.2 M magnesium chloride; 0.1 M hepes; 25% (w/v) 
polyethylene glycol 3350 
24 6.6 6.5 30% (w/v) polyethylene glycol monomethyl ether 5000; 0.2 M 
ammonium sulfate; 0.1 M mes 
23 6.3 4.6 0.1 M sodium acetate; 2 M sodium formate 
22 7.1 7.5 8% (v/v) ethylene glycol; 10% (w/v) polyethylene glycol 
8000; 0.1 M hepes 
22 7.3 7.5 20% (w/v) polyethylene glycol 10000; 0.1 M hepes 
21 6.6 6.5 20% (w/v) polyethylene glycol monomethyl ether 5000; 0.1 M 
bis-tris 
20 6.1 6 20% (w/v) polyethylene glycol 8000; 0.1 M mes; 0.2 M 
calcium acetate 
20 5.2 4.6 30% (v/v) 2-methyl-2,4-pentanediol; 0.1 M sodium acetate; 
0.02 M calcium chloride 
20 8.0 8.5 0.2 M magnesium chloride; 0.1 M tris chloride; 25% (w/v) 
polyethylene glycol 3350 
20 7.9 7.5 0.1 M hepes; 1.4 M trisodium citrate 
20 5.1 4.6 0.1 M sodium acetate; 30% (w/v) polyethylene glycol 
monomethyl ether 2000; 0.2 M ammonium sulfate 
20 8.0 8.5 0.2 M lithium sulfate; 0.1 M tris chloride; 30% (w/v) 
polyethylene glycol 4000 
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19 7.1 7.5 0.1 M hepes; 25% (w/v) polyethylene glycol 3350 
18 7.2 7.5 28% (v/v) polyethylene glycol 400; 0.2 M calcium chloride; 
0.1 M hepes 
18 7.0 7 2.4 M sodium malonate 
18 7.9 7.5 0.1 M hepes; 1.4 M sodium citrate 
17 5.9 5.6 2 M ammonium sulfate; 0.1 M sodium citrate; 0.2 M 
potassium sodium tartrate 
17 6.9 7.5 0.2 M ammonium sulfate; 25% (w/v) polyethylene glycol 
3350; 0.1 M hepes 
16 7.0 6.5 1 M sodium citrate; 0.1 M sodium cacodylate 
16   0.1 M sodium chloride; 0.005 M dithiothreitol; 0.02% (v/v) 
sodium azide; 0.01 M tris chloride 
16 8.2 8.5 20% (w/v) polyethylene glycol 8000; 0.2 M magnesium 
chloride; 0.1 M tris 
16 5.9 5.5 0.1 M sodium citrate; 20% (w/v) polyethylene glycol 3000 
16 5.3 4.6 0.1 M sodium acetate; 8% (w/v) polyethylene glycol 4000 
16 7.2 7.5 10% (w/v) polyethylene glycol 6000; 5% (v/v) 2-methyl-2,4-
pentanediol; 0.1 M hepes 
16 5.7 5.5 0.1 M bis-tris; 2 M ammonium sulfate 
15 6.2 5.5 1 M ammonium sulfate; 0.1 M bis-tris; 1% (w/v) polyethylene 
glycol 3350 
15 7.7 7.5 1.5 M lithium sulfate; 0.1 M hepes 
15 6.9 7.5 25% (w/v) polyethylene glycol 3350; 0.1 M hepes; 0.2 M 
ammonium acetate 
15 7.3 7.5 20% (w/v) polyethylene glycol 8000; 0.1 M hepes 
15 6.3 6.5 25% (w/v) polyethylene glycol 3350; 0.2 M lithium sulfate; 
0.1 M bis-tris 
15 7.2 7.5 0.2 M lithium sulfate; 0.1 M hepes; 25% (w/v) polyethylene 
glycol 3350 
14 7.6 9 2.4 M ammonium sulfate; 0.1 M bicine 
14 6.2 6.5 0.1 M bis-tris; 0.05 M calcium chloride; 30% (v/v) 
polyethylene glycol monomethyl ether 550 
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14 7.2 7.5 30% (v/v) polyethylene glycol 400; 0.2 M magnesium 
chloride; 0.1 M hepes 
14 8.0 8.5 30% (w/v) polyethylene glycol 4000; 0.2 M lithium sulfate; 
0.1 M tris 
14 6.7 6.5 1.6 M magnesium sulfate; 0.1 M mes 
14 6.5 6.5 18% (w/v) polyethylene glycol 8000; 0.1 M sodium 
cacodylate; 0.2 M calcium acetate 
14 6.8 6.5 2 M ammonium sulfate; 0.1 M bis-tris 
14 6.4 6.5 30% (w/v) polyethylene glycol 8000; 0.1 M sodium 
cacodylate; 0.2 M sodium acetate 
13 6.1 6.5 0.1 M bis-tris; 28% (w/v) polyethylene glycol monomethyl 
ether 2000 
13 7.8 8 10% (w/v) polyethylene glycol 8000; 0.1 M imidazole; 0.2 M 
calcium acetate 
13   60% (v/v) tacsimate 
12   2.1 M dl-malic acid 
12   0.15 M dl-malic acid; 20% (w/v) polyethylene glycol 3350 
12 6.8 6.5 2 M ammonium sulfate; 0.2 M sodium chloride; 0.1 M sodium 
cacodylate 
12   4 M sodium formate 
11 7.1 6.5 1.4 M sodium acetate; 0.1 M sodium cacodylate 
11 7.2 7.5 0.2 M sodium chloride; 0.1 M hepes; 25% (w/v) polyethylene 
glycol 3350 
11 7.4 7.5 4.3 M sodium chloride; 0.1 M hepes 
11   20% (w/v) polyethylene glycol 3350; 0.2 M ammonium 
chloride 
11   20% (w/v) polyethylene glycol 3350; 0.2 M sodium formate 
10 6.4 6.6 0.2 M ammonium formate; 20% (w/v) polyethylene glycol 
3350 
10 7.0 7.3 0.2 M calcium acetate; 20% (w/v) polyethylene glycol 3350 
10 5.9 5.6 0.2 M potassium sodium tartrate; 0.1 M trisodium citrate; 2 M 
ammonium sulfate 
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10 6.4 6.5 1.8 M ammonium sulfate; 0.01 M cobalt chloride; 0.1 M mes 
10 6.7 10.5 1.2 M sodium dihydrogen phosphate; 0.8 M dipotassium 
hydrogen phosphate; 0.1 M caps; 0.2 M lithium sulfate 
10 6.3 6.5 40% (v/v) polyethylene glycol 300; 0.1 M sodium cacodylate; 
0.2 M calcium acetate 
10 5.5 4.5 0.1 M sodium acetate; 2 M ammonium sulfate 
10 6.5 7.5 0.1 M hepes; 70% (v/v) 2-methyl-2,4-pentanediol 
10 6.7 7.5 20% (w/v) polyethylene glycol 4000; 10% (v/v) 2-propanol; 
0.1 M sodium hepes 
10 8.0 8.5 25% (w/v) polyethylene glycol 3350; 0.2 M magnesium 
chloride; 0.1 M tris 
10 7.4 7.5 0.1 M sodium hepes; 2% (v/v) polyethylene glycol 400; 2 M 
ammonium sulfate 
10 6.3 6.5 0.1 M bis-tris; 0.2 M sodium chloride; 25% (w/v) polyethylene 
glycol 3350 
10 7.7 8.5 2 M ammonium sulfate; 0.1 M tris 
9 5.1 4.5 30% (w/v) polyethylene glycol 8000; 0.1 M sodium acetate; 
0.2 M lithium sulfate 
9 6.1 6 20% (w/v) polyethylene glycol 6000; 1 M lithium chloride; 0.1 
M mes 
9 6.9 4.6 3.5 M sodium formate; 0.1 M sodium acetate 
9 8.6 9.5 0.1 M ches; 20% (w/v) polyethylene glycol 8000 
9 9.0 9.5 1 M sodium citrate; 0.1 M ches 
9 4.8 4.2 20% (w/v) polyethylene glycol 1000; 0.2 M lithium sulfate; 
0.1 M phosphate-citrate 
9 8.0 7 2.8 M sodium acetate 
9 7.2 6.5 1.6 M sodium citrate 
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Appendix C 
The Changing pH of PEGs Overtime  
It is known that the pH of a crystallisation solution can be imperative to the success 
of trial. Many crystallisation solutions are unbuffered or contain a buffer at a 
concentration that is not capable of stabilising the pH with some chemicals. 
Chemicals such as dihydrogen-, hydroxide-, and weak acid salts modify the pH most, 
but ammonia-containing compounds and PEGs undergo degradation overtime and 
therefore modify the pH in an unpredictable manner. PEGs are the most successful 
crystallisation reagents, their inclusion in screens is common and so their potential to 
modify pH is of particular interest. Here, we assess the effects of storage conditions 
on PEGs of various molecular weights that were purchased from four different 
suppliers as shown in Table 20. 
 
Aldrich (A) Fluka (F) Hampton Research (HR) Molecular Dimensions (MD) 
2000 (S) - - 2000 
2000 MME (S) - 2000 MME 2000 MME 
- 4000 (S) 4000 (S) 4000  
10000 (S) 10000 (S) 10000 10000 
 
- Unavailable  
(S) Solid form 
 
Table 20: The different weight PEGs purchased from various suppliers. 
 
Those PEGs that were purchased in a solid form (waxy granules) were made up to a 
50% weight per volume solution by dissolving the granules in warmed ultrapure 
water and allowing cooling to room temperature. PEGs purchased as solutions were 
also 50% (w/v). For each available molecular weight from each manufacturer, 
solutions were dispensed into twelve 5ml polystyrene containers with a plastic screw 
cap and the pH measured immediately from two aliquots using a pH meter. The 
remaining ten containers (for each molecular weight and manufacturer) were stored 
in pairs in the following conditions: 
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 FD: -18°C and dark (freezer) 
 DC: 6°C and dark (cold room cupboard) 
 LC: 6°C and light (cold room shelf) 
 DR: 20°C and dark (laboratory cupboard) 
 LR: 20°C and light (laboratory shelf) 
 
After 115 days, two containers (for each molecular weight and manufacturer) were 
removed from storage and the pH measured. This was repeated after a further 78 
days (193 days from dispensation).  
 
Results 
 
t 0 115 193 
 
1 2 1 2 1 2 
A-2000-DC 7.7 7.8 7.9 7.9 8.2 8.3 
A-2000 MME-
DC 
8.3 8.3 6.8 6.9 8.3 8.4 
A-10000-DC 6.2 6.3 6.0 5.9 6.0 6.0 
 
(a) The pH measurements for PEGs purchased from Aldrich stored in the cold and 
dark. 
t 0 115 193 
 A-2000-DC 7.8 7.9 8.2 0.4 
A-2000 MME-
DC 
8.3 6.8 8.4 0 
A-10000-DC 6.2 5.9 6 0.2 
 
(b) The pH measurements for each initial and last time interval averaged, with the 
maximum absolute difference in measurements shown in red. 
Table 21: pH measurements for PEGs purchased from Aldrich. 
The pH measurements for PEG 2000 purchased from Aldrich and stored in the fridge in a 
cupboard (dark cold). Table (a) shows the raw data and table (b) shows how it was averaged. 
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In addition to the PEGs shown in Table 21, PEG 400 was also purchased from each 
supplier. However, we found that it was not possible to obtain a stable pH 
measurement at this molecular weight and therefore, the pH of PEG 400 is not 
included here.  
 
Table 21 shows an example set of recordings and how they were averaged and 
analysed. Whilst the pH for PEG 2000 gradually increased over the 193 days from an 
average of pH 7.8 to 8.2, increasing 0.4 pH units overtime, whereas PEG 2000 MME 
only changed by 0.04 pH units, well within the error expected for a pH meter.  
 
Figure 72a shows the pH measurement for each time point averaged over all storage 
conditions and all manufacturers supplying the different molecular weights. The 
results suggest that, on average, the pH of PEG 4000 changes most from a basic pH 
of 7.3 to an acidic one of 6.3. The smallest change in pH is for PEG 10000 which 
remains constant around the already acidic pH of 5.5.  
 
 
(a) Each molecular weight averaged over manufacturer and storage conditions. 
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(b) Each manufacturer averaged over molecular weight and storage conditions. 
 
(c) Each storage condition averaged over molecular weight and manufacturer. 
 
Figure 72: The change in pH over time associated with different parameters. 
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The pH measurements were averaged over combinations of the three major parameters: 
molecular weight, manufacturer and storage conditions. (a) shows the results for each 
molecular weight averaged over manufacturer and storage conditions. (b) shows the results 
for each manufacturer averaged over molecular weight and storage conditions. (c) shows the 
results for each storage condition averaged over molecular weight and manufacturer. The 
error bars shown are standard error, defined as the standard deviation over the square root of 
the number of observations. 
 
The measurements were also averaged over all molecular weights and storage 
conditions to determine any patterns due to manufacturer (Figure 1b) and over all 
molecular weights and manufacturers to examine differences between storage 
conditions. Figure 72b shows that the chemicals obtained from Fluka (F) and 
Hampton Research (HR) become more acidic, whereas those from Molecular 
Dimensions (MD) and Aldrich (A) seem to remain constant. For the storage 
conditions, the largest change in pH is seen for PEGs stored at room temperature, 
with averages for both light and dark falling from around pH 6.7 to 5.3. On the other 
hand the chemicals stored in the cold became slightly more basic from an average 
around 6.7 increasing to a more neutral pH. 
 
Taking the mean absolute difference (MAD) between the time of dispensation and 
the final measurement provides summary statistics for the PEGs by molecular 
weight, manufacturer and storage method. The PEG weights which changed the least 
across all storage methods and all manufacturers were PEG 2000 and 10000, with a 
MAD of 0.73 for both. The largest MAD of 1.3 was for PEG 4000, as shown in 
Figure 72. However, the largest MADs for the manufacturers were Molecular 
Dimensions (1.3) and the smallest Aldrich (0.45). On closer inspection we found that 
the MD solutions change in both an acidic and a basic direction creating an illusion 
of little change. For example, MD 2000 which was frozen or in the fridge became 
more basic by at least half a unit and MD 2000 which was at room temperature 
became more acidic by over 1.5 units. The storage method with the lowest MAD was 
dark and cold with a value of 0.5, similarly low was frozen (0.6) and light cold (0.5) 
and the largest MAD was for light room of 1.6 and dark room 1.4 as suggest by the 
graph in Figure 72. Those PEGs that were made up from solid had a MAD of 0.7 and 
those already in solution of 1.1. On an individual basic, MD-4000-DR changed 3.2 
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units from pH 7.3 to 4.1, whereas HR-2000 MME-DC only changed in the 
hundredths of the measurement. 
 
Conclusions 
 
Manufacturers (MolecularDimensions, 2015) suggest that light can affect PEG 
solutions: 
 
“PEG solutions are light sensitive and can degrade over time if kept in 
the light. Therefore, we recommend keeping them in the dark.” 
 
Our results suggest that it is temperature rather than light that causes the largest 
change in the pH of PEGs. Storage in both light and dark gave similar results for a 
given temperature. Certain molecular weights, PEG 4000 and PEG 2000 MME have 
a pH that is susceptible to change, whereas PEG 10000 appears to be more stable 
and, therefore, requires less monitoring. It might be possible to conclude that the 
purchasing of chemicals in their dry form from Aldrich and Fluka (where available) 
and making them up might results in a more consistent PEG pH. It is possible, as 
shown in Figure 73, that PEGs in solution are already undergoing change, as 
suggested supported by the average initial pH for liquid (on purchased) PEGs being 
6.2, whereas those solid PEGs (we made into solutions) having an initial average pH 
of 7.1, which is closer to the expected neutral. Through continued monitoring it will 
be possible to determine any longer term effects due to differences in molecular 
weight, manufacturer and storage method.  
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Figure 73: The pH of PEGs for the two different forms purchased. 
PEGs were purchased in either granular (solid) form or liquid form (premade solution). The 
solid PEGS that we made into solution have a more neutral pH than those premade. Initially, 
the standard deviation of both types is 0.87. Standard error bars are shown. 
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